data_2msg_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2msg _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 10.6 mm-40 . . . . . 0 CA--C 1.516 -0.36 0 CA-C-O 120.986 0.422 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.429 ' CD1' ' CG ' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -142.1 136.75 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.432 ' HB3' ' HG1' ' A' ' 66' ' ' THR . 6.3 m-30 -108.2 136.13 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.939 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.99 133.59 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -106.29 134.02 50.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.939 0.399 . . . . 0.0 110.976 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 p -117.14 150.85 38.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.156 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.66 -3.87 3.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.9 m -91.12 -8.97 47.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.39 78.16 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -77.42 124.57 28.06 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.675 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -82.31 121.21 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.228 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.4 tt -120.1 129.46 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.712 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 p -117.21 137.76 52.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.755 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -115.48 147.17 40.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.9 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.91 109.85 22.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG21 ' O ' ' A' ' 18' ' ' GLU . 11.0 p -149.88 175.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.836 -177.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.648 ' O ' HG21 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -102.0 173.95 3.22 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.1 Cg_exo -74.51 -6.49 18.36 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 CA-C-N 120.751 1.304 . . . . 0.0 110.92 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.736 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -77.22 -27.34 53.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 116.833 -1.947 . . . . 0.0 105.745 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.684 ' O ' HD11 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 31.57 64.01 0.22 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.551 168.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -83.73 135.89 34.39 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 114.903 -2.719 . . . . 0.0 106.469 -175.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.671 HG13 ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -52.78 -41.07 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.203 -1.817 . . . . 0.0 110.843 -173.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.511 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 0.0 OUTLIER -61.6 -30.0 70.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 22' ' ' THR . 11.1 t30 -79.28 -46.02 18.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.995 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.654 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.3 t -72.47 -45.64 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.08 0.467 . . . . 0.0 110.172 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' ILE . 2.7 mmtm -54.83 -51.86 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.367 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.22 -35.99 70.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.512 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -64.23 -36.68 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 26' ' ' VAL . 73.3 mt -75.88 -28.93 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.547 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.588 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -56.72 -35.29 68.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -44.75 73.09 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -60.92 -52.28 65.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 56.1 mt-10 -146.65 154.24 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.94 116.64 4.65 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 119.042 -1.551 . . . . 0.0 111.241 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.588 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 2.7 pp -149.47 117.25 3.72 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.13 131.06 16.13 Favored 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.911 1.741 . . . . 0.0 111.833 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 -45.29 22.59 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.908 1.739 . . . . 0.0 111.926 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.55 -16.71 40.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.621 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -111.09 -15.72 13.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.165 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.525 ' OE1' ' CD1' ' A' ' 36' ' ' ILE . 52.4 tt0 -111.4 138.32 48.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 mtp-105 -128.48 144.85 51.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.745 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.516 HD22 ' HZ3' ' A' ' 27' ' ' LYS . 18.0 mt -116.27 174.47 6.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -134.75 138.27 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.507 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.36 117.31 21.96 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.721 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 44.66 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.31 -20.38 17.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -78.55 135.41 37.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -84.65 118.75 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.39 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.475 HD23 ' CE2' ' A' ' 59' ' ' TYR . 13.2 mt -81.05 146.31 30.69 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.671 ' O ' HG13 ' A' ' 23' ' ' ILE . 2.6 mt-10 -96.62 -173.33 2.71 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -54.97 8.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 111.343 -2.662 . . . . 0.0 114.306 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 23' ' ' ILE . . . 121.58 43.05 0.43 Allowed Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.708 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mmt-85 -83.12 165.62 19.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 172.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 m -87.27 142.32 27.99 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 116.96 -1.896 . . . . 0.0 111.124 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.684 HD11 ' O ' ' A' ' 21' ' ' ASP . 3.2 mp -76.97 -33.53 57.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.409 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.736 ' H ' ' HA ' ' A' ' 20' ' ' SER . 15.8 m -57.53 -36.11 71.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -24.14 64.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.475 ' CE2' HD23 ' A' ' 50' ' ' LEU . 2.8 m-85 -83.49 6.53 19.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.51 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.6 43.2 28.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.182 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.458 HG13 ' CD2' ' A' ' 56' ' ' LEU . 20.7 mm -65.73 140.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 122.181 0.991 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.825 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 23.3 tt0 -94.47 -176.49 3.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.35 -1.75 . . . . 0.0 113.254 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.825 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.2 tmtm? -41.15 25.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.546 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.771 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.3 pt-20 91.01 53.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.265 1.031 . . . . 0.0 113.429 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.61 152.62 18.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.43 177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.432 ' HG1' ' HB3' ' A' ' 4' ' ' PHE . 30.8 m -86.71 119.36 26.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.167 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 4.8 mp -98.8 131.13 45.16 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -120.32 138.56 53.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.933 0.397 . . . . 0.0 111.227 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.458 ' H ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.192 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 . . . . . 0 C--O 1.23 0.07 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -117.13 151.35 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.316 0.579 . . . . 0.0 110.261 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -139.95 132.47 28.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.646 -179.005 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.543 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 87.8 t -119.79 132.3 69.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -101.87 121.86 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.926 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p -89.32 161.34 16.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.34 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.35 -4.81 28.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -95.72 1.76 53.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.97 -4.01 63.16 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -72.61 123.08 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.834 0.35 . . . . 0.0 110.281 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -91.95 125.01 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.973 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 1.2 tp -119.03 121.62 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.788 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 p -110.79 133.08 53.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 145.9 42.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.635 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 8.4 mp0 -96.25 110.68 22.95 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.1 p -150.52 149.61 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.764 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.938 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.4 pm0 -70.55 177.04 1.55 Allowed Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.0 Cg_exo -74.49 -6.56 18.46 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 121.584 1.522 . . . . 0.0 111.868 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 56' ' ' LEU . 83.2 p -78.82 -27.32 44.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 116.365 -2.134 . . . . 0.0 107.647 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.938 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 31.54 67.86 0.13 Allowed 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.885 169.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.637 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.14 133.4 36.06 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 114.331 -2.947 . . . . 0.0 106.097 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.571 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -54.41 -35.1 29.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 112.872 -1.967 . . . . 0.0 110.744 -173.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -62.88 -33.29 74.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.637 ' HB3' ' O ' ' A' ' 22' ' ' THR . 3.4 t30 -78.86 -45.68 20.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.345 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' THR . 16.9 t -72.6 -37.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.403 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.563 ' HZ1' ' CG ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.7 -51.34 65.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.457 . . . . 0.0 110.418 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.06 -35.38 69.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.382 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -63.48 -37.77 88.57 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.16 -42.6 79.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.639 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -69.14 -32.27 71.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.716 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -58.93 -37.73 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.816 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -61.83 -54.12 46.51 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 110.736 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.639 ' O ' ' O ' ' A' ' 31' ' ' GLN . 36.9 mt-10 -140.94 176.63 8.65 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.68 113.8 3.83 Favored Glycine 0 CA--C 1.51 -0.252 0 C-N-CA 118.532 -1.794 . . . . 0.0 110.637 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.403 HG23 HD11 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -151.83 118.86 3.21 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.67 130.14 16.6 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 120.564 0.843 . . . . 0.0 111.722 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 3.3 Cg_exo -57.82 -34.46 98.29 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.047 1.831 . . . . 0.0 111.597 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -66.57 -26.75 67.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.044 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -104.42 0.67 29.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.814 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.501 ' NE2' ' N ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -104.71 126.74 52.09 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.597 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.501 ' N ' ' NE2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.08 142.43 50.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.563 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 7.2 mt -118.44 162.42 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.7 mt -136.03 139.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.27 119.44 17.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.287 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 35.41 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.336 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.98 -19.7 24.46 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -82.18 116.84 21.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.397 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.37 127.77 33.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -76.73 127.76 33.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.571 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 1.2 mp0 -81.65 -169.81 2.51 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -48.8 6.09 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 111.646 -2.524 . . . . 0.0 115.09 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 117.85 44.1 0.55 Allowed Glycine 0 C--N 1.316 -0.534 0 C-N-CA 119.93 -1.129 . . . . 0.0 111.964 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -81.67 159.14 24.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -79.08 141.17 37.58 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 116.916 -1.914 . . . . 0.0 110.039 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.71 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.2 mm? -74.52 -32.5 62.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.985 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.673 ' N ' ' O ' ' A' ' 19' ' ' PRO . 7.2 t -54.77 -30.71 57.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.98 -29.29 64.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 19.0 m-85 -79.4 -6.39 56.73 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.66 44.64 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.843 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.507 HG12 HD12 ' A' ' 56' ' ' LEU . 31.7 mm -64.43 137.66 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.947 0.879 . . . . 0.0 110.152 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 64' ' ' GLU . 10.8 pt20 -102.55 -174.37 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.714 -1.584 . . . . 0.0 114.057 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.584 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 49.1 mttt -42.05 30.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.365 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 62' ' ' GLN . 9.1 mt-10 91.38 53.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.919 0.866 . . . . 0.0 113.282 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.402 ' H ' ' HG ' ' A' ' 65' ' ' SER . 0.3 OUTLIER -63.75 153.57 35.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.745 176.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.8 t -86.24 126.68 34.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.06 139.19 35.07 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -88.49 138.04 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 111.23 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.199 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -120.61 155.65 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.613 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 2.5 t80 -137.21 132.72 34.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.857 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.6 t -128.8 146.74 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.725 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -98.34 120.63 39.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 p -87.19 161.77 17.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.187 0.518 . . . . 0.0 111.382 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.556 HD11 ' H ' ' A' ' 8' ' ' LEU . 4.6 mp -71.77 -11.8 60.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.662 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -94.01 -10.89 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.34 2.15 77.33 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -81.07 131.51 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 110.564 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.79 121.84 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 11.6 tt -115.04 122.09 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.117 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -112.74 137.64 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.057 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.75 147.83 39.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.128 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.26 109.77 21.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 18' ' ' GLU . 11.6 p -150.51 173.6 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.496 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.648 ' O ' HG22 ' A' ' 17' ' ' VAL . 2.0 mp0 -99.4 175.98 2.18 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -73.54 -7.54 20.42 Favored 'Trans proline' 0 C--N 1.288 -2.633 0 C-N-CA 121.245 1.297 . . . . 0.0 111.066 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.658 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.11 -28.21 48.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 116.542 -2.063 . . . . 0.0 106.807 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER 32.88 67.19 0.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.994 169.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -80.62 133.44 35.74 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 114.645 -2.822 . . . . 0.0 105.826 -175.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.567 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 1.1 mt -55.13 -43.58 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.015 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -59.73 -29.58 68.24 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 175.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -77.66 -44.68 27.3 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.821 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 22' ' ' THR . 10.7 t -72.25 -39.73 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.347 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.518 ' NZ ' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.53 -41.99 70.34 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.596 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.68 78.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HZ2' ' CB ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -67.25 -36.4 81.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 26' ' ' VAL . 21.1 mm -62.04 -40.35 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' O ' ' A' ' 34' ' ' GLU . 4.9 tt0 -69.1 -31.99 71.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.2 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.37 -44.64 88.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.93 -53.59 55.38 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.935 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.7 mt-10 -135.92 155.56 50.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.94 112.37 3.47 Favored Glycine 0 CA--C 1.505 -0.54 0 C-N-CA 118.529 -1.796 . . . . 0.0 110.72 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pt -152.85 119.03 2.98 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.49 128.91 32.03 Favored 'Trans proline' 0 C--N 1.287 -2.695 0 CA-C-N 118.839 0.621 . . . . 0.0 110.706 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 40' ' ' GLN . 3.3 Cg_exo -60.21 -34.91 93.67 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.934 1.756 . . . . 0.0 112.288 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.5 -8.18 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.175 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 38' ' ' PRO . 78.7 mt-30 -109.99 -12.96 14.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -83.82 126.0 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -129.38 128.28 42.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -131.61 149.75 52.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.444 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.25 143.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.604 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 41.0 t80 -120.59 115.54 23.6 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.916 0.389 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 39.22 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 -20.9 34.0 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 20.2 mttm -79.19 117.5 20.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' GLN . 12.4 pt20 -76.79 121.3 23.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.298 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.476 HD23 ' CD2' ' A' ' 59' ' ' TYR . 67.6 mt -76.99 127.03 31.96 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.567 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 22.3 mt-10 -90.63 -169.32 2.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -174.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -47.59 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 111.798 -2.456 . . . . 0.0 114.504 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.81 44.6 0.58 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.383 -176.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -81.17 160.55 24.33 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -79.37 140.44 37.46 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 116.257 -2.177 . . . . 0.0 110.34 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.2 mp -77.54 -30.46 52.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.009 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.658 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.9 t -54.96 -30.51 59.13 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.27 -27.72 62.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.242 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 56' ' ' LEU . 10.5 m-85 -79.25 -5.4 54.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.968 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.47 45.13 11.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.402 HG13 ' CD2' ' A' ' 56' ' ' LEU . 37.9 mm -64.42 136.89 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.141 0.972 . . . . 0.0 109.978 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.68 ' O ' ' N ' ' A' ' 64' ' ' GLU . 9.0 pt20 -97.53 -173.76 2.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.291 -1.777 . . . . 0.0 114.284 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.703 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 1.6 pttm -41.62 26.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 112.123 -2.308 . . . . 0.0 115.259 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.703 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER 90.64 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.875 1.321 . . . . 0.0 113.111 -178.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.4 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.5 OUTLIER -62.4 157.02 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.74 177.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.561 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.8 p -84.16 131.55 34.76 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.751 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.09 142.84 28.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.794 0.33 . . . . 0.0 110.504 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 134.99 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 179.096 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.754 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.8 mp0 . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.02 135.78 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 121.489 0.661 . . . . 0.0 110.262 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 4.3 m-30 -110.29 142.62 41.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.543 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.54 59.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -101.19 122.83 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -98.06 151.79 19.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -71.25 -10.74 60.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.13 2.41 56.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.577 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.98 15.11 78.47 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -93.49 127.57 39.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -86.55 115.92 24.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 19.1 tt -112.6 118.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.915 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.21 138.56 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.86 145.27 43.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 109.98 22.33 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 18' ' ' GLU . 11.6 p -149.64 171.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.937 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.636 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -95.8 172.48 5.22 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.649 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -75.18 -7.88 19.39 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 121.392 1.394 . . . . 0.0 111.074 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 56' ' ' LEU . 1.1 m -78.0 -27.08 48.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 116.712 -1.995 . . . . 0.0 105.805 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER 33.43 68.27 0.16 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.795 169.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -79.46 132.74 36.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 114.25 -2.98 . . . . 0.0 105.481 -175.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.56 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -55.69 -40.37 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.878 -1.965 . . . . 0.0 110.859 -173.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -60.38 -29.9 69.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -78.01 -44.58 26.18 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.956 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.578 ' O ' HG12 ' A' ' 30' ' ' ILE . 6.8 t -72.2 -35.73 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.302 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -51.85 63.8 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.808 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.71 76.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.65 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' NZ ' ' ND2' ' A' ' 25' ' ' ASN . 19.8 mttp -64.57 -36.76 85.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.2 mm -63.5 -45.7 97.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.631 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' O ' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -69.94 -33.16 71.77 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.45 -44.77 92.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -68.58 -54.5 16.18 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.766 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLN . 13.9 mm-40 -123.91 151.4 43.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.44 111.06 3.17 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 118.317 -1.897 . . . . 0.0 111.104 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 tt -154.19 117.0 2.58 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.4 129.68 32.38 Favored 'Trans proline' 0 C--N 1.288 -2.621 0 CA-C-N 119.093 0.712 . . . . 0.0 111.156 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.56 -27.48 76.96 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.095 1.863 . . . . 0.0 112.086 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.84 -27.46 68.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.017 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -107.35 7.74 29.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.54 HE21 ' N ' ' A' ' 42' ' ' ARG . 36.9 tp60 -89.19 127.01 35.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.988 0.423 . . . . 0.0 110.918 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.54 ' N ' HE21 ' A' ' 41' ' ' GLN . 55.7 mtp180 -128.23 132.84 48.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.104 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -124.06 151.44 43.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 110.762 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.5 mt -135.44 139.99 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.6 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 48' ' ' LYS . 70.7 t80 -121.75 116.4 24.44 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.584 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.09 33.54 3.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.03 -20.32 48.19 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 45' ' ' PHE . 55.2 mttm -78.15 120.38 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.901 0.381 . . . . 0.0 110.357 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -75.17 123.48 25.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -76.77 132.86 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.56 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 11.9 mt-10 -86.94 -170.6 3.14 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -49.0 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 111.595 -2.548 . . . . 0.0 114.781 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.62 44.18 0.6 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.856 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 159.32 23.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 102.874 -3.009 . . . . 0.0 102.874 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.411 HG21 ' H ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -78.29 140.36 38.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 116.179 -2.208 . . . . 0.0 109.254 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.658 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.0 mp -77.37 -31.14 54.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.368 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.654 ' H ' ' HA ' ' A' ' 20' ' ' SER . 35.6 p -55.12 -30.33 59.55 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 33.0 t0 -71.73 -26.32 62.42 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.846 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' LEU . 5.8 m-85 -79.22 3.86 16.62 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.522 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.69 40.45 19.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.423 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.97 132.17 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.031 0.92 . . . . 0.0 109.018 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.763 ' O ' ' N ' ' A' ' 64' ' ' GLU . 7.8 pt20 -96.82 -172.39 2.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.68 -1.6 . . . . 0.0 114.223 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.749 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 5.8 mmtt -41.03 26.3 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.482 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.763 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.8 pt-20 90.94 52.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.441 1.115 . . . . 0.0 113.246 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.6 OUTLIER -61.74 152.75 30.32 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.894 176.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -86.1 128.97 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -98.65 132.61 43.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -88.3 141.83 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.604 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.696 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 7.3 mt-30 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.469 0.176 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -120.74 159.96 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' A' ' 3' ' ' ILE . 5.1 t80 -140.92 134.74 30.44 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.012 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.528 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 71.4 t -130.72 141.51 46.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.84 140.4 36.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.095 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -106.15 149.44 26.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.926 0.393 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mt -72.85 -11.97 60.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 p -91.82 -10.61 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.02 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.66 -4.86 73.06 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -78.87 128.29 33.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.203 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 m -76.49 116.14 16.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.527 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 7.5 tt -115.51 113.5 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.256 0.551 . . . . 0.0 110.182 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 p -117.6 139.61 50.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.13 144.13 43.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -95.81 111.08 23.14 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.636 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 11.2 p -149.86 174.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.338 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.636 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 2.9 mp0 -100.04 177.32 1.58 Allowed Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.08 -7.62 20.08 Favored 'Trans proline' 0 C--N 1.29 -2.539 0 C-N-CA 121.459 1.439 . . . . 0.0 112.155 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.675 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -78.17 -28.47 48.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 116.238 -2.185 . . . . 0.0 106.525 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.514 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER 32.24 66.86 0.17 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.234 168.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.636 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -81.5 135.41 35.61 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 115.118 -2.633 . . . . 0.0 105.83 -176.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -54.27 -43.95 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.152 -173.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.18 -29.95 67.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 22' ' ' THR . 2.8 t-20 -78.26 -44.87 24.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.676 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.2 t -72.73 -39.42 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.638 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.616 ' HZ1' ' CD1' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -54.33 -52.05 62.76 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.153 0.501 . . . . 0.0 110.392 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.48 68.27 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.326 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -38.06 89.69 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 26' ' ' VAL . 19.4 mm -67.46 -39.79 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' O ' ' O ' ' A' ' 34' ' ' GLU . 14.9 tt0 -61.95 -34.06 75.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -59.24 -34.31 72.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.204 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.443 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 29.1 mmtt -60.17 -31.23 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.208 0.528 . . . . 0.0 109.928 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 31' ' ' GLN . 2.8 pt-20 -160.46 -116.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.54 111.4 0.52 Allowed Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.692 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.6 119.27 2.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 2.9 Cg_endo -71.76 140.45 35.57 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 121.313 1.342 . . . . 0.0 112.18 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.34 -27.7 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.131 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.11 -31.54 69.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.768 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.37 8.79 23.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' OE1' ' O ' ' A' ' 37' ' ' PRO . 3.0 mp0 -112.03 126.11 54.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.469 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -130.34 141.66 50.57 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.546 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.616 ' CD1' ' HZ1' ' A' ' 27' ' ' LYS . 16.2 mt -120.41 163.06 18.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.778 0.323 . . . . 0.0 110.69 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -135.58 143.33 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LYS . 8.2 t80 -141.47 125.08 16.79 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.774 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.44 45.74 17.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 -19.11 1.87 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -81.68 115.72 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 0.0 110.087 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.538 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -72.76 125.0 26.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.5 mt -77.3 137.38 38.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.569 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 16.4 mp0 -95.05 -171.54 2.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 5.6 t0 -47.92 7.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 111.907 -2.406 . . . . 0.0 114.599 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.71 43.46 0.53 Allowed Glycine 0 C--N 1.32 -0.361 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.884 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -82.63 161.94 22.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 20' ' ' SER . 51.9 m -85.34 143.15 28.83 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 117.188 -1.805 . . . . 0.0 111.763 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.5 mp -77.21 -32.88 56.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.999 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.675 ' H ' ' HA ' ' A' ' 20' ' ' SER . 5.4 t -55.85 -33.57 64.64 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.58 -26.91 61.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.571 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 9.7 m-85 -79.26 1.84 23.39 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 57.8 45.1 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.639 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.552 HG13 ' CD2' ' A' ' 56' ' ' LEU . 34.8 mm -64.93 139.66 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 122.111 0.957 . . . . 0.0 110.588 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.775 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 5.5 tt0 -95.25 -179.28 4.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.693 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.777 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 39.0 mttp -43.05 28.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.265 -2.243 . . . . 0.0 115.197 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.777 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.52 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.837 1.303 . . . . 0.0 112.756 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 p -61.96 154.29 26.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.055 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.88 115.9 24.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.198 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -98.16 137.97 36.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.01 142.73 31.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 2.8 mp0 . . . . . 0 N--CA 1.461 0.095 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -118.3 152.62 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.336 0.589 . . . . 0.0 109.505 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 63.3 t80 -138.89 132.51 30.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.702 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.16 140.34 49.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -128.66 144.13 51.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 110.548 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 p -115.91 173.09 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.2 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.83 -7.85 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -92.73 -11.48 33.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.592 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.44 6.49 84.12 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -61.49 132.17 52.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 t -89.51 115.36 26.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.599 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.477 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 8.1 tt -121.47 120.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.295 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 p -117.28 135.65 53.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.181 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -116.15 146.42 42.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.772 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -95.8 111.0 23.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.598 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 14.1 p -148.68 171.79 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.162 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.598 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 1.3 pm0 -105.55 153.55 39.75 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.824 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.3 Cg_endo -52.02 -8.86 0.37 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 121.881 1.721 . . . . 0.0 112.641 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 21' ' ' ASP . 5.9 t -77.61 -28.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 115.224 -2.59 . . . . 0.0 105.988 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER 31.32 65.64 0.17 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.339 168.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.633 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -81.48 132.67 35.33 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 114.374 -2.931 . . . . 0.0 105.893 -175.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 1.2 mt -54.9 -39.52 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 CA-C-N 112.686 -2.052 . . . . 0.0 110.819 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.68 -29.87 70.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.633 ' H ' ' HG1' ' A' ' 22' ' ' THR . 4.6 t-20 -78.55 -44.62 23.81 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.187 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 22' ' ' THR . 3.4 t -72.34 -32.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.223 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -50.86 -47.92 60.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -178.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.2 76.17 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.513 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -65.93 -35.98 82.09 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.3 mm -61.7 -45.56 98.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.68 -33.1 70.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.977 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -58.35 -44.85 88.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -62.76 -54.26 41.81 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.479 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 31' ' ' GLN . 75.8 mt-10 -132.59 157.21 45.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.58 111.87 3.34 Favored Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 118.445 -1.836 . . . . 0.0 110.597 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 pt -153.86 119.55 2.8 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.78 127.52 21.77 Favored 'Trans proline' 0 C--N 1.288 -2.607 0 CA-C-N 119.401 0.822 . . . . 0.0 110.977 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.57 -42.9 24.1 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.282 1.988 . . . . 0.0 112.269 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.26 -17.67 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.693 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -109.97 7.41 23.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 6.0 tp60 -116.58 128.64 55.6 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.151 0.501 . . . . 0.0 111.217 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mtp-105 -126.42 140.77 52.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.857 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.72 148.65 47.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.874 0.369 . . . . 0.0 111.28 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.94 141.33 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.97 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 48' ' ' LYS . 39.6 t80 -123.64 131.7 53.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.135 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.17 44.25 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.902 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.1 -20.64 6.54 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 45' ' ' PHE . 20.6 mtpt -79.58 138.46 37.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -92.06 121.49 33.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.726 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.29 106.04 7.69 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.544 ' C ' ' H ' ' A' ' 53' ' ' GLY . 4.1 mt-10 -69.13 -168.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 31.7 t0 -46.79 5.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 111.644 -2.526 . . . . 0.0 115.159 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.88 45.47 0.55 Allowed Glycine 0 C--N 1.318 -0.461 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.69 -176.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.75 26.92 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 172.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.454 HG21 ' H ' ' A' ' 57' ' ' SER . 1.2 m -77.87 140.91 39.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 116.382 -2.127 . . . . 0.0 110.52 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 59' ' ' TYR . 2.9 mp -76.35 -30.06 57.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.726 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.824 ' N ' ' O ' ' A' ' 19' ' ' PRO . 6.2 t -54.77 -32.8 60.53 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -72.66 -26.0 61.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.176 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 56' ' ' LEU . 7.9 m-85 -79.29 4.85 13.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.233 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.73 44.64 29.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.6 137.56 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.719 0.771 . . . . 0.0 109.669 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.71 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.9 pt20 -101.78 -173.97 2.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.304 -1.316 . . . . 0.0 113.975 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.672 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 3.4 ttpm? -41.74 28.66 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 111.867 -2.424 . . . . 0.0 115.07 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.71 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.2 pt-20 91.35 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 122.846 1.308 . . . . 0.0 112.874 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -61.63 153.77 26.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.384 177.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 m -85.51 123.86 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.85 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 6.9 mp -98.41 136.79 38.04 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 0.5 OUTLIER -83.25 135.48 34.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.875 -179.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 mt . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.108 179.738 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 59.9 mt-30 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.767 0.318 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -120.41 156.42 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 2.7 t80 -140.89 132.72 27.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.242 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 79.6 t -129.84 142.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.243 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -122.44 121.33 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.45 ' OG1' ' OG1' ' A' ' 9' ' ' THR . 3.2 p -84.17 175.1 9.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 9.9 mp -69.95 -10.04 57.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.443 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.45 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 60.9 p -91.8 -4.19 55.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.317 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.24 82.25 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -65.0 131.52 46.82 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.45 116.23 28.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.42 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 13.6 tt -120.07 122.53 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.364 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.513 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 10.1 p -116.0 139.95 49.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.738 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.99 148.1 37.5 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -94.25 109.78 21.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 18' ' ' GLU . 9.6 p -150.36 171.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.864 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.635 ' O ' HG22 ' A' ' 17' ' ' VAL . 1.6 pm0 -93.99 174.29 3.91 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.16 -5.91 17.67 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 121.293 1.329 . . . . 0.0 111.768 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.519 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.32 -28.73 57.02 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 116.226 -2.19 . . . . 0.0 105.764 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' CG2' ' A' ' 17' ' ' VAL . 3.4 m-20 32.71 64.96 0.25 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.026 168.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -84.68 137.7 33.09 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 115.849 -2.34 . . . . 0.0 107.375 -175.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 51' ' ' GLU . 1.1 mm -53.07 -40.98 40.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.311 -174.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.86 -33.12 71.39 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.618 ' HB3' ' O ' ' A' ' 22' ' ' THR . 13.6 t-20 -78.79 -46.55 18.54 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.78 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.604 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.4 t -73.51 -35.3 44.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.146 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HZ2' HD11 ' A' ' 43' ' ' LEU . 1.6 mmtm -54.3 -51.88 63.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.95 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.6 76.14 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.004 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -61.31 -36.01 78.94 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.7 mm -63.46 -45.87 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.696 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' GLU . 24.6 tt0 -69.23 -31.96 70.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.022 0.439 . . . . 0.0 111.062 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -41.67 82.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.347 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 14.6 mmtp -64.45 -54.42 32.89 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.244 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.9 mt-10 -141.22 171.69 13.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.39 112.14 3.41 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 118.647 -1.739 . . . . 0.0 110.551 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 tt -153.85 122.0 3.03 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.84 126.23 14.97 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 CA-C-N 119.392 0.819 . . . . 0.0 111.404 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 -45.56 9.5 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.649 2.233 . . . . 0.0 112.62 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.96 -27.01 66.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.448 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.68 9.2 43.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.307 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.571 HE22 ' CD2' ' A' ' 69' ' ' LEU . 2.1 tm0? -112.12 126.76 55.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.565 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -129.48 138.1 51.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.107 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.492 HD11 ' HZ2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -131.55 159.5 38.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.709 0.29 . . . . 0.0 110.265 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.6 tt -136.4 140.34 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.352 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 48' ' ' LYS . 6.5 t80 -128.57 134.68 48.69 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.11 33.9 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.925 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.6 -21.0 11.78 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 45' ' ' PHE . 5.8 mtmm -80.52 115.33 19.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -71.05 121.51 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.64 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.453 HD21 ' CE2' ' A' ' 59' ' ' TYR . 64.4 mt -77.4 114.07 15.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' A' ' 53' ' ' GLY . 16.9 mt-10 -87.95 -167.69 1.97 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -45.65 8.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 111.902 -2.408 . . . . 0.0 114.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 119.68 44.62 0.46 Allowed Glycine 0 C--N 1.318 -0.451 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.161 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 150.22 28.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -79.41 141.18 37.08 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 116.912 -1.915 . . . . 0.0 111.364 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.9 mp -78.06 -31.7 50.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.802 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.615 ' N ' ' O ' ' A' ' 19' ' ' PRO . 5.8 t -54.38 -31.59 55.15 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -72.36 -30.26 64.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.649 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 56' ' ' LEU . 6.7 m-85 -79.06 5.36 12.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 52.18 45.02 29.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.306 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 56' ' ' LEU . 24.8 mm -64.8 138.1 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.173 0.987 . . . . 0.0 110.636 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.68 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.0 pt20 -100.72 -173.31 2.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.899 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.786 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 56.8 mttm -41.24 28.66 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 111.681 -2.509 . . . . 0.0 115.749 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.786 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.94 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.859 1.314 . . . . 0.0 113.271 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -60.55 154.74 20.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.766 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.63 126.75 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 6.5 mp -98.93 134.37 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.312 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.506 ' NE2' ' O ' ' A' ' 69' ' ' LEU . 6.3 t-80 -85.84 132.48 34.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.923 0.392 . . . . 0.0 110.218 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.571 ' CD2' HE22 ' A' ' 41' ' ' GLN . 12.6 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.528 0.204 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 1.6 mt -121.11 152.44 24.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.397 0.617 . . . . 0.0 110.817 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.17 133.64 31.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.903 -179.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 89.5 t -123.82 144.24 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 111.133 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -100.58 139.57 36.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 p -115.95 161.21 19.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.622 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.99 -4.01 15.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.262 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -92.07 -14.01 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 15.16 80.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -94.0 130.94 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 t -76.82 120.21 21.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 10.0 tt -116.37 117.95 57.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.888 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -115.73 135.56 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.275 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -115.21 147.55 40.2 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -95.63 109.4 21.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.598 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 10.6 p -149.95 174.19 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.953 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.598 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 0.6 OUTLIER -109.27 155.06 41.74 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.826 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.2 Cg_endo -49.77 -7.96 0.1 Allowed 'Trans proline' 0 C--N 1.29 -2.512 0 C-N-CA 121.725 1.617 . . . . 0.0 113.348 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 56' ' ' LEU . 66.1 m -75.81 -28.81 58.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 114.992 -2.683 . . . . 0.0 105.553 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.7 OUTLIER 30.53 64.65 0.16 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 117.892 -1.052 . . . . 0.0 111.682 168.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -82.56 135.35 35.11 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 114.683 -2.807 . . . . 0.0 106.586 -175.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.56 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.88 -31.1 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.831 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.709 -173.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -29.83 67.57 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.635 ' N ' ' O ' ' A' ' 22' ' ' THR . 1.6 t-20 -78.23 -44.47 25.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' THR . 64.1 t -72.23 -34.72 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.27 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.64 -51.94 61.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -178.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -61.02 -35.07 75.89 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -62.17 -36.86 83.14 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 26' ' ' VAL . 30.4 mm -62.78 -37.05 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -70.54 -35.77 73.31 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 4.9 m-20 -62.78 -44.35 96.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -61.45 -54.28 45.5 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.25 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -138.32 168.34 19.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.03 111.32 3.22 Favored Glycine 0 CA--C 1.507 -0.436 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.187 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 118.25 2.75 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.05 128.3 19.38 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.21 -27.51 85.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.845 1.697 . . . . 0.0 112.195 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -67.58 -27.93 67.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.388 . . . . 0.0 110.374 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -93.98 -13.05 27.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.449 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.414 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 6.7 tp-100 -81.09 139.66 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -124.45 136.59 54.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.379 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.05 130.95 53.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.842 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.2 mt -135.67 142.15 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.1 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' LYS . 7.2 t80 -144.68 137.69 26.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.915 0.388 . . . . 0.0 111.199 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.04 44.48 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.39 -19.71 1.06 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 46' ' ' ALA . 5.7 mtmt -83.4 124.98 31.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 110.828 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.669 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -79.55 126.43 30.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.552 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 14.0 mt -76.44 129.26 36.29 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.56 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 17.4 mt-10 -87.26 -169.56 2.67 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.51 5.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 111.806 -2.452 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 117.9 45.35 0.51 Allowed Glycine 0 C--N 1.321 -0.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.241 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.615 ' NH2' ' H ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -80.37 159.3 25.77 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 173.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.615 ' H ' ' NH2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -78.45 139.45 38.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 116.341 -2.144 . . . . 0.0 109.52 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.602 ' O ' ' N ' ' A' ' 59' ' ' TYR . 5.0 mp -77.41 -28.93 52.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.689 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 19' ' ' PRO . 3.6 t -53.51 -30.14 39.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -73.36 -28.08 61.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.023 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 56' ' ' LEU . 13.6 m-85 -78.9 2.07 21.41 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.341 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.94 46.09 27.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.644 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.8 mm -63.71 139.1 21.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.87 0.843 . . . . 0.0 110.67 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.748 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 24.1 tt0 -96.92 -179.37 4.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.214 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.748 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 6.1 mtpm? -43.28 30.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.353 -2.203 . . . . 0.0 115.001 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.627 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.6 mt-10 91.02 52.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.166 0.984 . . . . 0.0 111.498 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -62.89 152.11 37.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.194 177.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.01 123.45 32.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.414 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.91 144.96 29.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.815 0.34 . . . . 0.0 110.453 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -98.54 147.26 24.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.56 ' CD1' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.689 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 2.6 mt-30 . . . . . 0 CA--C 1.52 -0.198 0 CA-C-O 120.557 0.218 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 12.7 mt -140.97 142.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.807 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -141.01 133.99 29.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.475 0.655 . . . . 0.0 110.945 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 t -109.54 131.1 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.283 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.53 124.84 50.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.63 0.252 . . . . 0.0 110.449 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -97.11 158.65 15.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.754 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -3.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.194 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 7' ' ' THR . 21.3 p -90.54 6.99 41.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.475 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.73 16.83 74.54 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -98.24 123.43 42.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.704 0.287 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 t -100.69 120.39 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.483 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 20.5 tt -117.49 110.12 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.228 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -101.07 138.15 38.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.138 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.519 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.34 146.49 40.46 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.495 ' OE1' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -95.3 109.49 21.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 18' ' ' GLU . 10.0 p -150.07 162.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.726 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 1.4 mp0 -84.38 177.84 2.74 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 4.0 Cg_exo -73.76 -6.74 19.12 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 121.611 1.541 . . . . 0.0 111.786 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.671 ' HA ' ' H ' ' A' ' 57' ' ' SER . 8.0 t -80.28 -27.21 38.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 116.386 -2.125 . . . . 0.0 107.863 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.616 ' OD1' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER 33.36 68.76 0.15 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 117.698 -1.144 . . . . 0.0 111.955 170.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -79.83 132.71 36.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 114.437 -2.905 . . . . 0.0 105.297 -175.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.645 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -55.47 -37.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 112.878 -1.964 . . . . 0.0 111.557 -172.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.35 -31.15 68.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' THR . 5.0 t-20 -78.83 -44.65 22.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.043 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.4 t -72.37 -49.21 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.476 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.662 ' CE ' ' O ' ' A' ' 41' ' ' GLN . 10.4 mmmm -55.18 -35.33 64.7 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.586 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.44 -35.84 78.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -65.91 -36.92 84.71 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.25 -42.01 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 34' ' ' GLU . 51.8 tt0 -69.91 -34.22 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.732 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.83 -45.49 92.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.128 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -67.19 -52.9 35.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.094 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 31' ' ' GLN . 77.6 tt0 -129.01 153.81 47.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.95 113.89 3.91 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.276 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -151.96 120.23 3.31 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.83 130.66 19.64 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 CA-C-N 119.458 0.842 . . . . 0.0 110.976 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -49.68 -40.44 46.91 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.364 2.042 . . . . 0.0 112.222 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -59.49 -29.22 67.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -98.89 7.85 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.662 ' O ' ' CE ' ' A' ' 27' ' ' LYS . 3.9 tp-100 -121.64 129.38 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -131.21 142.52 50.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.022 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.04 146.5 48.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 pt -135.92 142.56 38.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.47 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -124.67 115.84 21.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 111.51 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.74 42.5 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.427 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -21.2 32.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -80.78 115.22 20.16 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -79.36 122.34 26.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.477 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 mt -79.55 130.61 35.55 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.612 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 17.2 mt-10 -95.35 -169.47 1.98 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -47.42 7.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 111.926 -2.397 . . . . 0.0 114.432 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.98 44.46 0.49 Allowed Glycine 0 N--CA 1.461 0.325 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.134 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -81.52 153.76 26.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -78.45 141.16 38.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 116.402 -2.119 . . . . 0.0 110.336 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TYR . 6.7 mp -76.7 -31.58 57.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.22 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.671 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.3 t -55.59 -33.28 63.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.35 -25.6 62.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.437 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 56' ' ' LEU . 4.0 m-85 -79.93 1.11 28.58 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.591 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.22 44.18 22.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.427 HG13 ' CD2' ' A' ' 56' ' ' LEU . 16.5 mm -65.57 138.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.98 0.895 . . . . 0.0 110.254 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.765 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 30.6 tt0 -96.24 -178.35 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.732 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.765 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 19.0 ttpt -43.27 29.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.544 -2.116 . . . . 0.0 114.889 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.717 ' N ' ' O ' ' A' ' 62' ' ' GLN . 19.5 tt0 92.37 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.958 0.885 . . . . 0.0 112.59 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.15 154.93 25.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.774 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 66' ' ' THR . 9.3 t -86.62 125.08 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.874 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.1 mp -98.86 138.82 35.45 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -83.56 138.87 33.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 111.529 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.176 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.075 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 1.2 mt -118.52 158.78 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.822 0.82 . . . . 0.0 111.003 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -139.33 135.02 33.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.641 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.588 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 12.1 t -130.67 143.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.052 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -102.3 133.49 47.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.246 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 21.6 p -85.61 163.83 18.09 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.619 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.0 -10.82 59.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -96.39 -15.12 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -6.51 50.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.436 ' O ' ' OG1' ' A' ' 7' ' ' THR . 45.9 mttp -70.29 124.75 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 p -80.19 115.55 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.383 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.512 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 11.9 tt -110.72 112.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.911 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 p -104.05 139.62 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.07 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.605 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.16 143.68 44.41 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.59 109.43 21.67 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.656 HG21 ' O ' ' A' ' 18' ' ' GLU . 8.9 p -151.02 171.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.04 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.656 ' O ' HG21 ' A' ' 17' ' ' VAL . 3.3 pm0 -92.13 174.68 3.96 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.3 Cg_exo -73.59 -6.49 18.8 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 C-N-CA 121.237 1.291 . . . . 0.0 112.35 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.66 ' HA ' ' H ' ' A' ' 57' ' ' SER . 89.8 p -78.03 -27.64 48.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 116.296 -2.162 . . . . 0.0 107.173 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER 32.92 69.76 0.12 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.557 168.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.56 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -80.55 135.93 36.18 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 115.07 -2.652 . . . . 0.0 106.15 -175.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -54.71 -46.75 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 113.318 -1.765 . . . . 0.0 111.077 -173.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -57.71 -29.21 64.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -77.88 -39.46 43.15 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.181 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 22' ' ' THR . 36.2 t -72.47 -48.53 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.702 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -56.39 -41.69 76.7 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.522 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -38.09 68.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -67.59 -37.78 83.07 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 26' ' ' VAL . 27.5 mm -67.7 -32.23 55.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.634 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 27' ' ' LYS . 7.4 tt0 -68.95 -33.37 73.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.669 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -58.91 -45.22 90.84 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -70.03 -53.91 15.48 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.2 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -130.82 155.02 47.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 114.4 3.85 Favored Glycine 0 C--O 1.23 -0.102 0 C-N-CA 119.003 -1.57 . . . . 0.0 111.733 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 tp -151.84 117.47 3.12 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.54 137.36 30.29 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 121.362 1.374 . . . . 0.0 111.945 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.4 -36.01 29.5 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.605 2.203 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -61.88 -25.93 67.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -109.32 9.34 25.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.42 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.575 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 25.4 tp60 -113.54 124.5 52.52 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.45 ' H ' HE21 ' A' ' 41' ' ' GLN . 6.2 ptp85 -131.81 134.5 45.86 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mt -122.88 159.32 28.44 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.8 143.8 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.252 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -144.54 128.92 17.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.7 45.38 18.08 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.33 -20.45 1.24 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.41 124.21 27.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -81.79 122.45 27.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.943 0.402 . . . . 0.0 111.337 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.514 HD21 ' CD2' ' A' ' 59' ' ' TYR . 73.1 mt -77.18 117.46 18.74 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 53' ' ' GLY . 15.7 mt-10 -92.83 -168.02 1.86 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -174.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.69 7.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 111.325 -2.671 . . . . 0.0 115.481 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.82 43.14 0.54 Allowed Glycine 0 C--N 1.318 -0.456 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.193 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.451 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 36.6 mtt85 -82.59 152.46 25.93 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.49 HG21 ' H ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -78.31 141.69 38.29 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.989 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.3 mp -76.42 -30.71 57.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.022 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.66 ' H ' ' HA ' ' A' ' 20' ' ' SER . 10.9 t -53.27 -30.69 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.4 -28.67 62.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.184 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 56' ' ' LEU . 9.4 m-85 -79.33 6.17 10.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.694 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m120 51.65 44.75 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.539 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.465 HG13 ' CD2' ' A' ' 56' ' ' LEU . 34.7 mm -64.18 138.84 22.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 122.178 0.99 . . . . 0.0 111.09 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . 0.764 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 47.3 tt0 -96.57 -179.76 4.72 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.195 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.764 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.5 ttpt -43.36 30.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.623 -2.08 . . . . 0.0 115.225 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.631 ' N ' ' O ' ' A' ' 62' ' ' GLN . 10.0 mt-10 91.73 54.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.181 0.991 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -61.7 156.9 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 m -82.53 126.52 32.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.0 110.189 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.561 HD11 ' N ' ' A' ' 67' ' ' LEU . 10.5 mp -98.57 137.65 36.91 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -91.64 137.45 32.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.994 0.426 . . . . 0.0 111.295 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 69' ' ' LEU . 5.9 mp . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.409 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.637 ' O ' ' O ' ' A' ' 17' ' ' VAL . 3.7 mmt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 10.6 mm-40 -74.78 164.3 26.72 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.986 0.422 . . . . 0.0 110.701 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.429 ' CD1' ' CG ' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -142.1 136.75 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.432 ' HB3' ' HG1' ' A' ' 66' ' ' THR . 6.3 m-30 -108.2 136.13 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.939 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.99 133.59 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -106.29 134.02 50.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.939 0.399 . . . . 0.0 110.976 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 p -117.14 150.85 38.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.156 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.66 -3.87 3.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.9 m -91.12 -8.97 47.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.594 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.39 78.16 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -77.42 124.57 28.06 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.675 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -82.31 121.21 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.228 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.4 tt -120.1 129.46 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.712 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 p -117.21 137.76 52.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.755 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -115.48 147.17 40.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.9 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.91 109.85 22.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG21 ' O ' ' A' ' 18' ' ' GLU . 11.0 p -149.88 175.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.836 -177.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.648 ' O ' HG21 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -102.0 173.95 3.22 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.1 Cg_exo -74.51 -6.49 18.36 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 CA-C-N 120.751 1.304 . . . . 0.0 110.92 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.736 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -77.22 -27.34 53.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 116.833 -1.947 . . . . 0.0 105.745 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.684 ' O ' HD11 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 31.57 64.01 0.22 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.551 168.674 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -83.73 135.89 34.39 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 114.903 -2.719 . . . . 0.0 106.469 -175.616 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.671 HG13 ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -52.78 -41.07 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.203 -1.817 . . . . 0.0 110.843 -173.111 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.511 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 0.0 OUTLIER -61.6 -30.0 70.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 22' ' ' THR . 11.1 t30 -79.28 -46.02 18.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.995 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.654 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.3 t -72.47 -45.64 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.08 0.467 . . . . 0.0 110.172 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.528 ' CG ' ' O ' ' A' ' 23' ' ' ILE . 2.7 mmtm -54.83 -51.86 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.367 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.22 -35.99 70.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.512 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -64.23 -36.68 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 26' ' ' VAL . 73.3 mt -75.88 -28.93 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.547 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.588 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -56.72 -35.29 68.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -44.75 73.09 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -60.92 -52.28 65.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 56.1 mt-10 -146.65 154.24 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.94 116.64 4.65 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 119.042 -1.551 . . . . 0.0 111.241 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.588 ' O ' ' NE2' ' A' ' 31' ' ' GLN . 2.7 pp -149.47 117.25 3.72 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo -73.13 131.06 16.13 Favored 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.911 1.741 . . . . 0.0 111.833 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 -45.29 22.59 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.908 1.739 . . . . 0.0 111.926 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.55 -16.71 40.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.621 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -111.09 -15.72 13.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.165 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.525 ' OE1' ' CD1' ' A' ' 36' ' ' ILE . 52.4 tt0 -111.4 138.32 48.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 29.0 mtp-105 -128.48 144.85 51.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.745 179.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.516 HD22 ' HZ3' ' A' ' 27' ' ' LYS . 18.0 mt -116.27 174.47 6.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -134.75 138.27 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.507 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.36 117.31 21.96 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.721 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 44.66 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.31 -20.38 17.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -78.55 135.41 37.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -84.65 118.75 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.39 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.475 HD23 ' CE2' ' A' ' 59' ' ' TYR . 13.2 mt -81.05 146.31 30.69 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.671 ' O ' HG13 ' A' ' 23' ' ' ILE . 2.6 mt-10 -96.62 -173.33 2.71 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -54.97 8.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 111.343 -2.662 . . . . 0.0 114.306 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.489 ' HA2' ' CB ' ' A' ' 23' ' ' ILE . . . 121.58 43.05 0.43 Allowed Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.708 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mmt-85 -83.12 165.62 19.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 172.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 67.8 m -87.27 142.32 27.99 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 116.96 -1.896 . . . . 0.0 111.124 -179.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.684 HD11 ' O ' ' A' ' 21' ' ' ASP . 3.2 mp -76.97 -33.53 57.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.409 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.736 ' H ' ' HA ' ' A' ' 20' ' ' SER . 15.8 m -57.53 -36.11 71.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -24.14 64.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.475 ' CE2' HD23 ' A' ' 50' ' ' LEU . 2.8 m-85 -83.49 6.53 19.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.51 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.6 43.2 28.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.182 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.458 HG13 ' CD2' ' A' ' 56' ' ' LEU . 20.7 mm -65.73 140.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 122.181 0.991 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.825 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 23.3 tt0 -94.47 -176.49 3.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.35 -1.75 . . . . 0.0 113.254 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.825 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.2 tmtm? -41.15 25.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.546 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.771 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.3 pt-20 91.01 53.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.265 1.031 . . . . 0.0 113.429 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.61 152.62 18.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.43 177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.432 ' HG1' ' HB3' ' A' ' 4' ' ' PHE . 30.8 m -86.71 119.36 26.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.167 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.588 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 4.8 mp -98.8 131.13 45.16 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -120.32 138.56 53.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.933 0.397 . . . . 0.0 111.227 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.458 ' H ' HD11 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -121.76 131.47 54.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.192 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 4.7 p -137.21 151.83 27.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.123 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -138.68 19.33 2.69 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.127 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.309 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 17' ' ' VAL . 1.8 mpp? . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -127.12 168.26 14.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.134 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.421 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -117.13 151.35 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.316 0.579 . . . . 0.0 110.261 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -139.95 132.47 28.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.646 -179.005 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.543 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 87.8 t -119.79 132.3 69.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -101.87 121.86 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.926 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p -89.32 161.34 16.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.34 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.35 -4.81 28.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -95.72 1.76 53.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.97 -4.01 63.16 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -72.61 123.08 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.834 0.35 . . . . 0.0 110.281 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -91.95 125.01 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.973 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.46 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 1.2 tp -119.03 121.62 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.788 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 p -110.79 133.08 53.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.8 145.9 42.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.635 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 8.4 mp0 -96.25 110.68 22.95 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 18' ' ' GLU . 7.1 p -150.52 149.61 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.764 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.938 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.4 pm0 -70.55 177.04 1.55 Allowed Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.0 Cg_exo -74.49 -6.56 18.46 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 121.584 1.522 . . . . 0.0 111.868 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 56' ' ' LEU . 83.2 p -78.82 -27.32 44.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 116.365 -2.134 . . . . 0.0 107.647 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.938 ' OD1' ' O ' ' A' ' 18' ' ' GLU . 0.0 OUTLIER 31.54 67.86 0.13 Allowed 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.885 169.883 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.637 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.14 133.4 36.06 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 114.331 -2.947 . . . . 0.0 106.097 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.571 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -54.41 -35.1 29.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 112.872 -1.967 . . . . 0.0 110.744 -173.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.8 tt0 -62.88 -33.29 74.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.637 ' HB3' ' O ' ' A' ' 22' ' ' THR . 3.4 t30 -78.86 -45.68 20.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.345 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' THR . 16.9 t -72.6 -37.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.403 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.563 ' HZ1' ' CG ' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.7 -51.34 65.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.457 . . . . 0.0 110.418 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.06 -35.38 69.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.382 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -63.48 -37.77 88.57 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.16 -42.6 79.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.639 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -69.14 -32.27 71.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.716 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -58.93 -37.73 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.816 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -61.83 -54.12 46.51 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 110.736 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.639 ' O ' ' O ' ' A' ' 31' ' ' GLN . 36.9 mt-10 -140.94 176.63 8.65 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.68 113.8 3.83 Favored Glycine 0 CA--C 1.51 -0.252 0 C-N-CA 118.532 -1.794 . . . . 0.0 110.637 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.403 HG23 HD11 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -151.83 118.86 3.21 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -71.67 130.14 16.6 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 120.564 0.843 . . . . 0.0 111.722 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 3.3 Cg_exo -57.82 -34.46 98.29 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.047 1.831 . . . . 0.0 111.597 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -66.57 -26.75 67.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.044 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -104.42 0.67 29.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.814 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.501 ' NE2' ' N ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -104.71 126.74 52.09 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.597 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.501 ' N ' ' NE2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.08 142.43 50.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.563 ' CG ' ' HZ1' ' A' ' 27' ' ' LYS . 7.2 mt -118.44 162.42 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.7 mt -136.03 139.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.27 119.44 17.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.287 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 35.41 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.336 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.98 -19.7 24.46 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -82.18 116.84 21.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.397 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.37 127.77 33.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 43.5 mt -76.73 127.76 33.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.571 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 1.2 mp0 -81.65 -169.81 2.51 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -48.8 6.09 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 111.646 -2.524 . . . . 0.0 115.09 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.507 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 117.85 44.1 0.55 Allowed Glycine 0 C--N 1.316 -0.534 0 C-N-CA 119.93 -1.129 . . . . 0.0 111.964 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -81.67 159.14 24.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.495 HG23 ' H ' ' A' ' 57' ' ' SER . 0.7 OUTLIER -79.08 141.17 37.58 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 116.916 -1.914 . . . . 0.0 110.039 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.71 ' N ' ' O ' ' A' ' 20' ' ' SER . 2.2 mm? -74.52 -32.5 62.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.985 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.673 ' N ' ' O ' ' A' ' 19' ' ' PRO . 7.2 t -54.77 -30.71 57.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -71.98 -29.29 64.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 19.0 m-85 -79.4 -6.39 56.73 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.66 44.64 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.843 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.507 HG12 HD12 ' A' ' 56' ' ' LEU . 31.7 mm -64.43 137.66 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.947 0.879 . . . . 0.0 110.152 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 64' ' ' GLU . 10.8 pt20 -102.55 -174.37 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.714 -1.584 . . . . 0.0 114.057 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.584 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 49.1 mttt -42.05 30.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.365 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 62' ' ' GLN . 9.1 mt-10 91.38 53.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.919 0.866 . . . . 0.0 113.282 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.402 ' H ' ' HG ' ' A' ' 65' ' ' SER . 0.3 OUTLIER -63.75 153.57 35.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.745 176.517 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.8 t -86.24 126.68 34.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.06 139.19 35.07 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -88.49 138.04 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 111.23 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mt -113.28 157.21 22.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.199 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -143.56 149.77 17.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.447 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.07 -47.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.395 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 72' ' ' ARG . 8.7 ttm105 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.324 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.522 ' O ' ' O ' ' A' ' 17' ' ' VAL . 4.1 mpp? . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -127.12 163.56 23.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.192 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.571 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -120.61 155.65 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.613 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 2.5 t80 -137.21 132.72 34.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.857 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.6 t -128.8 146.74 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.725 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -98.34 120.63 39.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 p -87.19 161.77 17.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.187 0.518 . . . . 0.0 111.382 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.556 HD11 ' H ' ' A' ' 8' ' ' LEU . 4.6 mp -71.77 -11.8 60.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.662 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -94.01 -10.89 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.34 2.15 77.33 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -81.07 131.51 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 110.564 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.79 121.84 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.427 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 11.6 tt -115.04 122.09 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.117 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -112.74 137.64 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.057 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.75 147.83 39.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.128 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.26 109.77 21.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 18' ' ' GLU . 11.6 p -150.51 173.6 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.496 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.648 ' O ' HG22 ' A' ' 17' ' ' VAL . 2.0 mp0 -99.4 175.98 2.18 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -73.54 -7.54 20.42 Favored 'Trans proline' 0 C--N 1.288 -2.633 0 C-N-CA 121.245 1.297 . . . . 0.0 111.066 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.658 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.11 -28.21 48.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 116.542 -2.063 . . . . 0.0 106.807 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER 32.88 67.19 0.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.994 169.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.608 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -80.62 133.44 35.74 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 114.645 -2.822 . . . . 0.0 105.826 -175.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.567 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 1.1 mt -55.13 -43.58 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.015 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -59.73 -29.58 68.24 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 175.18 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -77.66 -44.68 27.3 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.821 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.608 ' N ' ' O ' ' A' ' 22' ' ' THR . 10.7 t -72.25 -39.73 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.347 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.518 ' NZ ' ' CG2' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.53 -41.99 70.34 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.596 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.68 78.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HZ2' ' CB ' ' A' ' 29' ' ' LYS . 0.0 OUTLIER -67.25 -36.4 81.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.521 HG12 ' O ' ' A' ' 26' ' ' VAL . 21.1 mm -62.04 -40.35 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' O ' ' A' ' 34' ' ' GLU . 4.9 tt0 -69.1 -31.99 71.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.2 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.37 -44.64 88.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.442 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.93 -53.59 55.38 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.935 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.7 mt-10 -135.92 155.56 50.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.94 112.37 3.47 Favored Glycine 0 CA--C 1.505 -0.54 0 C-N-CA 118.529 -1.796 . . . . 0.0 110.72 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pt -152.85 119.03 2.98 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.49 128.91 32.03 Favored 'Trans proline' 0 C--N 1.287 -2.695 0 CA-C-N 118.839 0.621 . . . . 0.0 110.706 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.43 ' C ' ' H ' ' A' ' 40' ' ' GLN . 3.3 Cg_exo -60.21 -34.91 93.67 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.934 1.756 . . . . 0.0 112.288 -179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.5 -8.18 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.175 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.43 ' H ' ' C ' ' A' ' 38' ' ' PRO . 78.7 mt-30 -109.99 -12.96 14.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 26.1 mm100 -83.82 126.0 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.4 mtt180 -129.38 128.28 42.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 43' ' ' LEU . 0.1 OUTLIER -131.61 149.75 52.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.444 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.25 143.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.604 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 41.0 t80 -120.59 115.54 23.6 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.916 0.389 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 39.22 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 -20.9 34.0 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.4 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 20.2 mttm -79.19 117.5 20.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' GLN . 12.4 pt20 -76.79 121.3 23.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.298 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.476 HD23 ' CD2' ' A' ' 59' ' ' TYR . 67.6 mt -76.99 127.03 31.96 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.567 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 22.3 mt-10 -90.63 -169.32 2.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -174.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -47.59 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 111.798 -2.456 . . . . 0.0 114.504 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.557 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.81 44.6 0.58 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.383 -176.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -81.17 160.55 24.33 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.7 m -79.37 140.44 37.46 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 116.257 -2.177 . . . . 0.0 110.34 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.619 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.2 mp -77.54 -30.46 52.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.009 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.658 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.9 t -54.96 -30.51 59.13 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.27 -27.72 62.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.242 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 56' ' ' LEU . 10.5 m-85 -79.25 -5.4 54.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.968 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.47 45.13 11.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.402 HG13 ' CD2' ' A' ' 56' ' ' LEU . 37.9 mm -64.42 136.89 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.141 0.972 . . . . 0.0 109.978 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.68 ' O ' ' N ' ' A' ' 64' ' ' GLU . 9.0 pt20 -97.53 -173.76 2.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.291 -1.777 . . . . 0.0 114.284 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.703 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 1.6 pttm -41.62 26.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 112.123 -2.308 . . . . 0.0 115.259 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.703 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.9 OUTLIER 90.64 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.875 1.321 . . . . 0.0 113.111 -178.407 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.4 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.5 OUTLIER -62.4 157.02 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.74 177.318 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.561 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.8 p -84.16 131.55 34.76 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.751 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.09 142.84 28.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.794 0.33 . . . . 0.0 110.504 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 134.99 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mp -122.05 167.99 12.47 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -118.85 166.48 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.143 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 70' ' ' VAL . 9.9 tp 77.46 121.36 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.29 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.59 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' VAL . 2.8 tpt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.754 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.8 mp0 -90.8 165.31 13.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.02 135.78 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 121.489 0.661 . . . . 0.0 110.262 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 4.3 m-30 -110.29 142.62 41.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.543 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.54 59.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -101.19 122.83 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -98.06 151.79 19.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.3 OUTLIER -71.25 -10.74 60.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.13 2.41 56.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.577 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.98 15.11 78.47 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -93.49 127.57 39.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -86.55 115.92 24.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 19.1 tt -112.6 118.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.915 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -107.21 138.56 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 -178.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.48 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.86 145.27 43.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 109.98 22.33 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 18' ' ' GLU . 11.6 p -149.64 171.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.937 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.636 ' O ' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -95.8 172.48 5.22 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.649 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -75.18 -7.88 19.39 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 121.392 1.394 . . . . 0.0 111.074 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.658 ' O ' ' N ' ' A' ' 56' ' ' LEU . 1.1 m -78.0 -27.08 48.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 116.712 -1.995 . . . . 0.0 105.805 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.5 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER 33.43 68.27 0.16 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.795 169.109 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -79.46 132.74 36.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 114.25 -2.98 . . . . 0.0 105.481 -175.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.56 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -55.69 -40.37 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.878 -1.965 . . . . 0.0 110.859 -173.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -60.38 -29.9 69.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -78.01 -44.58 26.18 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.956 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.578 ' O ' HG12 ' A' ' 30' ' ' ILE . 6.8 t -72.2 -35.73 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.302 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.5 -51.85 63.8 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.808 -178.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.71 76.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.65 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' NZ ' ' ND2' ' A' ' 25' ' ' ASN . 19.8 mttp -64.57 -36.76 85.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.2 mm -63.5 -45.7 97.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.631 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' O ' ' OE1' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -69.94 -33.16 71.77 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.45 -44.77 92.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 2.6 mtpt -68.58 -54.5 16.18 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.766 -179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLN . 13.9 mm-40 -123.91 151.4 43.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.44 111.06 3.17 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 118.317 -1.897 . . . . 0.0 111.104 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 tt -154.19 117.0 2.58 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 175.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.4 129.68 32.38 Favored 'Trans proline' 0 C--N 1.288 -2.621 0 CA-C-N 119.093 0.712 . . . . 0.0 111.156 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.56 -27.48 76.96 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.095 1.863 . . . . 0.0 112.086 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.84 -27.46 68.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.017 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -107.35 7.74 29.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.54 HE21 ' N ' ' A' ' 42' ' ' ARG . 36.9 tp60 -89.19 127.01 35.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.988 0.423 . . . . 0.0 110.918 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.54 ' N ' HE21 ' A' ' 41' ' ' GLN . 55.7 mtp180 -128.23 132.84 48.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.104 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -124.06 151.44 43.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 110.762 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.5 mt -135.44 139.99 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.6 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.488 ' O ' ' N ' ' A' ' 48' ' ' LYS . 70.7 t80 -121.75 116.4 24.44 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.584 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.09 33.54 3.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.03 -20.32 48.19 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.488 ' N ' ' O ' ' A' ' 45' ' ' PHE . 55.2 mttm -78.15 120.38 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.901 0.381 . . . . 0.0 110.357 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -75.17 123.48 25.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 83.8 mt -76.77 132.86 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.56 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 11.9 mt-10 -86.94 -170.6 3.14 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -49.0 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 111.595 -2.548 . . . . 0.0 114.781 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.522 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.62 44.18 0.6 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.856 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 159.32 23.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 102.874 -3.009 . . . . 0.0 102.874 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.411 HG21 ' H ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -78.29 140.36 38.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 116.179 -2.208 . . . . 0.0 109.254 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.658 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.0 mp -77.37 -31.14 54.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.368 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.654 ' H ' ' HA ' ' A' ' 20' ' ' SER . 35.6 p -55.12 -30.33 59.55 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 58' ' ' ASP . 33.0 t0 -71.73 -26.32 62.42 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.846 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' LEU . 5.8 m-85 -79.22 3.86 16.62 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.522 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.69 40.45 19.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.423 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 21.9 mm -64.97 132.17 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.031 0.92 . . . . 0.0 109.018 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.763 ' O ' ' N ' ' A' ' 64' ' ' GLU . 7.8 pt20 -96.82 -172.39 2.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.68 -1.6 . . . . 0.0 114.223 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.749 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 5.8 mmtt -41.03 26.3 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.482 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.763 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.8 pt-20 90.94 52.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.441 1.115 . . . . 0.0 113.246 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.6 OUTLIER -61.74 152.75 30.32 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.894 176.537 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -86.1 128.97 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -98.65 132.61 43.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -88.3 141.83 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.604 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.36 162.03 21.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.696 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.8 m -146.06 163.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.303 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.409 ' N ' HD13 ' A' ' 71' ' ' LEU . 6.0 mp -105.53 -55.38 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.322 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.32 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' O ' ' A' ' 17' ' ' VAL . 2.7 mtp . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 7.3 mt-30 -126.8 164.79 20.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.747 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -120.74 159.96 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' A' ' 3' ' ' ILE . 5.1 t80 -140.92 134.74 30.44 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.012 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.528 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 71.4 t -130.72 141.51 46.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.84 140.4 36.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.095 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -106.15 149.44 26.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.926 0.393 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mt -72.85 -11.97 60.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 p -91.82 -10.61 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.02 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.66 -4.86 73.06 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -78.87 128.29 33.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.203 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 m -76.49 116.14 16.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.527 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 7.5 tt -115.51 113.5 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.256 0.551 . . . . 0.0 110.182 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 p -117.6 139.61 50.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.13 144.13 43.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -95.81 111.08 23.14 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.636 ' CG2' ' H ' ' A' ' 18' ' ' GLU . 11.2 p -149.86 174.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.338 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.636 ' H ' ' CG2' ' A' ' 17' ' ' VAL . 2.9 mp0 -100.04 177.32 1.58 Allowed Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.08 -7.62 20.08 Favored 'Trans proline' 0 C--N 1.29 -2.539 0 C-N-CA 121.459 1.439 . . . . 0.0 112.155 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.675 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -78.17 -28.47 48.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 116.238 -2.185 . . . . 0.0 106.525 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.514 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER 32.24 66.86 0.17 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.234 168.675 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.636 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -81.5 135.41 35.61 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 115.118 -2.633 . . . . 0.0 105.83 -176.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.529 HG13 ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -54.27 -43.95 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.152 -173.586 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.18 -29.95 67.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 22' ' ' THR . 2.8 t-20 -78.26 -44.87 24.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.676 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.636 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.2 t -72.73 -39.42 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.638 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.616 ' HZ1' ' CD1' ' A' ' 43' ' ' LEU . 0.7 OUTLIER -54.33 -52.05 62.76 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.153 0.501 . . . . 0.0 110.392 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.48 68.27 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.326 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -38.06 89.69 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 26' ' ' VAL . 19.4 mm -67.46 -39.79 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' O ' ' O ' ' A' ' 34' ' ' GLU . 14.9 tt0 -61.95 -34.06 75.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -59.24 -34.31 72.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.204 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.443 ' H ' ' HG2' ' A' ' 33' ' ' LYS . 29.1 mmtt -60.17 -31.23 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.208 0.528 . . . . 0.0 109.928 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 31' ' ' GLN . 2.8 pt-20 -160.46 -116.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.54 111.4 0.52 Allowed Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.692 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -153.6 119.27 2.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 2.9 Cg_endo -71.76 140.45 35.57 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 121.313 1.342 . . . . 0.0 112.18 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.34 -27.7 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.131 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.11 -31.54 69.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.768 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.37 8.79 23.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' OE1' ' O ' ' A' ' 37' ' ' PRO . 3.0 mp0 -112.03 126.11 54.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.469 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.5 mtt85 -130.34 141.66 50.57 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.546 179.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.616 ' CD1' ' HZ1' ' A' ' 27' ' ' LYS . 16.2 mt -120.41 163.06 18.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.778 0.323 . . . . 0.0 110.69 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -135.58 143.33 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LYS . 8.2 t80 -141.47 125.08 16.79 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.774 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.539 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.44 45.74 17.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 -19.11 1.87 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.539 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -81.68 115.72 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 0.0 110.087 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.538 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -72.76 125.0 26.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 45.5 mt -77.3 137.38 38.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.569 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 16.4 mp0 -95.05 -171.54 2.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 5.6 t0 -47.92 7.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 111.907 -2.406 . . . . 0.0 114.599 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.556 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.71 43.46 0.53 Allowed Glycine 0 C--N 1.32 -0.361 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.884 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -82.63 161.94 22.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 20' ' ' SER . 51.9 m -85.34 143.15 28.83 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 117.188 -1.805 . . . . 0.0 111.763 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.555 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.5 mp -77.21 -32.88 56.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.999 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.675 ' H ' ' HA ' ' A' ' 20' ' ' SER . 5.4 t -55.85 -33.57 64.64 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.58 -26.91 61.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.571 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.543 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 9.7 m-85 -79.26 1.84 23.39 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 57.8 45.1 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.639 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.552 HG13 ' CD2' ' A' ' 56' ' ' LEU . 34.8 mm -64.93 139.66 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 122.111 0.957 . . . . 0.0 110.588 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.775 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 5.5 tt0 -95.25 -179.28 4.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.693 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.777 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 39.0 mttp -43.05 28.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.265 -2.243 . . . . 0.0 115.197 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.777 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.52 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.837 1.303 . . . . 0.0 112.756 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 p -61.96 154.29 26.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.055 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.88 115.9 24.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.198 179.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mp -98.16 137.97 36.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.01 142.73 31.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -120.95 115.91 24.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.94 151.95 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.971 0.415 . . . . 0.0 110.554 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mt -103.07 -37.46 7.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.341 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.504 179.906 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 2.8 mp0 -100.42 167.19 10.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.072 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.444 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -118.3 152.62 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.336 0.589 . . . . 0.0 109.505 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 63.3 t80 -138.89 132.51 30.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.702 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 85.1 t -130.16 140.34 49.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -128.66 144.13 51.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 110.548 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 p -115.91 173.09 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.2 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.83 -7.85 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -92.73 -11.48 33.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.592 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.44 6.49 84.12 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -61.49 132.17 52.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 7.9 t -89.51 115.36 26.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.599 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.477 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 8.1 tt -121.47 120.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.295 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 p -117.28 135.65 53.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.181 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.553 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -116.15 146.42 42.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.772 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -95.8 111.0 23.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.598 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 14.1 p -148.68 171.79 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.162 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.598 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 1.3 pm0 -105.55 153.55 39.75 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.824 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.3 Cg_endo -52.02 -8.86 0.37 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 121.881 1.721 . . . . 0.0 112.641 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 21' ' ' ASP . 5.9 t -77.61 -28.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 115.224 -2.59 . . . . 0.0 105.988 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.6 OUTLIER 31.32 65.64 0.17 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.339 168.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.633 ' HG1' ' H ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -81.48 132.67 35.33 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 114.374 -2.931 . . . . 0.0 105.893 -175.586 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.521 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 1.2 mt -54.9 -39.52 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 CA-C-N 112.686 -2.052 . . . . 0.0 110.819 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.68 -29.87 70.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.633 ' H ' ' HG1' ' A' ' 22' ' ' THR . 4.6 t-20 -78.55 -44.62 23.81 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.187 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 22' ' ' THR . 3.4 t -72.34 -32.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.223 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -50.86 -47.92 60.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -178.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.2 76.17 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.513 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -65.93 -35.98 82.09 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.514 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.3 mm -61.7 -45.56 98.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.68 -33.1 70.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.977 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -58.35 -44.85 88.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -62.76 -54.26 41.81 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.479 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 31' ' ' GLN . 75.8 mt-10 -132.59 157.21 45.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.58 111.87 3.34 Favored Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 118.445 -1.836 . . . . 0.0 110.597 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 pt -153.86 119.55 2.8 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.78 127.52 21.77 Favored 'Trans proline' 0 C--N 1.288 -2.607 0 CA-C-N 119.401 0.822 . . . . 0.0 110.977 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.57 -42.9 24.1 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.282 1.988 . . . . 0.0 112.269 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.26 -17.67 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.693 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -109.97 7.41 23.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 6.0 tp60 -116.58 128.64 55.6 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.151 0.501 . . . . 0.0 111.217 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mtp-105 -126.42 140.77 52.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.857 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.72 148.65 47.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.874 0.369 . . . . 0.0 111.28 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.94 141.33 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.97 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 48' ' ' LYS . 39.6 t80 -123.64 131.7 53.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.135 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.17 44.25 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.902 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.1 -20.64 6.54 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 45' ' ' PHE . 20.6 mtpt -79.58 138.46 37.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -92.06 121.49 33.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.726 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 67.3 mt -76.29 106.04 7.69 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' C ' ' H ' ' A' ' 53' ' ' GLY . 4.1 mt-10 -69.13 -168.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.476 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' OD1' ' O ' ' A' ' 52' ' ' ASP . 31.7 t0 -46.79 5.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 111.644 -2.526 . . . . 0.0 115.159 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.544 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.88 45.47 0.55 Allowed Glycine 0 C--N 1.318 -0.461 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.69 -176.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.75 26.92 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 172.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.454 HG21 ' H ' ' A' ' 57' ' ' SER . 1.2 m -77.87 140.91 39.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 116.382 -2.127 . . . . 0.0 110.52 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 59' ' ' TYR . 2.9 mp -76.35 -30.06 57.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.726 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.824 ' N ' ' O ' ' A' ' 19' ' ' PRO . 6.2 t -54.77 -32.8 60.53 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -72.66 -26.0 61.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.176 177.079 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 56' ' ' LEU . 7.9 m-85 -79.29 4.85 13.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.233 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.73 44.64 29.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 35.3 mm -64.6 137.56 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.719 0.771 . . . . 0.0 109.669 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.71 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.9 pt20 -101.78 -173.97 2.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.304 -1.316 . . . . 0.0 113.975 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.672 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 3.4 ttpm? -41.74 28.66 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 111.867 -2.424 . . . . 0.0 115.07 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.71 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.2 pt-20 91.35 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 122.846 1.308 . . . . 0.0 112.874 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -61.63 153.77 26.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.384 177.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.3 m -85.51 123.86 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.85 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.497 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 6.9 mp -98.41 136.79 38.04 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 0.5 OUTLIER -83.25 135.48 34.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.875 -179.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 42.3 mt -111.88 128.18 56.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.108 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.18 154.37 23.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.103 0.478 . . . . 0.0 110.667 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tp -149.09 119.65 7.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.046 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.418 -179.608 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 tpp . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.426 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 59.9 mt-30 -86.21 165.25 16.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.701 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.499 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.8 OUTLIER -120.41 156.42 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 2.7 t80 -140.89 132.72 27.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.242 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 79.6 t -129.84 142.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.243 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -122.44 121.33 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.45 ' OG1' ' OG1' ' A' ' 9' ' ' THR . 3.2 p -84.17 175.1 9.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.45 ' CD1' ' N ' ' A' ' 8' ' ' LEU . 9.9 mp -69.95 -10.04 57.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.443 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.45 ' OG1' ' OG1' ' A' ' 7' ' ' THR . 60.9 p -91.8 -4.19 55.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.317 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.24 82.25 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -65.0 131.52 46.82 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.45 116.23 28.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.42 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.45 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 13.6 tt -120.07 122.53 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.364 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.513 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 10.1 p -116.0 139.95 49.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.738 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.99 148.1 37.5 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -94.25 109.78 21.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 18' ' ' GLU . 9.6 p -150.36 171.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.864 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.635 ' O ' HG22 ' A' ' 17' ' ' VAL . 1.6 pm0 -93.99 174.29 3.91 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.16 -5.91 17.67 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 121.293 1.329 . . . . 0.0 111.768 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.519 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.32 -28.73 57.02 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 116.226 -2.19 . . . . 0.0 105.764 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.519 ' OD1' ' CG2' ' A' ' 17' ' ' VAL . 3.4 m-20 32.71 64.96 0.25 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.026 168.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.618 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -84.68 137.7 33.09 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 115.849 -2.34 . . . . 0.0 107.375 -175.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.588 HG13 ' O ' ' A' ' 51' ' ' GLU . 1.1 mm -53.07 -40.98 40.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.311 -174.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.86 -33.12 71.39 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.618 ' HB3' ' O ' ' A' ' 22' ' ' THR . 13.6 t-20 -78.79 -46.55 18.54 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.78 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.604 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.4 t -73.51 -35.3 44.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.146 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HZ2' HD11 ' A' ' 43' ' ' LEU . 1.6 mmtm -54.3 -51.88 63.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.95 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.6 76.14 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.004 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -61.31 -36.01 78.94 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.7 mm -63.46 -45.87 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.696 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' GLU . 24.6 tt0 -69.23 -31.96 70.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.022 0.439 . . . . 0.0 111.062 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -41.67 82.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.347 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 14.6 mmtp -64.45 -54.42 32.89 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.244 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.9 mt-10 -141.22 171.69 13.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.39 112.14 3.41 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 118.647 -1.739 . . . . 0.0 110.551 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 tt -153.85 122.0 3.03 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.84 126.23 14.97 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 CA-C-N 119.392 0.819 . . . . 0.0 111.404 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 -45.56 9.5 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.649 2.233 . . . . 0.0 112.62 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.96 -27.01 66.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.448 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.68 9.2 43.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.307 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.571 HE22 ' CD2' ' A' ' 69' ' ' LEU . 2.1 tm0? -112.12 126.76 55.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.565 ' N ' ' OE1' ' A' ' 41' ' ' GLN . 0.9 OUTLIER -129.48 138.1 51.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.107 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.492 HD11 ' HZ2' ' A' ' 27' ' ' LYS . 0.1 OUTLIER -131.55 159.5 38.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.709 0.29 . . . . 0.0 110.265 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.6 tt -136.4 140.34 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.352 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 48' ' ' LYS . 6.5 t80 -128.57 134.68 48.69 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.11 33.9 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.925 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.6 -21.0 11.78 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 45' ' ' PHE . 5.8 mtmm -80.52 115.33 19.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -71.05 121.51 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.64 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.453 HD21 ' CE2' ' A' ' 59' ' ' TYR . 64.4 mt -77.4 114.07 15.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.611 ' C ' ' H ' ' A' ' 53' ' ' GLY . 16.9 mt-10 -87.95 -167.69 1.97 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -45.65 8.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 111.902 -2.408 . . . . 0.0 114.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.611 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 119.68 44.62 0.46 Allowed Glycine 0 C--N 1.318 -0.451 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.161 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 150.22 28.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -79.41 141.18 37.08 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 116.912 -1.915 . . . . 0.0 111.364 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.567 ' O ' ' N ' ' A' ' 59' ' ' TYR . 3.9 mp -78.06 -31.7 50.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.802 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.615 ' N ' ' O ' ' A' ' 19' ' ' PRO . 5.8 t -54.38 -31.59 55.15 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -72.36 -30.26 64.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.649 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 56' ' ' LEU . 6.7 m-85 -79.06 5.36 12.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 52.18 45.02 29.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.306 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.467 HG13 ' CD2' ' A' ' 56' ' ' LEU . 24.8 mm -64.8 138.1 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.173 0.987 . . . . 0.0 110.636 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.68 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.0 pt20 -100.72 -173.31 2.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.899 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.786 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 56.8 mttm -41.24 28.66 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 111.681 -2.509 . . . . 0.0 115.749 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.786 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.94 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.859 1.314 . . . . 0.0 113.271 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -60.55 154.74 20.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.766 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.63 126.75 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' CD1' ' N ' ' A' ' 67' ' ' LEU . 6.5 mp -98.93 134.37 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.312 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.506 ' NE2' ' O ' ' A' ' 69' ' ' LEU . 6.3 t-80 -85.84 132.48 34.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.923 0.392 . . . . 0.0 110.218 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.571 ' CD2' HE22 ' A' ' 41' ' ' GLN . 12.6 mt -87.0 164.54 16.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.18 161.17 21.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.901 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 72' ' ' ARG . 9.3 mt -47.07 -71.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.464 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.448 ' HE ' HH12 ' A' ' 42' ' ' ARG . 87.5 mtm-85 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.578 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -85.24 164.42 18.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.512 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 1.6 mt -121.11 152.44 24.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.397 0.617 . . . . 0.0 110.817 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.17 133.64 31.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.903 -179.07 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 89.5 t -123.82 144.24 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 111.133 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 19.7 tttm -100.58 139.57 36.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 p -115.95 161.21 19.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.622 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.99 -4.01 15.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.262 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -92.07 -14.01 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 15.16 80.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -94.0 130.94 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.7 t -76.82 120.21 21.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.513 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 10.0 tt -116.37 117.95 57.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.888 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.4 p -115.73 135.56 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.275 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -115.21 147.55 40.2 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -95.63 109.4 21.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.598 ' CG2' ' N ' ' A' ' 18' ' ' GLU . 10.6 p -149.95 174.19 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.953 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.598 ' N ' ' CG2' ' A' ' 17' ' ' VAL . 0.6 OUTLIER -109.27 155.06 41.74 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.355 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.826 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.2 Cg_endo -49.77 -7.96 0.1 Allowed 'Trans proline' 0 C--N 1.29 -2.512 0 C-N-CA 121.725 1.617 . . . . 0.0 113.348 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 56' ' ' LEU . 66.1 m -75.81 -28.81 58.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 114.992 -2.683 . . . . 0.0 105.553 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.545 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.7 OUTLIER 30.53 64.65 0.16 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 117.892 -1.052 . . . . 0.0 111.682 168.356 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -82.56 135.35 35.11 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 114.683 -2.807 . . . . 0.0 106.586 -175.567 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.56 ' CD1' ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.88 -31.1 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.831 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.709 -173.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -29.83 67.57 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.635 ' N ' ' O ' ' A' ' 22' ' ' THR . 1.6 t-20 -78.23 -44.47 25.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' THR . 64.1 t -72.23 -34.72 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.27 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.64 -51.94 61.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -178.651 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -61.02 -35.07 75.89 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -62.17 -36.86 83.14 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 26' ' ' VAL . 30.4 mm -62.78 -37.05 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -70.54 -35.77 73.31 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 4.9 m-20 -62.78 -44.35 96.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -61.45 -54.28 45.5 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.25 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -138.32 168.34 19.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.03 111.32 3.22 Favored Glycine 0 CA--C 1.507 -0.436 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.187 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 118.25 2.75 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.05 128.3 19.38 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.21 -27.51 85.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.845 1.697 . . . . 0.0 112.195 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -67.58 -27.93 67.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.388 . . . . 0.0 110.374 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -93.98 -13.05 27.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.449 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.414 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 6.7 tp-100 -81.09 139.66 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 tpt85 -124.45 136.59 54.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.379 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 4.5 mp -125.05 130.95 53.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.842 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.2 mt -135.67 142.15 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.1 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' LYS . 7.2 t80 -144.68 137.69 26.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.915 0.388 . . . . 0.0 111.199 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.542 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.04 44.48 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.39 -19.71 1.06 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.542 ' H ' ' C ' ' A' ' 46' ' ' ALA . 5.7 mtmt -83.4 124.98 31.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 110.828 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.669 ' H ' ' NE2' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -79.55 126.43 30.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.552 ' CD2' ' CE2' ' A' ' 59' ' ' TYR . 14.0 mt -76.44 129.26 36.29 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.56 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 17.4 mt-10 -87.26 -169.56 2.67 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.51 5.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 111.806 -2.452 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 117.9 45.35 0.51 Allowed Glycine 0 C--N 1.321 -0.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.241 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.615 ' NH2' ' H ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -80.37 159.3 25.77 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 173.432 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.615 ' H ' ' NH2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -78.45 139.45 38.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 116.341 -2.144 . . . . 0.0 109.52 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.602 ' O ' ' N ' ' A' ' 59' ' ' TYR . 5.0 mp -77.41 -28.93 52.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.689 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 19' ' ' PRO . 3.6 t -53.51 -30.14 39.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -73.36 -28.08 61.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.023 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.602 ' N ' ' O ' ' A' ' 56' ' ' LEU . 13.6 m-85 -78.9 2.07 21.41 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.341 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.94 46.09 27.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.644 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 33.8 mm -63.71 139.1 21.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.87 0.843 . . . . 0.0 110.67 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.748 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 24.1 tt0 -96.92 -179.37 4.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.214 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.748 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 6.1 mtpm? -43.28 30.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.353 -2.203 . . . . 0.0 115.001 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.627 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.6 mt-10 91.02 52.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.166 0.984 . . . . 0.0 111.498 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -62.89 152.11 37.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.194 177.643 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.01 123.45 32.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.414 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.91 144.96 29.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.815 0.34 . . . . 0.0 110.453 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -98.54 147.26 24.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.56 ' CD1' ' H ' ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.69 136.93 51.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.2 t -146.13 163.37 10.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.316 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.47 ' CB ' ' O ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER 80.01 111.81 0.07 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.424 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.628 -179.839 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 61' ' ' ILE . 15.0 mtt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.689 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 2.6 mt-30 -75.55 165.72 24.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.551 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.515 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 12.7 mt -140.97 142.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.807 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -141.01 133.99 29.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.475 0.655 . . . . 0.0 110.945 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 t -109.54 131.1 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.283 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.53 124.84 50.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.63 0.252 . . . . 0.0 110.449 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.426 ' C ' ' H ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -97.11 158.65 15.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.754 179.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -3.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.194 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 7' ' ' THR . 21.3 p -90.54 6.99 41.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.475 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.73 16.83 74.54 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -98.24 123.43 42.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.704 0.287 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 t -100.69 120.39 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.483 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 20.5 tt -117.49 110.12 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.228 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 t -101.07 138.15 38.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.138 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.519 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.34 146.49 40.46 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.495 ' OE1' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -95.3 109.49 21.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.549 HG21 ' O ' ' A' ' 18' ' ' GLU . 10.0 p -150.07 162.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.726 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.58 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 1.4 mp0 -84.38 177.84 2.74 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 4.0 Cg_exo -73.76 -6.74 19.12 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 121.611 1.541 . . . . 0.0 111.786 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.671 ' HA ' ' H ' ' A' ' 57' ' ' SER . 8.0 t -80.28 -27.21 38.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 116.386 -2.125 . . . . 0.0 107.863 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.616 ' OD1' ' O ' ' A' ' 19' ' ' PRO . 0.0 OUTLIER 33.36 68.76 0.15 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 117.698 -1.144 . . . . 0.0 111.955 170.213 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.56 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -79.83 132.71 36.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 114.437 -2.905 . . . . 0.0 105.297 -175.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.645 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -55.47 -37.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 112.878 -1.964 . . . . 0.0 111.557 -172.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.35 -31.15 68.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' THR . 5.0 t-20 -78.83 -44.65 22.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.043 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.4 t -72.37 -49.21 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.476 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.662 ' CE ' ' O ' ' A' ' 41' ' ' GLN . 10.4 mmmm -55.18 -35.33 64.7 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.586 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.44 -35.84 78.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -65.91 -36.92 84.71 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.25 -42.01 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 34' ' ' GLU . 51.8 tt0 -69.91 -34.22 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.732 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.83 -45.49 92.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.128 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 23.2 mmtp -67.19 -52.9 35.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.094 -179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 31' ' ' GLN . 77.6 tt0 -129.01 153.81 47.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.95 113.89 3.91 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.276 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.491 ' O ' ' CG2' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -151.96 120.23 3.31 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -69.83 130.66 19.64 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 CA-C-N 119.458 0.842 . . . . 0.0 110.976 -179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -49.68 -40.44 46.91 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.364 2.042 . . . . 0.0 112.222 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -59.49 -29.22 67.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -98.89 7.85 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.662 ' O ' ' CE ' ' A' ' 27' ' ' LYS . 3.9 tp-100 -121.64 129.38 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -131.21 142.52 50.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.022 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.04 146.5 48.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 7.5 pt -135.92 142.56 38.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.47 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -124.67 115.84 21.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 111.51 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.74 42.5 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.427 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -21.2 32.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -80.78 115.22 20.16 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -79.36 122.34 26.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.477 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.1 mt -79.55 130.61 35.55 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.612 ' O ' ' CD1' ' A' ' 23' ' ' ILE . 17.2 mt-10 -95.35 -169.47 1.98 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -47.42 7.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 111.926 -2.397 . . . . 0.0 114.432 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.588 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.98 44.46 0.49 Allowed Glycine 0 N--CA 1.461 0.325 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.134 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -81.52 153.76 26.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 1.9 m -78.45 141.16 38.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 116.402 -2.119 . . . . 0.0 110.336 -178.142 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.541 ' O ' ' N ' ' A' ' 59' ' ' TYR . 6.7 mp -76.7 -31.58 57.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.22 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.671 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.3 t -55.59 -33.28 63.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.35 -25.6 62.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.437 176.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 56' ' ' LEU . 4.0 m-85 -79.93 1.11 28.58 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.591 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.22 44.18 22.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.507 ' O ' ' SD ' ' A' ' 1' ' ' MET . 16.5 mm -65.57 138.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.98 0.895 . . . . 0.0 110.254 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.765 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 30.6 tt0 -96.24 -178.35 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.732 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.765 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 19.0 ttpt -43.27 29.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.544 -2.116 . . . . 0.0 114.889 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.717 ' N ' ' O ' ' A' ' 62' ' ' GLN . 19.5 tt0 92.37 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.958 0.885 . . . . 0.0 112.59 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.15 154.93 25.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.774 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.415 ' O ' ' CG2' ' A' ' 66' ' ' THR . 9.3 t -86.62 125.08 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.874 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 67' ' ' LEU . 6.1 mp -98.86 138.82 35.45 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -83.56 138.87 33.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 111.529 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.73 124.05 46.35 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.075 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 30.9 t -120.52 162.14 19.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.612 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 9.7 mt -38.32 -56.71 1.2 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.723 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.336 179.845 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.27 166.45 11.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.86 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.585 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 1.2 mt -118.52 158.78 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.822 0.82 . . . . 0.0 111.003 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -139.33 135.02 33.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.641 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.588 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 12.1 t -130.67 143.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.052 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -102.3 133.49 47.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.246 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 11' ' ' LYS . 21.6 p -85.61 163.83 18.09 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.619 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 pp -70.0 -10.82 59.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -96.39 -15.12 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -6.51 50.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.436 ' O ' ' OG1' ' A' ' 7' ' ' THR . 45.9 mttp -70.29 124.75 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 p -80.19 115.55 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.383 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.512 ' O ' ' CG2' ' A' ' 13' ' ' ILE . 11.9 tt -110.72 112.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.911 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 24.0 p -104.05 139.62 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.07 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.605 ' N ' ' CD2' ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.16 143.68 44.41 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.59 109.43 21.67 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.656 HG21 ' O ' ' A' ' 18' ' ' GLU . 8.9 p -151.02 171.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.04 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.656 ' O ' HG21 ' A' ' 17' ' ' VAL . 3.3 pm0 -92.13 174.68 3.96 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.3 Cg_exo -73.59 -6.49 18.8 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 C-N-CA 121.237 1.291 . . . . 0.0 112.35 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.66 ' HA ' ' H ' ' A' ' 57' ' ' SER . 89.8 p -78.03 -27.64 48.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 116.296 -2.162 . . . . 0.0 107.173 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.486 ' C ' ' O ' ' A' ' 20' ' ' SER . 0.5 OUTLIER 32.92 69.76 0.12 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.557 168.784 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.56 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -80.55 135.93 36.18 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 115.07 -2.652 . . . . 0.0 106.15 -175.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.648 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -54.71 -46.75 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 113.318 -1.765 . . . . 0.0 111.077 -173.296 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -57.71 -29.21 64.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -77.88 -39.46 43.15 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.181 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 22' ' ' THR . 36.2 t -72.47 -48.53 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.702 ' HD2' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -56.39 -41.69 76.7 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.522 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -38.09 68.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -67.59 -37.78 83.07 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 26' ' ' VAL . 27.5 mm -67.7 -32.23 55.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.634 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 27' ' ' LYS . 7.4 tt0 -68.95 -33.37 73.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.669 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -58.91 -45.22 90.84 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 mmtp -70.03 -53.91 15.48 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.2 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -130.82 155.02 47.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 114.4 3.85 Favored Glycine 0 C--O 1.23 -0.102 0 C-N-CA 119.003 -1.57 . . . . 0.0 111.733 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 tp -151.84 117.47 3.12 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 176.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.54 137.36 30.29 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 121.362 1.374 . . . . 0.0 111.945 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.4 -36.01 29.5 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.605 2.203 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -61.88 -25.93 67.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -109.32 9.34 25.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.42 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.575 ' O ' ' NZ ' ' A' ' 27' ' ' LYS . 25.4 tp60 -113.54 124.5 52.52 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.45 ' H ' HE21 ' A' ' 41' ' ' GLN . 6.2 ptp85 -131.81 134.5 45.86 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mt -122.88 159.32 28.44 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.8 143.8 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.252 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -144.54 128.92 17.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.549 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.7 45.38 18.08 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.33 -20.45 1.24 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.41 124.21 27.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -81.79 122.45 27.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.943 0.402 . . . . 0.0 111.337 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.514 HD21 ' CD2' ' A' ' 59' ' ' TYR . 73.1 mt -77.18 117.46 18.74 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.52 ' C ' ' H ' ' A' ' 53' ' ' GLY . 15.7 mt-10 -92.83 -168.02 1.86 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -174.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.69 7.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 111.325 -2.671 . . . . 0.0 115.481 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.52 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.82 43.14 0.54 Allowed Glycine 0 C--N 1.318 -0.456 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.193 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.451 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 36.6 mtt85 -82.59 152.46 25.93 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.49 HG21 ' H ' ' A' ' 57' ' ' SER . 0.9 OUTLIER -78.31 141.69 38.29 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.989 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 20' ' ' SER . 3.3 mp -76.42 -30.71 57.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.022 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.66 ' H ' ' HA ' ' A' ' 20' ' ' SER . 10.9 t -53.27 -30.69 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -73.4 -28.67 62.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.184 176.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 56' ' ' LEU . 9.4 m-85 -79.33 6.17 10.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.694 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m120 51.65 44.75 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.539 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.465 HG13 ' CD2' ' A' ' 56' ' ' LEU . 34.7 mm -64.18 138.84 22.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 122.178 0.99 . . . . 0.0 111.09 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . 0.764 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 47.3 tt0 -96.57 -179.76 4.72 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.195 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.764 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.5 ttpt -43.36 30.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.623 -2.08 . . . . 0.0 115.225 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.631 ' N ' ' O ' ' A' ' 62' ' ' GLN . 10.0 mt-10 91.73 54.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.181 0.991 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -61.7 156.9 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 m -82.53 126.52 32.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.0 110.189 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.561 HD11 ' N ' ' A' ' 67' ' ' LEU . 10.5 mp -98.57 137.65 36.91 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 -179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -91.64 137.45 32.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.994 0.426 . . . . 0.0 111.295 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD11 ' N ' ' A' ' 69' ' ' LEU . 5.9 mp -121.45 167.36 12.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.409 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.52 157.14 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.939 0.399 . . . . 0.0 110.273 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.466 ' CD2' ' N ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -162.88 149.43 12.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.675 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.776 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 10.6 mm-40 . . . . . 0 CA--C 1.516 -0.36 0 CA-C-O 120.986 0.422 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.429 ' CD1' ' CG ' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -142.1 136.75 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 6.3 m-30 -108.2 136.13 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.939 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.99 133.59 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -106.29 134.02 50.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.939 0.399 . . . . 0.0 110.976 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 p -117.14 150.85 38.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.156 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.66 -3.87 3.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 9' ' ' THR . 29.9 m -91.12 -8.97 47.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.594 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.39 78.16 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -77.42 124.57 28.06 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.675 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -82.31 121.21 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.228 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 13' ' ' ILE . 19.4 tt -120.1 129.46 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.712 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 p -117.21 137.76 52.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.755 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -115.48 147.17 40.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.9 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.91 109.85 22.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.789 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.0 p -149.88 175.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.836 -177.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.789 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -102.0 173.95 3.22 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.1 Cg_exo -74.51 -6.49 18.36 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 CA-C-N 120.751 1.304 . . . . 0.0 110.92 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.796 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -77.22 -27.34 53.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 116.833 -1.947 . . . . 0.0 105.745 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.787 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 31.57 64.01 0.22 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.551 168.674 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -83.73 135.89 34.39 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 114.903 -2.719 . . . . 0.0 106.469 -175.616 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.676 HG13 ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -52.78 -41.07 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.203 -1.817 . . . . 0.0 110.843 -173.111 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 0.0 OUTLIER -61.6 -30.0 70.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 22' ' ' THR . 11.1 t30 -79.28 -46.02 18.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.995 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.654 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.3 t -72.47 -45.64 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.08 0.467 . . . . 0.0 110.172 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.705 ' NZ ' HD12 ' A' ' 30' ' ' ILE . 2.7 mmtm -54.83 -51.86 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.367 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.22 -35.99 70.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.512 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -64.23 -36.68 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.705 HD12 ' NZ ' ' A' ' 27' ' ' LYS . 73.3 mt -75.88 -28.93 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.547 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.452 ' OE1' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -56.72 -35.29 68.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -44.75 73.09 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -60.92 -52.28 65.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 56.1 mt-10 -146.65 154.24 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.94 116.64 4.65 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 119.042 -1.551 . . . . 0.0 111.241 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.975 HD13 ' OE1' ' A' ' 41' ' ' GLN . 2.7 pp -149.47 117.25 3.72 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 2.9 Cg_endo -73.13 131.06 16.13 Favored 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.911 1.741 . . . . 0.0 111.833 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 -45.29 22.59 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.908 1.739 . . . . 0.0 111.926 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.55 -16.71 40.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.621 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -111.09 -15.72 13.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.165 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.975 ' OE1' HD13 ' A' ' 36' ' ' ILE . 52.4 tt0 -111.4 138.32 48.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.405 HH11 ' HB3' ' A' ' 42' ' ' ARG . 29.0 mtp-105 -128.48 144.85 51.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.745 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' HZ1' ' A' ' 27' ' ' LYS . 18.0 mt -116.27 174.47 6.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -134.75 138.27 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.507 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.36 117.31 21.96 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.721 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 44.66 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.31 -20.38 17.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -78.55 135.41 37.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -84.65 118.75 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.39 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 56' ' ' LEU . 13.2 mt -81.05 146.31 30.69 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.676 ' O ' HG13 ' A' ' 23' ' ' ILE . 2.6 mt-10 -96.62 -173.33 2.71 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -54.97 8.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 111.343 -2.662 . . . . 0.0 114.306 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.52 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . 121.58 43.05 0.43 Allowed Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.708 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mmt-85 -83.12 165.62 19.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 172.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 57' ' ' SER . 67.8 m -87.27 142.32 27.99 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 116.96 -1.896 . . . . 0.0 111.124 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' ' 21' ' ' ASP . 3.2 mp -76.97 -33.53 57.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.409 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.796 ' H ' ' HA ' ' A' ' 20' ' ' SER . 15.8 m -57.53 -36.11 71.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -24.14 64.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 2.8 m-85 -83.49 6.53 19.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.51 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.6 43.2 28.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.182 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.661 HG13 HD23 ' A' ' 56' ' ' LEU . 20.7 mm -65.73 140.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 122.181 0.991 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.819 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 23.3 tt0 -94.47 -176.49 3.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.35 -1.75 . . . . 0.0 113.254 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.819 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.2 tmtm? -41.15 25.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.546 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.771 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.3 pt-20 91.01 53.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.265 1.031 . . . . 0.0 113.429 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.61 152.62 18.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.43 177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.507 ' C ' HD12 ' A' ' 67' ' ' LEU . 30.8 m -86.71 119.36 26.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.167 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.783 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.8 mp -98.8 131.13 45.16 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -120.32 138.56 53.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.933 0.397 . . . . 0.0 111.227 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.569 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.192 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 . . . . . 0 C--O 1.23 0.07 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.512 HG12 HG21 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -117.13 151.35 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.316 0.579 . . . . 0.0 110.261 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -139.95 132.47 28.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.646 -179.005 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.543 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 87.8 t -119.79 132.3 69.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -101.87 121.86 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.926 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p -89.32 161.34 16.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.34 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.35 -4.81 28.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -95.72 1.76 53.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.97 -4.01 63.16 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -72.61 123.08 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.834 0.35 . . . . 0.0 110.281 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -91.95 125.01 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.973 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 13' ' ' ILE . 1.2 tp -119.03 121.62 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.788 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 p -110.79 133.08 53.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.8 145.9 42.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.635 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 8.4 mp0 -96.25 110.68 22.95 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 18' ' ' GLU . 7.1 p -150.52 149.61 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.764 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.938 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.4 pm0 -70.55 177.04 1.55 Allowed Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.0 Cg_exo -74.49 -6.56 18.46 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 121.584 1.522 . . . . 0.0 111.868 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 56' ' ' LEU . 83.2 p -78.82 -27.32 44.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 116.365 -2.134 . . . . 0.0 107.647 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 1.128 ' O ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 31.54 67.86 0.13 Allowed 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.885 169.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.65 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.14 133.4 36.06 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 114.331 -2.947 . . . . 0.0 106.097 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -54.41 -35.1 29.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 112.872 -1.967 . . . . 0.0 110.744 -173.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' H ' ' HA2' ' A' ' 53' ' ' GLY . 15.8 tt0 -62.88 -33.29 74.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 22' ' ' THR . 3.4 t30 -78.86 -45.68 20.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.345 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' THR . 16.9 t -72.6 -37.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.403 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.608 ' NZ ' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.7 -51.34 65.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.457 . . . . 0.0 110.418 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.06 -35.38 69.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.382 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -63.48 -37.77 88.57 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.16 -42.6 79.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.639 ' O ' ' O ' ' A' ' 34' ' ' GLU . 8.6 tm0? -69.14 -32.27 71.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.716 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -58.93 -37.73 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.816 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -61.83 -54.12 46.51 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 110.736 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.639 ' O ' ' O ' ' A' ' 31' ' ' GLN . 36.9 mt-10 -140.94 176.63 8.65 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.68 113.8 3.83 Favored Glycine 0 CA--C 1.51 -0.252 0 C-N-CA 118.532 -1.794 . . . . 0.0 110.637 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.476 HD13 ' HD2' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -151.83 118.86 3.21 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.476 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' HD13 ' A' ' 36' ' ' ILE . 3.4 Cg_exo -71.67 130.14 16.6 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 120.564 0.843 . . . . 0.0 111.722 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 3.3 Cg_exo -57.82 -34.46 98.29 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.047 1.831 . . . . 0.0 111.597 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -66.57 -26.75 67.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.044 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -104.42 0.67 29.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.814 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.501 ' NE2' ' N ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -104.71 126.74 52.09 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.597 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.501 ' N ' ' NE2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.08 142.43 50.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.608 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 7.2 mt -118.44 162.42 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.7 mt -136.03 139.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.27 119.44 17.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.287 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 35.41 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.336 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.98 -19.7 24.46 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -82.18 116.84 21.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.397 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.37 127.77 33.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' A' ' 23' ' ' ILE . 43.5 mt -76.73 127.76 33.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.889 ' O ' HD12 ' A' ' 23' ' ' ILE . 1.2 mp0 -81.65 -169.81 2.51 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -48.8 6.09 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 111.646 -2.524 . . . . 0.0 115.09 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 23' ' ' ILE . . . 117.85 44.1 0.55 Allowed Glycine 0 C--N 1.316 -0.534 0 C-N-CA 119.93 -1.129 . . . . 0.0 111.964 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -81.67 159.14 24.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 173.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -79.08 141.17 37.58 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 116.916 -1.914 . . . . 0.0 110.039 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.128 HD23 ' O ' ' A' ' 21' ' ' ASP . 2.2 mm? -74.52 -32.5 62.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.985 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.69 ' H ' ' HA ' ' A' ' 20' ' ' SER . 7.2 t -54.77 -30.71 57.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.542 ' H ' HG22 ' A' ' 55' ' ' THR . 8.6 t70 -71.98 -29.29 64.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 19.0 m-85 -79.4 -6.39 56.73 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.66 44.64 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.843 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.909 ' CG1' HD12 ' A' ' 56' ' ' LEU . 31.7 mm -64.43 137.66 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.947 0.879 . . . . 0.0 110.152 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.696 ' O ' ' N ' ' A' ' 64' ' ' GLU . 10.8 pt20 -102.55 -174.37 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.714 -1.584 . . . . 0.0 114.057 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.584 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 49.1 mttt -42.05 30.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.365 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 62' ' ' GLN . 9.1 mt-10 91.38 53.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.919 0.866 . . . . 0.0 113.282 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 153.57 35.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.745 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 66' ' ' THR . 5.8 t -86.24 126.68 34.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.06 139.19 35.07 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -88.49 138.04 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 111.23 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.199 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -120.61 155.65 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 2.5 t80 -137.21 132.72 34.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.857 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.6 t -128.8 146.74 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.725 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -98.34 120.63 39.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 p -87.19 161.77 17.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.187 0.518 . . . . 0.0 111.382 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 8' ' ' LEU . 4.6 mp -71.77 -11.8 60.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.662 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -94.01 -10.89 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.34 2.15 77.33 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -81.07 131.51 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 110.564 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.79 121.84 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 13' ' ' ILE . 11.6 tt -115.04 122.09 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.117 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -112.74 137.64 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.057 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.75 147.83 39.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.128 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.26 109.77 21.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.779 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.6 p -150.51 173.6 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.496 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.779 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.0 mp0 -99.4 175.98 2.18 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -73.54 -7.54 20.42 Favored 'Trans proline' 0 C--N 1.288 -2.633 0 C-N-CA 121.245 1.297 . . . . 0.0 111.066 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.721 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.11 -28.21 48.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 116.542 -2.063 . . . . 0.0 106.807 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.726 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 32.88 67.19 0.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.994 169.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -80.62 133.44 35.74 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 114.645 -2.822 . . . . 0.0 105.826 -175.886 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.809 HD12 ' O ' ' A' ' 51' ' ' GLU . 1.1 mt -55.13 -43.58 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.015 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -59.73 -29.58 68.24 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 175.18 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -77.66 -44.68 27.3 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.821 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 22' ' ' THR . 10.7 t -72.25 -39.73 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.347 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.706 ' HZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.53 -41.99 70.34 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.596 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.68 78.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -36.4 81.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 26' ' ' VAL . 21.1 mm -62.04 -40.35 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' O ' ' A' ' 34' ' ' GLU . 12.4 tt0 -69.1 -31.99 71.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.2 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.37 -44.64 88.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' H ' ' HD2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.93 -53.59 55.38 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.935 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.7 mt-10 -135.92 155.56 50.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.94 112.37 3.47 Favored Glycine 0 CA--C 1.505 -0.54 0 C-N-CA 118.529 -1.796 . . . . 0.0 110.72 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pt -152.85 119.03 2.98 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.49 128.91 32.03 Favored 'Trans proline' 0 C--N 1.287 -2.695 0 CA-C-N 118.839 0.621 . . . . 0.0 110.706 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.21 -34.91 93.67 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.934 1.756 . . . . 0.0 112.288 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.5 -8.18 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.175 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.99 -12.96 14.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -83.82 126.0 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.814 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.4 mtt180 -129.38 128.28 42.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -131.61 149.75 52.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.444 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.25 143.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.604 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 41.0 t80 -120.59 115.54 23.6 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.916 0.389 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 39.22 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 -20.9 34.0 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 20.2 mttm -79.19 117.5 20.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 12.4 pt20 -76.79 121.3 23.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.298 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.117 HD22 HD11 ' A' ' 56' ' ' LEU . 67.6 mt -76.99 127.03 31.96 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.809 ' O ' HD12 ' A' ' 23' ' ' ILE . 22.3 mt-10 -90.63 -169.32 2.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -174.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -47.59 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 111.798 -2.456 . . . . 0.0 114.504 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.81 44.6 0.58 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.383 -176.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -81.17 160.55 24.33 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 57' ' ' SER . 21.7 m -79.37 140.44 37.46 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 116.257 -2.177 . . . . 0.0 110.34 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.117 HD11 HD22 ' A' ' 50' ' ' LEU . 3.2 mp -77.54 -30.46 52.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.009 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.721 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.9 t -54.96 -30.51 59.13 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.27 -27.72 62.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.242 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 56' ' ' LEU . 10.5 m-85 -79.25 -5.4 54.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.968 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.47 45.13 11.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.729 HG13 HD23 ' A' ' 56' ' ' LEU . 37.9 mm -64.42 136.89 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.141 0.972 . . . . 0.0 109.978 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.74 ' O ' ' N ' ' A' ' 64' ' ' GLU . 9.0 pt20 -97.53 -173.76 2.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.291 -1.777 . . . . 0.0 114.284 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.703 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 1.6 pttm -41.62 26.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 112.123 -2.308 . . . . 0.0 115.259 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER 90.64 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.875 1.321 . . . . 0.0 113.111 -178.407 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.4 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.5 OUTLIER -62.4 157.02 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.74 177.318 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.561 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.8 p -84.16 131.55 34.76 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.751 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.09 142.84 28.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.794 0.33 . . . . 0.0 110.504 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 134.99 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 179.096 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.767 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.8 mp0 . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.02 135.78 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 121.489 0.661 . . . . 0.0 110.262 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.448 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 4.3 m-30 -110.29 142.62 41.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.543 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.54 59.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -101.19 122.83 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -98.06 151.79 19.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -71.25 -10.74 60.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.13 2.41 56.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.577 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.98 15.11 78.47 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -93.49 127.57 39.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -86.55 115.92 24.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 33' ' ' LYS . 19.1 tt -112.6 118.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.915 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.599 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -107.21 138.56 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.623 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.86 145.27 43.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 109.98 22.33 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.782 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.6 p -149.64 171.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.937 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.782 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -95.8 172.48 5.22 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.649 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -75.18 -7.88 19.39 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 121.392 1.394 . . . . 0.0 111.074 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.698 ' HA ' ' H ' ' A' ' 57' ' ' SER . 1.1 m -78.0 -27.08 48.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 116.712 -1.995 . . . . 0.0 105.805 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.724 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 33.43 68.27 0.16 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.795 169.109 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -79.46 132.74 36.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 114.25 -2.98 . . . . 0.0 105.481 -175.674 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -55.69 -40.37 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.878 -1.965 . . . . 0.0 110.859 -173.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -60.38 -29.9 69.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' THR . 13.6 t-20 -78.01 -44.58 26.18 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.956 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 30' ' ' ILE . 6.8 t -72.2 -35.73 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.302 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.638 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.5 -51.85 63.8 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.808 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.71 76.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.65 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HZ2' ' CG ' ' A' ' 25' ' ' ASN . 19.8 mttp -64.57 -36.76 85.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.2 mm -63.5 -45.7 97.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.631 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -69.94 -33.16 71.77 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.45 -44.77 92.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.743 ' HB2' HD11 ' A' ' 13' ' ' ILE . 2.6 mtpt -68.58 -54.5 16.18 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.766 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLN . 13.9 mm-40 -123.91 151.4 43.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.44 111.06 3.17 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 118.317 -1.897 . . . . 0.0 111.104 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.513 HD13 ' OE1' ' A' ' 41' ' ' GLN . 1.8 tt -154.19 117.0 2.58 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.4 129.68 32.38 Favored 'Trans proline' 0 C--N 1.288 -2.621 0 CA-C-N 119.093 0.712 . . . . 0.0 111.156 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.56 -27.48 76.96 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.095 1.863 . . . . 0.0 112.086 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.84 -27.46 68.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.017 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -107.35 7.74 29.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.566 HE21 ' N ' ' A' ' 42' ' ' ARG . 36.9 tp60 -89.19 127.01 35.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.988 0.423 . . . . 0.0 110.918 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.566 ' N ' HE21 ' A' ' 41' ' ' GLN . 55.7 mtp180 -128.23 132.84 48.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.104 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -124.06 151.44 43.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 110.762 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.5 mt -135.44 139.99 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.6 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' LYS . 70.7 t80 -121.75 116.4 24.44 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.584 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.09 33.54 3.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.03 -20.32 48.19 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' PHE . 55.2 mttm -78.15 120.38 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.901 0.381 . . . . 0.0 110.357 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -75.17 123.48 25.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 56' ' ' LEU . 83.8 mt -76.77 132.86 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.849 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.9 mt-10 -86.94 -170.6 3.14 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -49.0 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 111.595 -2.548 . . . . 0.0 114.781 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.62 44.18 0.6 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.856 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 159.32 23.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 102.874 -3.009 . . . . 0.0 102.874 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -78.29 140.36 38.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 116.179 -2.208 . . . . 0.0 109.254 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HD22 ' A' ' 50' ' ' LEU . 3.0 mp -77.37 -31.14 54.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.368 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.698 ' H ' ' HA ' ' A' ' 20' ' ' SER . 35.6 p -55.12 -30.33 59.55 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 55' ' ' THR . 33.0 t0 -71.73 -26.32 62.42 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.846 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' LEU . 5.8 m-85 -79.22 3.86 16.62 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.522 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.69 40.45 19.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.423 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.629 HG13 HD23 ' A' ' 56' ' ' LEU . 21.9 mm -64.97 132.17 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.031 0.92 . . . . 0.0 109.018 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.763 ' O ' ' N ' ' A' ' 64' ' ' GLU . 7.8 pt20 -96.82 -172.39 2.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.68 -1.6 . . . . 0.0 114.223 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.749 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 5.8 mmtt -41.03 26.3 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.482 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.767 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 1.8 pt-20 90.94 52.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.441 1.115 . . . . 0.0 113.246 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.6 OUTLIER -61.74 152.75 30.32 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.894 176.537 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -86.1 128.97 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -98.65 132.61 43.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -88.3 141.83 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.604 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.696 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 7.3 mt-30 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.469 0.176 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -120.74 159.96 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' A' ' 3' ' ' ILE . 5.1 t80 -140.92 134.74 30.44 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.012 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.528 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 71.4 t -130.72 141.51 46.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.84 140.4 36.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.095 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -106.15 149.44 26.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.926 0.393 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mt -72.85 -11.97 60.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 p -91.82 -10.61 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.02 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.66 -4.86 73.06 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -78.87 128.29 33.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.203 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 m -76.49 116.14 16.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.5 tt -115.51 113.5 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.256 0.551 . . . . 0.0 110.182 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 p -117.6 139.61 50.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.13 144.13 43.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.189 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -95.81 111.08 23.14 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.808 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.2 p -149.86 174.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.338 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.808 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.9 mp0 -100.04 177.32 1.58 Allowed Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.08 -7.62 20.08 Favored 'Trans proline' 0 C--N 1.29 -2.539 0 C-N-CA 121.459 1.439 . . . . 0.0 112.155 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.731 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -78.17 -28.47 48.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 116.238 -2.185 . . . . 0.0 106.525 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.821 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 32.24 66.86 0.17 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.234 168.675 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -81.5 135.41 35.61 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 115.118 -2.633 . . . . 0.0 105.83 -176.065 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.727 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -54.27 -43.95 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.152 -173.586 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.18 -29.95 67.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 22' ' ' THR . 2.8 t-20 -78.26 -44.87 24.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.676 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.2 t -72.73 -39.42 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.638 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.66 ' NZ ' HD11 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -54.33 -52.05 62.76 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.153 0.501 . . . . 0.0 110.392 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.48 68.27 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.326 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -38.06 89.69 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.627 HG22 HD11 ' A' ' 36' ' ' ILE . 19.4 mm -67.46 -39.79 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' O ' ' O ' ' A' ' 34' ' ' GLU . 14.9 tt0 -61.95 -34.06 75.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -59.24 -34.31 72.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.204 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HG3' HD11 ' A' ' 13' ' ' ILE . 29.1 mmtt -60.17 -31.23 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.208 0.528 . . . . 0.0 109.928 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 31' ' ' GLN . 2.8 pt-20 -160.46 -116.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.54 111.4 0.52 Allowed Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.692 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -153.6 119.27 2.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 2.9 Cg_endo -71.76 140.45 35.57 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 121.313 1.342 . . . . 0.0 112.18 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.34 -27.7 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.131 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.11 -31.54 69.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.768 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.37 8.79 23.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' OE1' ' O ' ' A' ' 37' ' ' PRO . 3.0 mp0 -112.03 126.11 54.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.469 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 42' ' ' ARG . 54.5 mtt85 -130.34 141.66 50.57 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.546 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.66 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 16.2 mt -120.41 163.06 18.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.778 0.323 . . . . 0.0 110.69 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -135.58 143.33 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LYS . 8.2 t80 -141.47 125.08 16.79 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.774 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.44 45.74 17.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 -19.11 1.87 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -81.68 115.72 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 0.0 110.087 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.625 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -72.76 125.0 26.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.666 HD13 HD11 ' A' ' 56' ' ' LEU . 45.5 mt -77.3 137.38 38.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.569 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 16.4 mp0 -95.05 -171.54 2.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 5.6 t0 -47.92 7.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 111.907 -2.406 . . . . 0.0 114.599 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.71 43.46 0.53 Allowed Glycine 0 C--N 1.32 -0.361 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.884 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -82.63 161.94 22.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 57' ' ' SER . 51.9 m -85.34 143.15 28.83 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 117.188 -1.805 . . . . 0.0 111.763 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.863 HD23 HG13 ' A' ' 61' ' ' ILE . 3.5 mp -77.21 -32.88 56.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.999 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.731 ' H ' ' HA ' ' A' ' 20' ' ' SER . 5.4 t -55.85 -33.57 64.64 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.58 -26.91 61.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.571 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 9.7 m-85 -79.26 1.84 23.39 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 57.8 45.1 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.639 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 56' ' ' LEU . 34.8 mm -64.93 139.66 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 122.111 0.957 . . . . 0.0 110.588 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.762 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 38.8 tt0 -95.25 -179.28 4.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.693 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.777 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 39.0 mttp -43.05 28.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.265 -2.243 . . . . 0.0 115.197 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.777 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.52 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.837 1.303 . . . . 0.0 112.756 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 p -61.96 154.29 26.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.055 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 66' ' ' THR . 0.0 OUTLIER -86.88 115.9 24.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.198 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.8 mp -98.16 137.97 36.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.01 142.73 31.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.401 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 22.7 mp0 . . . . . 0 N--CA 1.461 0.095 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.796 HD11 HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -118.3 152.62 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.336 0.589 . . . . 0.0 109.505 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 63.3 t80 -138.89 132.51 30.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.702 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 69' ' ' LEU . 85.1 t -130.16 140.34 49.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -128.66 144.13 51.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 110.548 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 p -115.91 173.09 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.2 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.83 -7.85 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -92.73 -11.48 33.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.592 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.44 6.49 84.12 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -61.49 132.17 52.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 12' ' ' THR . 7.9 t -89.51 115.36 26.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 13' ' ' ILE . 8.1 tt -121.47 120.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.295 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.677 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.8 p -117.28 135.65 53.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.181 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -116.15 146.42 42.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.772 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -95.8 111.0 23.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.769 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.1 p -148.68 171.79 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.162 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.769 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.3 pm0 -105.55 153.55 39.75 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.824 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.3 Cg_endo -52.02 -8.86 0.37 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 121.881 1.721 . . . . 0.0 112.641 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 21' ' ' ASP . 5.9 t -77.61 -28.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 115.224 -2.59 . . . . 0.0 105.988 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.728 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 31.32 65.64 0.17 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.339 168.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.61 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -81.48 132.67 35.33 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 114.374 -2.931 . . . . 0.0 105.893 -175.586 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 51' ' ' GLU . 1.2 mt -54.9 -39.52 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 CA-C-N 112.686 -2.052 . . . . 0.0 110.819 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.68 -29.87 70.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' THR . 4.6 t-20 -78.55 -44.62 23.81 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.187 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 22' ' ' THR . 3.4 t -72.34 -32.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.223 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' CD ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.86 -47.92 60.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -178.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.2 76.17 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.513 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -65.93 -35.98 82.09 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.3 mm -61.7 -45.56 98.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.68 -33.1 70.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.977 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -58.35 -44.85 88.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -62.76 -54.26 41.81 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.479 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 31' ' ' GLN . 75.8 mt-10 -132.59 157.21 45.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.58 111.87 3.34 Favored Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 118.445 -1.836 . . . . 0.0 110.597 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 30' ' ' ILE . 1.4 pt -153.86 119.55 2.8 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.78 127.52 21.77 Favored 'Trans proline' 0 C--N 1.288 -2.607 0 CA-C-N 119.401 0.822 . . . . 0.0 110.977 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.57 -42.9 24.1 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.282 1.988 . . . . 0.0 112.269 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.26 -17.67 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.693 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -109.97 7.41 23.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -116.58 128.64 55.6 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.151 0.501 . . . . 0.0 111.217 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mtp-105 -126.42 140.77 52.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.857 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.72 148.65 47.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.874 0.369 . . . . 0.0 111.28 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.94 141.33 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.97 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 48' ' ' LYS . 39.6 t80 -123.64 131.7 53.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.135 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.17 44.25 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.902 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.1 -20.64 6.54 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 45' ' ' PHE . 20.6 mtpt -79.58 138.46 37.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -92.06 121.49 33.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.726 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.873 HD22 HD11 ' A' ' 56' ' ' LEU . 67.3 mt -76.29 106.04 7.69 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.816 ' O ' HD12 ' A' ' 23' ' ' ILE . 4.1 mt-10 -69.13 -168.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 31.7 t0 -46.79 5.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 111.644 -2.526 . . . . 0.0 115.159 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.88 45.47 0.55 Allowed Glycine 0 C--N 1.318 -0.461 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.69 -176.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.75 26.92 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 172.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 20' ' ' SER . 1.2 m -77.87 140.91 39.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 116.382 -2.127 . . . . 0.0 110.52 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.873 HD11 HD22 ' A' ' 50' ' ' LEU . 2.9 mp -76.35 -30.06 57.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.726 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.824 ' N ' ' O ' ' A' ' 19' ' ' PRO . 6.2 t -54.77 -32.8 60.53 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 55' ' ' THR . 30.9 t70 -72.66 -26.0 61.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.176 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' LEU . 7.9 m-85 -79.29 4.85 13.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.233 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.73 44.64 29.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.65 HG13 HD23 ' A' ' 56' ' ' LEU . 35.3 mm -64.6 137.56 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.719 0.771 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.733 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.9 pt20 -101.78 -173.97 2.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.304 -1.316 . . . . 0.0 113.975 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.672 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 3.4 ttpm? -41.74 28.66 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 111.867 -2.424 . . . . 0.0 115.07 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.733 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.2 pt-20 91.35 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 122.846 1.308 . . . . 0.0 112.874 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -61.63 153.77 26.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.384 177.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.434 ' C ' HD12 ' A' ' 67' ' ' LEU . 10.3 m -85.51 123.86 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.85 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.9 mp -98.41 136.79 38.04 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -83.25 135.48 34.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.875 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.641 HD11 ' CG1' ' A' ' 5' ' ' VAL . 42.3 mt . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.108 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 59.9 mt-30 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.767 0.318 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.636 HD11 HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -120.41 156.42 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 2.7 t80 -140.89 132.72 27.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.242 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 79.6 t -129.84 142.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.243 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -122.44 121.33 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -84.17 175.1 9.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.9 mp -69.95 -10.04 57.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.443 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.9 p -91.8 -4.19 55.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.317 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.24 82.25 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -65.0 131.52 46.82 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.45 116.23 28.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.42 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 33' ' ' LYS . 13.6 tt -120.07 122.53 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.364 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.488 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 10.1 p -116.0 139.95 49.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.738 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.99 148.1 37.5 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -94.25 109.78 21.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.82 HG21 ' OD1' ' A' ' 21' ' ' ASP . 9.6 p -150.36 171.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.864 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.772 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.6 pm0 -93.99 174.29 3.91 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.16 -5.91 17.67 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 121.293 1.329 . . . . 0.0 111.768 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.32 -28.73 57.02 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 116.226 -2.19 . . . . 0.0 105.764 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.82 ' OD1' HG21 ' A' ' 17' ' ' VAL . 3.4 m-20 32.71 64.96 0.25 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.026 168.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.664 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -84.68 137.7 33.09 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 115.849 -2.34 . . . . 0.0 107.375 -175.682 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.613 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.1 mm -53.07 -40.98 40.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.311 -174.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.86 -33.12 71.39 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.634 ' HB3' ' O ' ' A' ' 22' ' ' THR . 13.6 t-20 -78.79 -46.55 18.54 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.78 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.4 t -73.51 -35.3 44.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.146 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' NZ ' HD21 ' A' ' 43' ' ' LEU . 1.6 mmtm -54.3 -51.88 63.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.95 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.6 76.14 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.004 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -61.31 -36.01 78.94 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.7 mm -63.46 -45.87 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.696 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' GLU . 24.6 tt0 -69.23 -31.96 70.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.022 0.439 . . . . 0.0 111.062 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -41.67 82.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.347 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' CB ' HD11 ' A' ' 13' ' ' ILE . 14.6 mmtp -64.45 -54.42 32.89 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.244 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.9 mt-10 -141.22 171.69 13.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.39 112.14 3.41 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 118.647 -1.739 . . . . 0.0 110.551 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 tt -153.85 122.0 3.03 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.84 126.23 14.97 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 CA-C-N 119.392 0.819 . . . . 0.0 111.404 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 -45.56 9.5 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.649 2.233 . . . . 0.0 112.62 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.96 -27.01 66.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.448 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -97.68 9.2 43.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.307 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.608 HE22 ' CD2' ' A' ' 69' ' ' LEU . 2.1 tm0? -112.12 126.76 55.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.741 ' C ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -129.48 138.1 51.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.107 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -131.55 159.5 38.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.709 0.29 . . . . 0.0 110.265 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 68' ' ' HIS . 7.6 tt -136.4 140.34 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.352 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 48' ' ' LYS . 6.5 t80 -128.57 134.68 48.69 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.11 33.9 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.925 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.6 -21.0 11.78 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 45' ' ' PHE . 5.8 mtmm -80.52 115.33 19.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -71.05 121.51 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.64 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.959 HD22 HD11 ' A' ' 56' ' ' LEU . 64.4 mt -77.4 114.07 15.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.601 ' O ' HG13 ' A' ' 23' ' ' ILE . 16.9 mt-10 -87.95 -167.69 1.97 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -45.65 8.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 111.902 -2.408 . . . . 0.0 114.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 119.68 44.62 0.46 Allowed Glycine 0 C--N 1.318 -0.451 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.161 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 150.22 28.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -79.41 141.18 37.08 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 116.912 -1.915 . . . . 0.0 111.364 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.959 HD11 HD22 ' A' ' 50' ' ' LEU . 3.9 mp -78.06 -31.7 50.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.802 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.615 ' N ' ' O ' ' A' ' 19' ' ' PRO . 5.8 t -54.38 -31.59 55.15 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -72.36 -30.26 64.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.649 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 56' ' ' LEU . 6.7 m-85 -79.06 5.36 12.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 52.18 45.02 29.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.306 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.696 HG13 HD23 ' A' ' 56' ' ' LEU . 24.8 mm -64.8 138.1 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.173 0.987 . . . . 0.0 110.636 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.68 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.0 pt20 -100.72 -173.31 2.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.899 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.786 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 56.8 mttm -41.24 28.66 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 111.681 -2.509 . . . . 0.0 115.749 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.786 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.94 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.859 1.314 . . . . 0.0 113.271 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -60.55 154.74 20.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.766 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.438 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -85.63 126.75 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 6.5 mp -98.93 134.37 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.312 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.559 ' O ' HG22 ' A' ' 44' ' ' ILE . 6.3 t-80 -85.84 132.48 34.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.923 0.392 . . . . 0.0 110.218 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' CD2' HE22 ' A' ' 41' ' ' GLN . 12.6 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.528 0.204 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.593 HD12 ' CG ' ' A' ' 21' ' ' ASP . 1.6 mt -121.11 152.44 24.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.397 0.617 . . . . 0.0 110.817 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.17 133.64 31.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.903 -179.07 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 89.5 t -123.82 144.24 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 111.133 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.701 ' O ' HD11 ' A' ' 69' ' ' LEU . 19.7 tttm -100.58 139.57 36.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 p -115.95 161.21 19.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.835 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.99 -4.01 15.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.262 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -92.07 -14.01 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 15.16 80.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -94.0 130.94 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 12' ' ' THR . 1.7 t -76.82 120.21 21.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 13' ' ' ILE . 10.0 tt -116.37 117.95 57.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.888 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.787 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.4 p -115.73 135.56 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.275 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -115.21 147.55 40.2 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -95.63 109.4 21.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.778 HG22 ' N ' ' A' ' 18' ' ' GLU . 10.6 p -149.95 174.19 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.953 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.778 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -109.27 155.06 41.74 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.355 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.826 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.2 Cg_endo -49.77 -7.96 0.1 Allowed 'Trans proline' 0 C--N 1.29 -2.512 0 C-N-CA 121.725 1.617 . . . . 0.0 113.348 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 56' ' ' LEU . 66.1 m -75.81 -28.81 58.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 114.992 -2.683 . . . . 0.0 105.553 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.745 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER 30.53 64.65 0.16 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 117.892 -1.052 . . . . 0.0 111.682 168.356 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -82.56 135.35 35.11 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 114.683 -2.807 . . . . 0.0 106.586 -175.567 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.88 -31.1 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.831 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.709 -173.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -29.83 67.57 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.635 ' N ' ' O ' ' A' ' 22' ' ' THR . 1.6 t-20 -78.23 -44.47 25.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' THR . 64.1 t -72.23 -34.72 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.27 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.64 -51.94 61.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -178.651 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -61.02 -35.07 75.89 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -62.17 -36.86 83.14 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.683 HG21 ' HG2' ' A' ' 41' ' ' GLN . 30.4 mm -62.78 -37.05 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -70.54 -35.77 73.31 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 4.9 m-20 -62.78 -44.35 96.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -61.45 -54.28 45.5 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.25 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -138.32 168.34 19.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.03 111.32 3.22 Favored Glycine 0 CA--C 1.507 -0.436 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.187 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 118.25 2.75 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.05 128.3 19.38 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.21 -27.51 85.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.845 1.697 . . . . 0.0 112.195 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -67.58 -27.93 67.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.388 . . . . 0.0 110.374 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -93.98 -13.05 27.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.449 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.683 ' HG2' HG21 ' A' ' 30' ' ' ILE . 6.7 tp-100 -81.09 139.66 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 43' ' ' LEU . 2.3 tpt85 -124.45 136.59 54.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.379 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 42' ' ' ARG . 4.5 mp -125.05 130.95 53.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.842 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.2 mt -135.67 142.15 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.1 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' LYS . 7.2 t80 -144.68 137.69 26.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.915 0.388 . . . . 0.0 111.199 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.04 44.48 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.39 -19.71 1.06 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 46' ' ' ALA . 5.7 mtmt -83.4 124.98 31.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 110.828 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.636 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -79.55 126.43 30.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.647 ' HB3' HD13 ' A' ' 23' ' ' ILE . 14.0 mt -76.44 129.26 36.29 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.877 ' O ' HD12 ' A' ' 23' ' ' ILE . 17.4 mt-10 -87.26 -169.56 2.67 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.51 5.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 111.806 -2.452 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 117.9 45.35 0.51 Allowed Glycine 0 C--N 1.321 -0.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.241 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.605 ' NH2' ' H ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -80.37 159.3 25.77 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 173.432 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.605 ' H ' ' NH2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -78.45 139.45 38.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 116.341 -2.144 . . . . 0.0 109.52 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.796 HD23 HG13 ' A' ' 61' ' ' ILE . 5.0 mp -77.41 -28.93 52.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.689 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 19' ' ' PRO . 3.6 t -53.51 -30.14 39.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 55' ' ' THR . 74.4 m-20 -73.36 -28.08 61.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.023 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 56' ' ' LEU . 13.6 m-85 -78.9 2.07 21.41 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.341 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.94 46.09 27.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.644 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.796 HG13 HD23 ' A' ' 56' ' ' LEU . 33.8 mm -63.71 139.1 21.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.87 0.843 . . . . 0.0 110.67 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.739 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 24.1 tt0 -96.92 -179.37 4.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.214 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.739 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 6.1 mtpm? -43.28 30.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.353 -2.203 . . . . 0.0 115.001 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.6 mt-10 91.02 52.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.166 0.984 . . . . 0.0 111.498 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -62.89 152.11 37.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.194 177.643 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.01 123.45 32.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.414 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.91 144.96 29.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.815 0.34 . . . . 0.0 110.453 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -98.54 147.26 24.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.991 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.696 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 15.2 mt-30 . . . . . 0 CA--C 1.52 -0.198 0 CA-C-O 120.557 0.218 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 12.7 mt -140.97 142.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.807 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -141.01 133.99 29.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.475 0.655 . . . . 0.0 110.945 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 t -109.54 131.1 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.283 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.53 124.84 50.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.63 0.252 . . . . 0.0 110.449 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.11 158.65 15.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.754 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -3.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.194 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.3 p -90.54 6.99 41.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.475 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.73 16.83 74.54 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -98.24 123.43 42.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.704 0.287 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 t -100.69 120.39 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.696 HG23 ' O ' ' A' ' 13' ' ' ILE . 20.5 tt -117.49 110.12 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.228 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.667 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.3 t -101.07 138.15 38.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.138 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.34 146.49 40.46 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.3 109.49 21.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 18' ' ' GLU . 10.0 p -150.07 162.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.726 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 1.4 mp0 -84.38 177.84 2.74 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 4.0 Cg_exo -73.76 -6.74 19.12 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 121.611 1.541 . . . . 0.0 111.786 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.733 ' HA ' ' H ' ' A' ' 57' ' ' SER . 8.0 t -80.28 -27.21 38.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 116.386 -2.125 . . . . 0.0 107.863 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.955 ' O ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 33.36 68.76 0.15 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 117.698 -1.144 . . . . 0.0 111.955 170.213 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -79.83 132.71 36.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 114.437 -2.905 . . . . 0.0 105.297 -175.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -55.47 -37.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 112.878 -1.964 . . . . 0.0 111.557 -172.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.35 -31.15 68.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' THR . 5.0 t-20 -78.83 -44.65 22.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.043 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.4 t -72.37 -49.21 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.476 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.679 ' CG ' HG22 ' A' ' 23' ' ' ILE . 10.4 mmmm -55.18 -35.33 64.7 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.586 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.44 -35.84 78.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -65.91 -36.92 84.71 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.25 -42.01 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 34' ' ' GLU . 51.8 tt0 -69.91 -34.22 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.732 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.83 -45.49 92.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.128 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' CB ' HD11 ' A' ' 13' ' ' ILE . 23.2 mmtp -67.19 -52.9 35.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.094 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 31' ' ' GLN . 77.6 tt0 -129.01 153.81 47.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.95 113.89 3.91 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.276 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.647 HD13 ' HD2' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -151.96 120.23 3.31 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.647 ' HD2' HD13 ' A' ' 36' ' ' ILE . 3.1 Cg_exo -69.83 130.66 19.64 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 CA-C-N 119.458 0.842 . . . . 0.0 110.976 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -49.68 -40.44 46.91 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.364 2.042 . . . . 0.0 112.222 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -59.49 -29.22 67.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -98.89 7.85 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.662 ' O ' ' CE ' ' A' ' 27' ' ' LYS . 5.1 tp60 -121.64 129.38 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -131.21 142.52 50.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.022 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.04 146.5 48.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 44' ' ' ILE . 7.5 pt -135.92 142.56 38.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.47 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -124.67 115.84 21.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 111.51 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.74 42.5 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.427 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -21.2 32.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -80.78 115.22 20.16 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -79.36 122.34 26.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.477 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.637 ' HB3' HD13 ' A' ' 23' ' ' ILE . 42.1 mt -79.55 130.61 35.55 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.872 ' O ' HD12 ' A' ' 23' ' ' ILE . 17.2 mt-10 -95.35 -169.47 1.98 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -47.42 7.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 111.926 -2.397 . . . . 0.0 114.432 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.98 44.46 0.49 Allowed Glycine 0 N--CA 1.461 0.325 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.134 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -81.52 153.76 26.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 58' ' ' ASP . 1.9 m -78.45 141.16 38.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 116.402 -2.119 . . . . 0.0 110.336 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.955 HD13 ' O ' ' A' ' 21' ' ' ASP . 6.7 mp -76.7 -31.58 57.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.22 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.733 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.3 t -55.59 -33.28 63.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 55' ' ' THR . 15.6 t70 -71.35 -25.6 62.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.437 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 56' ' ' LEU . 4.0 m-85 -79.93 1.11 28.58 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.591 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.22 44.18 22.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.87 HG13 HD23 ' A' ' 56' ' ' LEU . 16.5 mm -65.57 138.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.98 0.895 . . . . 0.0 110.254 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.743 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 30.6 tt0 -96.24 -178.35 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.732 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.743 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 19.0 ttpt -43.27 29.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.544 -2.116 . . . . 0.0 114.889 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.717 ' N ' ' O ' ' A' ' 62' ' ' GLN . 19.5 tt0 92.37 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.958 0.885 . . . . 0.0 112.59 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.15 154.93 25.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.774 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.557 ' O ' HG23 ' A' ' 66' ' ' THR . 9.3 t -86.62 125.08 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.874 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.1 mp -98.86 138.82 35.45 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -83.56 138.87 33.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 111.529 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.176 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.075 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.768 HD11 HD23 ' A' ' 56' ' ' LEU . 1.2 mt -118.52 158.78 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.822 0.82 . . . . 0.0 111.003 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -139.33 135.02 33.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.641 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.588 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 12.1 t -130.67 143.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.052 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -102.3 133.49 47.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.246 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -85.61 163.83 18.09 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.619 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 8' ' ' LEU . 3.8 pp -70.0 -10.82 59.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -96.39 -15.12 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -6.51 50.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -70.29 124.75 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 p -80.19 115.55 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.383 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' ILE . 11.9 tt -110.72 112.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.911 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.709 ' C ' HD23 ' A' ' 15' ' ' LEU . 24.0 p -104.05 139.62 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.07 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.16 143.68 44.41 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.59 109.43 21.67 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.771 HG22 ' N ' ' A' ' 18' ' ' GLU . 8.9 p -151.02 171.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.04 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.771 ' N ' HG22 ' A' ' 17' ' ' VAL . 3.3 pm0 -92.13 174.68 3.96 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.3 Cg_exo -73.59 -6.49 18.8 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 C-N-CA 121.237 1.291 . . . . 0.0 112.35 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.721 ' HA ' ' H ' ' A' ' 57' ' ' SER . 89.8 p -78.03 -27.64 48.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 116.296 -2.162 . . . . 0.0 107.173 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.881 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 32.92 69.76 0.12 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.557 168.784 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.56 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -80.55 135.93 36.18 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 115.07 -2.652 . . . . 0.0 106.15 -175.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.818 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -54.71 -46.75 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 113.318 -1.765 . . . . 0.0 111.077 -173.296 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -57.71 -29.21 64.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -77.88 -39.46 43.15 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.181 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 22' ' ' THR . 36.2 t -72.47 -48.53 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.818 ' HD3' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.39 -41.69 76.7 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.522 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -38.09 68.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -67.59 -37.78 83.07 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 26' ' ' VAL . 27.5 mm -67.7 -32.23 55.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.634 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 27' ' ' LYS . 7.4 tt0 -68.95 -33.37 73.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.669 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -58.91 -45.22 90.84 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' CB ' HD11 ' A' ' 13' ' ' ILE . 19.3 mmtp -70.03 -53.91 15.48 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.2 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -130.82 155.02 47.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 114.4 3.85 Favored Glycine 0 C--O 1.23 -0.102 0 C-N-CA 119.003 -1.57 . . . . 0.0 111.733 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.0 tp -151.84 117.47 3.12 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.54 137.36 30.29 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 121.362 1.374 . . . . 0.0 111.945 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.4 -36.01 29.5 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.605 2.203 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -61.88 -25.93 67.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -109.32 9.34 25.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.42 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 6.4 tp-100 -113.54 124.5 52.52 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.2 ptp85 -131.81 134.5 45.86 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mt -122.88 159.32 28.44 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.8 143.8 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.252 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -144.54 128.92 17.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.7 45.38 18.08 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.33 -20.45 1.24 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.41 124.21 27.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -81.79 122.45 27.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.943 0.402 . . . . 0.0 111.337 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.089 HD22 HD11 ' A' ' 56' ' ' LEU . 73.1 mt -77.18 117.46 18.74 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.66 ' O ' HG21 ' A' ' 23' ' ' ILE . 15.7 mt-10 -92.83 -168.02 1.86 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -174.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.69 7.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 111.325 -2.671 . . . . 0.0 115.481 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.52 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . 118.82 43.14 0.54 Allowed Glycine 0 C--N 1.318 -0.456 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.193 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.451 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 36.6 mtt85 -82.59 152.46 25.93 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -78.31 141.69 38.29 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.989 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.089 HD11 HD22 ' A' ' 50' ' ' LEU . 3.3 mp -76.42 -30.71 57.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.022 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.721 ' H ' ' HA ' ' A' ' 20' ' ' SER . 10.9 t -53.27 -30.69 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 55' ' ' THR . 3.1 t70 -73.4 -28.67 62.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.184 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 56' ' ' LEU . 9.4 m-85 -79.33 6.17 10.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.694 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m120 51.65 44.75 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.539 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.694 HG13 HD23 ' A' ' 56' ' ' LEU . 34.7 mm -64.18 138.84 22.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 122.178 0.99 . . . . 0.0 111.09 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . 0.739 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 47.3 tt0 -96.57 -179.76 4.72 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.195 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.739 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.5 ttpt -43.36 30.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.623 -2.08 . . . . 0.0 115.225 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.688 ' N ' ' O ' ' A' ' 62' ' ' GLN . 10.0 mt-10 91.73 54.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.181 0.991 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -61.7 156.9 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 m -82.53 126.52 32.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.0 110.189 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.57 137.65 36.91 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -91.64 137.45 32.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.994 0.426 . . . . 0.0 111.295 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.431 HD11 ' CG1' ' A' ' 5' ' ' VAL . 5.9 mp . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.409 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.637 ' O ' ' O ' ' A' ' 17' ' ' VAL . 3.7 mmt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 10.6 mm-40 -74.78 164.3 26.72 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.986 0.422 . . . . 0.0 110.701 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.429 ' CD1' ' CG ' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -142.1 136.75 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 6.3 m-30 -108.2 136.13 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.939 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.99 133.59 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -106.29 134.02 50.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.939 0.399 . . . . 0.0 110.976 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 p -117.14 150.85 38.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.156 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.66 -3.87 3.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 9' ' ' THR . 29.9 m -91.12 -8.97 47.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.594 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.39 78.16 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -77.42 124.57 28.06 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.675 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -82.31 121.21 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.228 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 13' ' ' ILE . 19.4 tt -120.1 129.46 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.712 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 p -117.21 137.76 52.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.755 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -115.48 147.17 40.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.9 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.91 109.85 22.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.789 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.0 p -149.88 175.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.836 -177.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.789 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -102.0 173.95 3.22 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.1 Cg_exo -74.51 -6.49 18.36 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 CA-C-N 120.751 1.304 . . . . 0.0 110.92 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.796 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -77.22 -27.34 53.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 116.833 -1.947 . . . . 0.0 105.745 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.787 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 31.57 64.01 0.22 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.551 168.674 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -83.73 135.89 34.39 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 114.903 -2.719 . . . . 0.0 106.469 -175.616 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.676 HG13 ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -52.78 -41.07 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.203 -1.817 . . . . 0.0 110.843 -173.111 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 0.0 OUTLIER -61.6 -30.0 70.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 22' ' ' THR . 11.1 t30 -79.28 -46.02 18.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.995 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.654 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.3 t -72.47 -45.64 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.08 0.467 . . . . 0.0 110.172 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.705 ' NZ ' HD12 ' A' ' 30' ' ' ILE . 2.7 mmtm -54.83 -51.86 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.367 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.22 -35.99 70.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.512 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -64.23 -36.68 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.705 HD12 ' NZ ' ' A' ' 27' ' ' LYS . 73.3 mt -75.88 -28.93 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.547 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.452 ' OE1' ' O ' ' A' ' 36' ' ' ILE . 0.8 OUTLIER -56.72 -35.29 68.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -44.75 73.09 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -60.92 -52.28 65.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 56.1 mt-10 -146.65 154.24 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.94 116.64 4.65 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 119.042 -1.551 . . . . 0.0 111.241 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.975 HD13 ' OE1' ' A' ' 41' ' ' GLN . 2.7 pp -149.47 117.25 3.72 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 2.9 Cg_endo -73.13 131.06 16.13 Favored 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.911 1.741 . . . . 0.0 111.833 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 -45.29 22.59 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.908 1.739 . . . . 0.0 111.926 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.55 -16.71 40.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.621 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -111.09 -15.72 13.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.165 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.975 ' OE1' HD13 ' A' ' 36' ' ' ILE . 52.4 tt0 -111.4 138.32 48.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.405 HH11 ' HB3' ' A' ' 42' ' ' ARG . 29.0 mtp-105 -128.48 144.85 51.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.745 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' HZ1' ' A' ' 27' ' ' LYS . 18.0 mt -116.27 174.47 6.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -134.75 138.27 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.507 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.36 117.31 21.96 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.721 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 44.66 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.31 -20.38 17.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -78.55 135.41 37.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -84.65 118.75 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.39 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 56' ' ' LEU . 13.2 mt -81.05 146.31 30.69 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.676 ' O ' HG13 ' A' ' 23' ' ' ILE . 2.6 mt-10 -96.62 -173.33 2.71 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -54.97 8.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 111.343 -2.662 . . . . 0.0 114.306 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.52 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . 121.58 43.05 0.43 Allowed Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.708 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mmt-85 -83.12 165.62 19.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 172.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 57' ' ' SER . 67.8 m -87.27 142.32 27.99 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 116.96 -1.896 . . . . 0.0 111.124 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' ' 21' ' ' ASP . 3.2 mp -76.97 -33.53 57.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.409 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.796 ' H ' ' HA ' ' A' ' 20' ' ' SER . 15.8 m -57.53 -36.11 71.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -24.14 64.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 2.8 m-85 -83.49 6.53 19.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.51 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.6 43.2 28.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.182 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.661 HG13 HD23 ' A' ' 56' ' ' LEU . 20.7 mm -65.73 140.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 122.181 0.991 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.819 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 23.3 tt0 -94.47 -176.49 3.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.35 -1.75 . . . . 0.0 113.254 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.819 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.2 tmtm? -41.15 25.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.546 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.771 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.3 pt-20 91.01 53.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.265 1.031 . . . . 0.0 113.429 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.61 152.62 18.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.43 177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.507 ' C ' HD12 ' A' ' 67' ' ' LEU . 30.8 m -86.71 119.36 26.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.167 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.783 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.8 mp -98.8 131.13 45.16 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -120.32 138.56 53.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.933 0.397 . . . . 0.0 111.227 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.569 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -121.76 131.47 54.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.192 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 72' ' ' ARG . 4.7 p -137.21 151.83 27.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.123 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -138.68 19.33 2.69 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.127 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.492 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.309 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 17' ' ' VAL . 1.8 mpp? . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -127.12 168.26 14.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.134 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.512 HG12 HG21 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -117.13 151.35 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.316 0.579 . . . . 0.0 110.261 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -139.95 132.47 28.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.646 -179.005 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.543 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 87.8 t -119.79 132.3 69.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -101.87 121.86 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.926 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p -89.32 161.34 16.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.34 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.35 -4.81 28.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -95.72 1.76 53.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.97 -4.01 63.16 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -72.61 123.08 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.834 0.35 . . . . 0.0 110.281 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -91.95 125.01 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.973 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 13' ' ' ILE . 1.2 tp -119.03 121.62 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.788 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 p -110.79 133.08 53.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.8 145.9 42.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.635 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 8.4 mp0 -96.25 110.68 22.95 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 18' ' ' GLU . 7.1 p -150.52 149.61 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.764 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.938 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.4 pm0 -70.55 177.04 1.55 Allowed Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.0 Cg_exo -74.49 -6.56 18.46 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 121.584 1.522 . . . . 0.0 111.868 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 56' ' ' LEU . 83.2 p -78.82 -27.32 44.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 116.365 -2.134 . . . . 0.0 107.647 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 1.128 ' O ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 31.54 67.86 0.13 Allowed 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.885 169.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.65 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.14 133.4 36.06 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 114.331 -2.947 . . . . 0.0 106.097 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -54.41 -35.1 29.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 112.872 -1.967 . . . . 0.0 110.744 -173.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' H ' ' HA2' ' A' ' 53' ' ' GLY . 15.8 tt0 -62.88 -33.29 74.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 22' ' ' THR . 3.4 t30 -78.86 -45.68 20.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.345 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' THR . 16.9 t -72.6 -37.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.403 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.608 ' NZ ' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.7 -51.34 65.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.457 . . . . 0.0 110.418 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.06 -35.38 69.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.382 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -63.48 -37.77 88.57 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.16 -42.6 79.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.639 ' O ' ' O ' ' A' ' 34' ' ' GLU . 8.6 tm0? -69.14 -32.27 71.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.716 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -58.93 -37.73 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.816 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -61.83 -54.12 46.51 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 110.736 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.639 ' O ' ' O ' ' A' ' 31' ' ' GLN . 36.9 mt-10 -140.94 176.63 8.65 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.68 113.8 3.83 Favored Glycine 0 CA--C 1.51 -0.252 0 C-N-CA 118.532 -1.794 . . . . 0.0 110.637 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.476 HD13 ' HD2' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -151.83 118.86 3.21 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' HD13 ' A' ' 36' ' ' ILE . 3.4 Cg_exo -71.67 130.14 16.6 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 120.564 0.843 . . . . 0.0 111.722 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 3.3 Cg_exo -57.82 -34.46 98.29 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.047 1.831 . . . . 0.0 111.597 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -66.57 -26.75 67.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.044 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -104.42 0.67 29.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.814 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.501 ' NE2' ' N ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -104.71 126.74 52.09 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.597 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.501 ' N ' ' NE2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.08 142.43 50.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.608 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 7.2 mt -118.44 162.42 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.7 mt -136.03 139.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.27 119.44 17.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.287 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 35.41 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.336 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.98 -19.7 24.46 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -82.18 116.84 21.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.397 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.37 127.77 33.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' A' ' 23' ' ' ILE . 43.5 mt -76.73 127.76 33.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.889 ' O ' HD12 ' A' ' 23' ' ' ILE . 1.2 mp0 -81.65 -169.81 2.51 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -48.8 6.09 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 111.646 -2.524 . . . . 0.0 115.09 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 23' ' ' ILE . . . 117.85 44.1 0.55 Allowed Glycine 0 C--N 1.316 -0.534 0 C-N-CA 119.93 -1.129 . . . . 0.0 111.964 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -81.67 159.14 24.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 173.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -79.08 141.17 37.58 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 116.916 -1.914 . . . . 0.0 110.039 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.128 HD23 ' O ' ' A' ' 21' ' ' ASP . 2.2 mm? -74.52 -32.5 62.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.985 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.69 ' H ' ' HA ' ' A' ' 20' ' ' SER . 7.2 t -54.77 -30.71 57.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' H ' HG22 ' A' ' 55' ' ' THR . 8.6 t70 -71.98 -29.29 64.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 19.0 m-85 -79.4 -6.39 56.73 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.66 44.64 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.843 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.909 ' CG1' HD12 ' A' ' 56' ' ' LEU . 31.7 mm -64.43 137.66 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.947 0.879 . . . . 0.0 110.152 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.696 ' O ' ' N ' ' A' ' 64' ' ' GLU . 10.8 pt20 -102.55 -174.37 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.714 -1.584 . . . . 0.0 114.057 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.584 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 49.1 mttt -42.05 30.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.365 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 62' ' ' GLN . 9.1 mt-10 91.38 53.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.919 0.866 . . . . 0.0 113.282 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 153.57 35.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.745 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 66' ' ' THR . 5.8 t -86.24 126.68 34.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.06 139.19 35.07 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -88.49 138.04 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 111.23 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mt -113.28 157.21 22.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.199 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -143.56 149.77 17.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.447 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.07 -47.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.395 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 72' ' ' ARG . 8.7 ttm105 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.324 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.522 ' O ' ' O ' ' A' ' 17' ' ' VAL . 4.1 mpp? . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -127.12 163.56 23.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.192 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -120.61 155.65 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 2.5 t80 -137.21 132.72 34.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.857 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.6 t -128.8 146.74 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.725 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -98.34 120.63 39.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 p -87.19 161.77 17.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.187 0.518 . . . . 0.0 111.382 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 8' ' ' LEU . 4.6 mp -71.77 -11.8 60.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.662 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -94.01 -10.89 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.34 2.15 77.33 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -81.07 131.51 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 110.564 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.79 121.84 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 13' ' ' ILE . 11.6 tt -115.04 122.09 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.117 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -112.74 137.64 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.057 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.75 147.83 39.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.128 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.26 109.77 21.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.779 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.6 p -150.51 173.6 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.496 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.779 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.0 mp0 -99.4 175.98 2.18 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -73.54 -7.54 20.42 Favored 'Trans proline' 0 C--N 1.288 -2.633 0 C-N-CA 121.245 1.297 . . . . 0.0 111.066 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.721 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.11 -28.21 48.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 116.542 -2.063 . . . . 0.0 106.807 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.726 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 32.88 67.19 0.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.994 169.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -80.62 133.44 35.74 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 114.645 -2.822 . . . . 0.0 105.826 -175.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.809 HD12 ' O ' ' A' ' 51' ' ' GLU . 1.1 mt -55.13 -43.58 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.015 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -59.73 -29.58 68.24 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 175.18 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -77.66 -44.68 27.3 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.821 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 22' ' ' THR . 10.7 t -72.25 -39.73 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.347 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.706 ' HZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.53 -41.99 70.34 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.596 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.68 78.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -36.4 81.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 26' ' ' VAL . 21.1 mm -62.04 -40.35 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' O ' ' A' ' 34' ' ' GLU . 12.4 tt0 -69.1 -31.99 71.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.2 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.37 -44.64 88.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' H ' ' HD2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.93 -53.59 55.38 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.935 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.7 mt-10 -135.92 155.56 50.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.94 112.37 3.47 Favored Glycine 0 CA--C 1.505 -0.54 0 C-N-CA 118.529 -1.796 . . . . 0.0 110.72 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pt -152.85 119.03 2.98 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.49 128.91 32.03 Favored 'Trans proline' 0 C--N 1.287 -2.695 0 CA-C-N 118.839 0.621 . . . . 0.0 110.706 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.21 -34.91 93.67 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.934 1.756 . . . . 0.0 112.288 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.5 -8.18 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.175 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.99 -12.96 14.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.6 mm-40 -83.82 126.0 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 -179.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.814 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.4 mtt180 -129.38 128.28 42.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -131.61 149.75 52.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.444 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.25 143.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.604 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 41.0 t80 -120.59 115.54 23.6 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.916 0.389 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 39.22 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 -20.9 34.0 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 20.2 mttm -79.19 117.5 20.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 12.4 pt20 -76.79 121.3 23.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.298 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.117 HD22 HD11 ' A' ' 56' ' ' LEU . 67.6 mt -76.99 127.03 31.96 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.809 ' O ' HD12 ' A' ' 23' ' ' ILE . 22.3 mt-10 -90.63 -169.32 2.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -174.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -47.59 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 111.798 -2.456 . . . . 0.0 114.504 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.81 44.6 0.58 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.383 -176.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -81.17 160.55 24.33 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 57' ' ' SER . 21.7 m -79.37 140.44 37.46 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 116.257 -2.177 . . . . 0.0 110.34 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.117 HD11 HD22 ' A' ' 50' ' ' LEU . 3.2 mp -77.54 -30.46 52.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.009 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.721 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.9 t -54.96 -30.51 59.13 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.27 -27.72 62.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.242 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 56' ' ' LEU . 10.5 m-85 -79.25 -5.4 54.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.968 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.47 45.13 11.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.729 HG13 HD23 ' A' ' 56' ' ' LEU . 37.9 mm -64.42 136.89 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.141 0.972 . . . . 0.0 109.978 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.74 ' O ' ' N ' ' A' ' 64' ' ' GLU . 9.0 pt20 -97.53 -173.76 2.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.291 -1.777 . . . . 0.0 114.284 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.703 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 1.6 pttm -41.62 26.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 112.123 -2.308 . . . . 0.0 115.259 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER 90.64 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.875 1.321 . . . . 0.0 113.111 -178.407 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.4 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.5 OUTLIER -62.4 157.02 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.74 177.318 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.561 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.8 p -84.16 131.55 34.76 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.751 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.09 142.84 28.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.794 0.33 . . . . 0.0 110.504 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 134.99 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mp -122.05 167.99 12.47 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -118.85 166.48 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.143 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 70' ' ' VAL . 9.9 tp 77.46 121.36 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.29 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.59 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' VAL . 2.8 tpt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.767 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.8 mp0 -90.8 165.31 13.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.02 135.78 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 121.489 0.661 . . . . 0.0 110.262 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 4.3 m-30 -110.29 142.62 41.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.543 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.54 59.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -101.19 122.83 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -98.06 151.79 19.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -71.25 -10.74 60.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.13 2.41 56.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.577 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.98 15.11 78.47 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -93.49 127.57 39.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -86.55 115.92 24.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 33' ' ' LYS . 19.1 tt -112.6 118.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.915 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.599 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -107.21 138.56 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.86 145.27 43.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 109.98 22.33 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.782 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.6 p -149.64 171.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.937 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.782 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -95.8 172.48 5.22 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.649 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -75.18 -7.88 19.39 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 121.392 1.394 . . . . 0.0 111.074 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.698 ' HA ' ' H ' ' A' ' 57' ' ' SER . 1.1 m -78.0 -27.08 48.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 116.712 -1.995 . . . . 0.0 105.805 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.724 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 33.43 68.27 0.16 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.795 169.109 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -79.46 132.74 36.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 114.25 -2.98 . . . . 0.0 105.481 -175.674 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -55.69 -40.37 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.878 -1.965 . . . . 0.0 110.859 -173.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -60.38 -29.9 69.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' THR . 13.6 t-20 -78.01 -44.58 26.18 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.956 179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 30' ' ' ILE . 6.8 t -72.2 -35.73 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.302 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.638 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.5 -51.85 63.8 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.808 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.71 76.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.65 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.496 ' HZ2' ' CG ' ' A' ' 25' ' ' ASN . 19.8 mttp -64.57 -36.76 85.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.2 mm -63.5 -45.7 97.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.631 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -69.94 -33.16 71.77 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.45 -44.77 92.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.743 ' HB2' HD11 ' A' ' 13' ' ' ILE . 2.6 mtpt -68.58 -54.5 16.18 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.766 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLN . 13.9 mm-40 -123.91 151.4 43.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.44 111.06 3.17 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 118.317 -1.897 . . . . 0.0 111.104 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.513 HD13 ' OE1' ' A' ' 41' ' ' GLN . 1.8 tt -154.19 117.0 2.58 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.4 129.68 32.38 Favored 'Trans proline' 0 C--N 1.288 -2.621 0 CA-C-N 119.093 0.712 . . . . 0.0 111.156 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.56 -27.48 76.96 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.095 1.863 . . . . 0.0 112.086 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.84 -27.46 68.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.017 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -107.35 7.74 29.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.566 HE21 ' N ' ' A' ' 42' ' ' ARG . 36.9 tp60 -89.19 127.01 35.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.988 0.423 . . . . 0.0 110.918 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.566 ' N ' HE21 ' A' ' 41' ' ' GLN . 55.7 mtp180 -128.23 132.84 48.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.104 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -124.06 151.44 43.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 110.762 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.5 mt -135.44 139.99 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.6 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' LYS . 70.7 t80 -121.75 116.4 24.44 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.584 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.09 33.54 3.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.03 -20.32 48.19 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' PHE . 55.2 mttm -78.15 120.38 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.901 0.381 . . . . 0.0 110.357 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -75.17 123.48 25.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 56' ' ' LEU . 83.8 mt -76.77 132.86 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.849 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.9 mt-10 -86.94 -170.6 3.14 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -49.0 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 111.595 -2.548 . . . . 0.0 114.781 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.62 44.18 0.6 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.856 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 159.32 23.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 102.874 -3.009 . . . . 0.0 102.874 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -78.29 140.36 38.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 116.179 -2.208 . . . . 0.0 109.254 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HD22 ' A' ' 50' ' ' LEU . 3.0 mp -77.37 -31.14 54.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.368 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.698 ' H ' ' HA ' ' A' ' 20' ' ' SER . 35.6 p -55.12 -30.33 59.55 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 55' ' ' THR . 33.0 t0 -71.73 -26.32 62.42 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.846 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' LEU . 5.8 m-85 -79.22 3.86 16.62 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.522 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.69 40.45 19.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.423 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.629 HG13 HD23 ' A' ' 56' ' ' LEU . 21.9 mm -64.97 132.17 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.031 0.92 . . . . 0.0 109.018 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.763 ' O ' ' N ' ' A' ' 64' ' ' GLU . 7.8 pt20 -96.82 -172.39 2.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.68 -1.6 . . . . 0.0 114.223 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.749 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 5.8 mmtt -41.03 26.3 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.482 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.767 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 1.8 pt-20 90.94 52.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.441 1.115 . . . . 0.0 113.246 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.6 OUTLIER -61.74 152.75 30.32 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.894 176.537 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -86.1 128.97 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -98.65 132.61 43.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -88.3 141.83 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.604 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -121.36 162.03 21.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.696 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.8 m -146.06 163.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.303 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.53 -55.38 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.322 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.32 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' O ' ' A' ' 17' ' ' VAL . 2.7 mtp . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 7.3 mt-30 -126.8 164.79 20.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.747 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -120.74 159.96 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' A' ' 3' ' ' ILE . 5.1 t80 -140.92 134.74 30.44 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.012 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.528 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 71.4 t -130.72 141.51 46.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.84 140.4 36.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.095 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -106.15 149.44 26.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.926 0.393 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mt -72.85 -11.97 60.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 p -91.82 -10.61 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.02 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.66 -4.86 73.06 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -78.87 128.29 33.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.203 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 m -76.49 116.14 16.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.5 tt -115.51 113.5 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.256 0.551 . . . . 0.0 110.182 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 p -117.6 139.61 50.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.13 144.13 43.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.189 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -95.81 111.08 23.14 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.808 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.2 p -149.86 174.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.338 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.808 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.9 mp0 -100.04 177.32 1.58 Allowed Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.08 -7.62 20.08 Favored 'Trans proline' 0 C--N 1.29 -2.539 0 C-N-CA 121.459 1.439 . . . . 0.0 112.155 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.731 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -78.17 -28.47 48.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 116.238 -2.185 . . . . 0.0 106.525 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.821 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 32.24 66.86 0.17 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.234 168.675 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -81.5 135.41 35.61 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 115.118 -2.633 . . . . 0.0 105.83 -176.065 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.727 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -54.27 -43.95 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.152 -173.586 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.18 -29.95 67.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 22' ' ' THR . 2.8 t-20 -78.26 -44.87 24.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.676 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.2 t -72.73 -39.42 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.638 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.66 ' NZ ' HD11 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -54.33 -52.05 62.76 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.153 0.501 . . . . 0.0 110.392 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.48 68.27 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.326 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -38.06 89.69 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.627 HG22 HD11 ' A' ' 36' ' ' ILE . 19.4 mm -67.46 -39.79 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' O ' ' O ' ' A' ' 34' ' ' GLU . 14.9 tt0 -61.95 -34.06 75.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -59.24 -34.31 72.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.204 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HG3' HD11 ' A' ' 13' ' ' ILE . 29.1 mmtt -60.17 -31.23 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.208 0.528 . . . . 0.0 109.928 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 31' ' ' GLN . 2.8 pt-20 -160.46 -116.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.54 111.4 0.52 Allowed Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.692 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -153.6 119.27 2.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 2.9 Cg_endo -71.76 140.45 35.57 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 121.313 1.342 . . . . 0.0 112.18 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.34 -27.7 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.131 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.11 -31.54 69.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.768 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.37 8.79 23.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' OE1' ' O ' ' A' ' 37' ' ' PRO . 3.0 mp0 -112.03 126.11 54.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.469 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 42' ' ' ARG . 54.5 mtt85 -130.34 141.66 50.57 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.546 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.66 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 16.2 mt -120.41 163.06 18.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.778 0.323 . . . . 0.0 110.69 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -135.58 143.33 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LYS . 8.2 t80 -141.47 125.08 16.79 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.774 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.44 45.74 17.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 -19.11 1.87 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -81.68 115.72 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 0.0 110.087 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.625 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -72.76 125.0 26.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.666 HD13 HD11 ' A' ' 56' ' ' LEU . 45.5 mt -77.3 137.38 38.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.569 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 16.4 mp0 -95.05 -171.54 2.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 5.6 t0 -47.92 7.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 111.907 -2.406 . . . . 0.0 114.599 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.71 43.46 0.53 Allowed Glycine 0 C--N 1.32 -0.361 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.884 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -82.63 161.94 22.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 57' ' ' SER . 51.9 m -85.34 143.15 28.83 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 117.188 -1.805 . . . . 0.0 111.763 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.863 HD23 HG13 ' A' ' 61' ' ' ILE . 3.5 mp -77.21 -32.88 56.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.999 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.731 ' H ' ' HA ' ' A' ' 20' ' ' SER . 5.4 t -55.85 -33.57 64.64 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.58 -26.91 61.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.571 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 9.7 m-85 -79.26 1.84 23.39 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 57.8 45.1 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.639 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 56' ' ' LEU . 34.8 mm -64.93 139.66 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 122.111 0.957 . . . . 0.0 110.588 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.762 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 38.8 tt0 -95.25 -179.28 4.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.693 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.777 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 39.0 mttp -43.05 28.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.265 -2.243 . . . . 0.0 115.197 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.777 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.52 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.837 1.303 . . . . 0.0 112.756 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 p -61.96 154.29 26.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.055 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 66' ' ' THR . 0.0 OUTLIER -86.88 115.9 24.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.198 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.8 mp -98.16 137.97 36.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.01 142.73 31.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -120.95 115.91 24.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -140.94 151.95 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.971 0.415 . . . . 0.0 110.554 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mt -103.07 -37.46 7.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.341 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.504 179.906 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 22.7 mp0 -100.42 167.19 10.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.072 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.796 HD11 HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -118.3 152.62 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.336 0.589 . . . . 0.0 109.505 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 63.3 t80 -138.89 132.51 30.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.702 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 69' ' ' LEU . 85.1 t -130.16 140.34 49.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -128.66 144.13 51.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 110.548 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 p -115.91 173.09 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.2 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.83 -7.85 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -92.73 -11.48 33.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.592 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.44 6.49 84.12 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -61.49 132.17 52.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 12' ' ' THR . 7.9 t -89.51 115.36 26.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 13' ' ' ILE . 8.1 tt -121.47 120.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.295 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.677 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.8 p -117.28 135.65 53.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.181 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -116.15 146.42 42.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.772 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -95.8 111.0 23.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.769 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.1 p -148.68 171.79 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.162 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.769 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.3 pm0 -105.55 153.55 39.75 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.824 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.3 Cg_endo -52.02 -8.86 0.37 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 121.881 1.721 . . . . 0.0 112.641 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 21' ' ' ASP . 5.9 t -77.61 -28.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 115.224 -2.59 . . . . 0.0 105.988 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.728 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 31.32 65.64 0.17 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.339 168.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.61 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -81.48 132.67 35.33 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 114.374 -2.931 . . . . 0.0 105.893 -175.586 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 51' ' ' GLU . 1.2 mt -54.9 -39.52 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 CA-C-N 112.686 -2.052 . . . . 0.0 110.819 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.68 -29.87 70.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.271 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' THR . 4.6 t-20 -78.55 -44.62 23.81 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.187 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 22' ' ' THR . 3.4 t -72.34 -32.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.223 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' CD ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.86 -47.92 60.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -178.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.2 76.17 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.513 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -65.93 -35.98 82.09 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.3 mm -61.7 -45.56 98.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.68 -33.1 70.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.977 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -58.35 -44.85 88.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -62.76 -54.26 41.81 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.479 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 31' ' ' GLN . 75.8 mt-10 -132.59 157.21 45.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.58 111.87 3.34 Favored Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 118.445 -1.836 . . . . 0.0 110.597 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 30' ' ' ILE . 1.4 pt -153.86 119.55 2.8 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.78 127.52 21.77 Favored 'Trans proline' 0 C--N 1.288 -2.607 0 CA-C-N 119.401 0.822 . . . . 0.0 110.977 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.57 -42.9 24.1 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.282 1.988 . . . . 0.0 112.269 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.26 -17.67 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.693 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -109.97 7.41 23.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -116.58 128.64 55.6 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.151 0.501 . . . . 0.0 111.217 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mtp-105 -126.42 140.77 52.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.857 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.72 148.65 47.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.874 0.369 . . . . 0.0 111.28 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.94 141.33 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.97 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 48' ' ' LYS . 39.6 t80 -123.64 131.7 53.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.135 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.17 44.25 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.902 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.1 -20.64 6.54 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 45' ' ' PHE . 20.6 mtpt -79.58 138.46 37.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -92.06 121.49 33.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.726 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.873 HD22 HD11 ' A' ' 56' ' ' LEU . 67.3 mt -76.29 106.04 7.69 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.816 ' O ' HD12 ' A' ' 23' ' ' ILE . 4.1 mt-10 -69.13 -168.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.476 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 31.7 t0 -46.79 5.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 111.644 -2.526 . . . . 0.0 115.159 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.88 45.47 0.55 Allowed Glycine 0 C--N 1.318 -0.461 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.69 -176.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.75 26.92 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 172.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 20' ' ' SER . 1.2 m -77.87 140.91 39.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 116.382 -2.127 . . . . 0.0 110.52 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.873 HD11 HD22 ' A' ' 50' ' ' LEU . 2.9 mp -76.35 -30.06 57.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.726 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.824 ' N ' ' O ' ' A' ' 19' ' ' PRO . 6.2 t -54.77 -32.8 60.53 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 55' ' ' THR . 30.9 t70 -72.66 -26.0 61.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.176 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' LEU . 7.9 m-85 -79.29 4.85 13.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.233 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.73 44.64 29.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.65 HG13 HD23 ' A' ' 56' ' ' LEU . 35.3 mm -64.6 137.56 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.719 0.771 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.733 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.9 pt20 -101.78 -173.97 2.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.304 -1.316 . . . . 0.0 113.975 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.672 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 3.4 ttpm? -41.74 28.66 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 111.867 -2.424 . . . . 0.0 115.07 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.733 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.2 pt-20 91.35 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 122.846 1.308 . . . . 0.0 112.874 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -61.63 153.77 26.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.384 177.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.434 ' C ' HD12 ' A' ' 67' ' ' LEU . 10.3 m -85.51 123.86 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.85 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.9 mp -98.41 136.79 38.04 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -83.25 135.48 34.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.875 -179.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.641 HD11 ' CG1' ' A' ' 5' ' ' VAL . 42.3 mt -111.88 128.18 56.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.108 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.18 154.37 23.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.103 0.478 . . . . 0.0 110.667 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tp -149.09 119.65 7.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.046 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.418 -179.608 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 tpp . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 59.9 mt-30 -86.21 165.25 16.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.701 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.636 HD11 HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -120.41 156.42 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 2.7 t80 -140.89 132.72 27.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.242 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 79.6 t -129.84 142.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.243 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -122.44 121.33 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -84.17 175.1 9.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.9 mp -69.95 -10.04 57.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.443 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.9 p -91.8 -4.19 55.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.317 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.24 82.25 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -65.0 131.52 46.82 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.45 116.23 28.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.42 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 33' ' ' LYS . 13.6 tt -120.07 122.53 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.364 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.488 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 10.1 p -116.0 139.95 49.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.738 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.99 148.1 37.5 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -94.25 109.78 21.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.82 HG21 ' OD1' ' A' ' 21' ' ' ASP . 9.6 p -150.36 171.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.864 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.772 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.6 pm0 -93.99 174.29 3.91 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.16 -5.91 17.67 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 121.293 1.329 . . . . 0.0 111.768 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.32 -28.73 57.02 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 116.226 -2.19 . . . . 0.0 105.764 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.82 ' OD1' HG21 ' A' ' 17' ' ' VAL . 3.4 m-20 32.71 64.96 0.25 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.026 168.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.664 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -84.68 137.7 33.09 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 115.849 -2.34 . . . . 0.0 107.375 -175.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.613 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.1 mm -53.07 -40.98 40.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.311 -174.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.86 -33.12 71.39 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.634 ' HB3' ' O ' ' A' ' 22' ' ' THR . 13.6 t-20 -78.79 -46.55 18.54 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.78 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.4 t -73.51 -35.3 44.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.146 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' NZ ' HD21 ' A' ' 43' ' ' LEU . 1.6 mmtm -54.3 -51.88 63.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.95 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.6 76.14 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.004 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -61.31 -36.01 78.94 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.7 mm -63.46 -45.87 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.696 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' GLU . 24.6 tt0 -69.23 -31.96 70.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.022 0.439 . . . . 0.0 111.062 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -41.67 82.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.347 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' CB ' HD11 ' A' ' 13' ' ' ILE . 14.6 mmtp -64.45 -54.42 32.89 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.244 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.9 mt-10 -141.22 171.69 13.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.39 112.14 3.41 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 118.647 -1.739 . . . . 0.0 110.551 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 tt -153.85 122.0 3.03 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.84 126.23 14.97 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 CA-C-N 119.392 0.819 . . . . 0.0 111.404 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 -45.56 9.5 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.649 2.233 . . . . 0.0 112.62 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.96 -27.01 66.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.448 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -97.68 9.2 43.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.307 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.608 HE22 ' CD2' ' A' ' 69' ' ' LEU . 2.1 tm0? -112.12 126.76 55.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.741 ' C ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -129.48 138.1 51.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.107 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -131.55 159.5 38.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.709 0.29 . . . . 0.0 110.265 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 68' ' ' HIS . 7.6 tt -136.4 140.34 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.352 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 48' ' ' LYS . 6.5 t80 -128.57 134.68 48.69 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.11 33.9 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.925 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.6 -21.0 11.78 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 45' ' ' PHE . 5.8 mtmm -80.52 115.33 19.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -71.05 121.51 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.64 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.959 HD22 HD11 ' A' ' 56' ' ' LEU . 64.4 mt -77.4 114.07 15.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.601 ' O ' HG13 ' A' ' 23' ' ' ILE . 16.9 mt-10 -87.95 -167.69 1.97 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -45.65 8.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 111.902 -2.408 . . . . 0.0 114.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 119.68 44.62 0.46 Allowed Glycine 0 C--N 1.318 -0.451 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.161 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 150.22 28.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -79.41 141.18 37.08 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 116.912 -1.915 . . . . 0.0 111.364 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.959 HD11 HD22 ' A' ' 50' ' ' LEU . 3.9 mp -78.06 -31.7 50.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.802 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.615 ' N ' ' O ' ' A' ' 19' ' ' PRO . 5.8 t -54.38 -31.59 55.15 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -72.36 -30.26 64.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.649 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 56' ' ' LEU . 6.7 m-85 -79.06 5.36 12.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 52.18 45.02 29.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.306 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.696 HG13 HD23 ' A' ' 56' ' ' LEU . 24.8 mm -64.8 138.1 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.173 0.987 . . . . 0.0 110.636 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.68 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.0 pt20 -100.72 -173.31 2.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.899 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.786 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 56.8 mttm -41.24 28.66 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 111.681 -2.509 . . . . 0.0 115.749 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.786 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.94 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.859 1.314 . . . . 0.0 113.271 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -60.55 154.74 20.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.766 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.438 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -85.63 126.75 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 6.5 mp -98.93 134.37 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.312 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.559 ' O ' HG22 ' A' ' 44' ' ' ILE . 6.3 t-80 -85.84 132.48 34.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.923 0.392 . . . . 0.0 110.218 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' CD2' HE22 ' A' ' 41' ' ' GLN . 12.6 mt -87.0 164.54 16.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.18 161.17 21.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.901 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 72' ' ' ARG . 9.3 mt -47.07 -71.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.464 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.497 ' HE ' HH12 ' A' ' 42' ' ' ARG . 87.5 mtm-85 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.578 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -85.24 164.42 18.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.512 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.593 HD12 ' CG ' ' A' ' 21' ' ' ASP . 1.6 mt -121.11 152.44 24.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.397 0.617 . . . . 0.0 110.817 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.17 133.64 31.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.903 -179.07 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 89.5 t -123.82 144.24 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 111.133 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.701 ' O ' HD11 ' A' ' 69' ' ' LEU . 19.7 tttm -100.58 139.57 36.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 p -115.95 161.21 19.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.835 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.99 -4.01 15.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.262 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -92.07 -14.01 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 15.16 80.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -94.0 130.94 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 12' ' ' THR . 1.7 t -76.82 120.21 21.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 13' ' ' ILE . 10.0 tt -116.37 117.95 57.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.888 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.787 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.4 p -115.73 135.56 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.275 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -115.21 147.55 40.2 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -95.63 109.4 21.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.778 HG22 ' N ' ' A' ' 18' ' ' GLU . 10.6 p -149.95 174.19 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.953 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.778 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -109.27 155.06 41.74 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.355 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.826 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.2 Cg_endo -49.77 -7.96 0.1 Allowed 'Trans proline' 0 C--N 1.29 -2.512 0 C-N-CA 121.725 1.617 . . . . 0.0 113.348 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 56' ' ' LEU . 66.1 m -75.81 -28.81 58.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 114.992 -2.683 . . . . 0.0 105.553 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.745 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER 30.53 64.65 0.16 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 117.892 -1.052 . . . . 0.0 111.682 168.356 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -82.56 135.35 35.11 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 114.683 -2.807 . . . . 0.0 106.586 -175.567 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.88 -31.1 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.831 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.709 -173.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -29.83 67.57 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.635 ' N ' ' O ' ' A' ' 22' ' ' THR . 1.6 t-20 -78.23 -44.47 25.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' THR . 64.1 t -72.23 -34.72 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.27 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.64 -51.94 61.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -178.651 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -61.02 -35.07 75.89 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -62.17 -36.86 83.14 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.683 HG21 ' HG2' ' A' ' 41' ' ' GLN . 30.4 mm -62.78 -37.05 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -70.54 -35.77 73.31 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 4.9 m-20 -62.78 -44.35 96.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -61.45 -54.28 45.5 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.25 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -138.32 168.34 19.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.03 111.32 3.22 Favored Glycine 0 CA--C 1.507 -0.436 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.187 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 118.25 2.75 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.05 128.3 19.38 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.21 -27.51 85.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.845 1.697 . . . . 0.0 112.195 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -67.58 -27.93 67.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.388 . . . . 0.0 110.374 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -93.98 -13.05 27.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.449 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.683 ' HG2' HG21 ' A' ' 30' ' ' ILE . 6.7 tp-100 -81.09 139.66 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 43' ' ' LEU . 2.3 tpt85 -124.45 136.59 54.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.379 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 42' ' ' ARG . 4.5 mp -125.05 130.95 53.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.842 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.2 mt -135.67 142.15 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.1 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' LYS . 7.2 t80 -144.68 137.69 26.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.915 0.388 . . . . 0.0 111.199 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.04 44.48 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.39 -19.71 1.06 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 46' ' ' ALA . 5.7 mtmt -83.4 124.98 31.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 110.828 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.636 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.2 OUTLIER -79.55 126.43 30.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.647 ' HB3' HD13 ' A' ' 23' ' ' ILE . 14.0 mt -76.44 129.26 36.29 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.877 ' O ' HD12 ' A' ' 23' ' ' ILE . 17.4 mt-10 -87.26 -169.56 2.67 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.51 5.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 111.806 -2.452 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 117.9 45.35 0.51 Allowed Glycine 0 C--N 1.321 -0.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.241 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.605 ' NH2' ' H ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -80.37 159.3 25.77 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 173.432 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.605 ' H ' ' NH2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -78.45 139.45 38.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 116.341 -2.144 . . . . 0.0 109.52 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.796 HD23 HG13 ' A' ' 61' ' ' ILE . 5.0 mp -77.41 -28.93 52.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.689 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 19' ' ' PRO . 3.6 t -53.51 -30.14 39.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 55' ' ' THR . 74.4 m-20 -73.36 -28.08 61.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.023 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 56' ' ' LEU . 13.6 m-85 -78.9 2.07 21.41 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.341 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.94 46.09 27.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.644 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.796 HG13 HD23 ' A' ' 56' ' ' LEU . 33.8 mm -63.71 139.1 21.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.87 0.843 . . . . 0.0 110.67 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.739 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 24.1 tt0 -96.92 -179.37 4.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.214 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.739 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 6.1 mtpm? -43.28 30.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.353 -2.203 . . . . 0.0 115.001 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.6 mt-10 91.02 52.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.166 0.984 . . . . 0.0 111.498 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -62.89 152.11 37.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.194 177.643 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.01 123.45 32.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.414 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.91 144.96 29.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.815 0.34 . . . . 0.0 110.453 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -98.54 147.26 24.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.991 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.69 136.93 51.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.2 t -146.13 163.37 10.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.316 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.47 ' CB ' ' O ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER 80.01 111.81 0.07 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.424 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.628 -179.839 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 61' ' ' ILE . 15.0 mtt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.696 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 15.2 mt-30 -75.55 165.72 24.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.551 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 12.7 mt -140.97 142.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.807 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -141.01 133.99 29.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.475 0.655 . . . . 0.0 110.945 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 t -109.54 131.1 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.283 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.53 124.84 50.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.63 0.252 . . . . 0.0 110.449 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.11 158.65 15.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.754 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -3.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.194 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.3 p -90.54 6.99 41.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.475 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.73 16.83 74.54 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -98.24 123.43 42.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.704 0.287 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 t -100.69 120.39 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.696 HG23 ' O ' ' A' ' 13' ' ' ILE . 20.5 tt -117.49 110.12 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.228 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.667 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.3 t -101.07 138.15 38.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.138 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.34 146.49 40.46 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -95.3 109.49 21.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 18' ' ' GLU . 10.0 p -150.07 162.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.726 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 1.4 mp0 -84.38 177.84 2.74 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 4.0 Cg_exo -73.76 -6.74 19.12 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 121.611 1.541 . . . . 0.0 111.786 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.733 ' HA ' ' H ' ' A' ' 57' ' ' SER . 8.0 t -80.28 -27.21 38.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 116.386 -2.125 . . . . 0.0 107.863 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.955 ' O ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 33.36 68.76 0.15 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 117.698 -1.144 . . . . 0.0 111.955 170.213 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -79.83 132.71 36.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 114.437 -2.905 . . . . 0.0 105.297 -175.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -55.47 -37.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 112.878 -1.964 . . . . 0.0 111.557 -172.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.35 -31.15 68.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' THR . 5.0 t-20 -78.83 -44.65 22.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.043 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.4 t -72.37 -49.21 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.476 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.679 ' CG ' HG22 ' A' ' 23' ' ' ILE . 10.4 mmmm -55.18 -35.33 64.7 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.586 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.44 -35.84 78.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -65.91 -36.92 84.71 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 32.6 mm -63.25 -42.01 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 34' ' ' GLU . 51.8 tt0 -69.91 -34.22 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.732 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.83 -45.49 92.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.128 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' CB ' HD11 ' A' ' 13' ' ' ILE . 23.2 mmtp -67.19 -52.9 35.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.094 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 31' ' ' GLN . 77.6 tt0 -129.01 153.81 47.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.95 113.89 3.91 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.276 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.647 HD13 ' HD2' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -151.96 120.23 3.31 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.647 ' HD2' HD13 ' A' ' 36' ' ' ILE . 3.1 Cg_exo -69.83 130.66 19.64 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 CA-C-N 119.458 0.842 . . . . 0.0 110.976 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -49.68 -40.44 46.91 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.364 2.042 . . . . 0.0 112.222 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -59.49 -29.22 67.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -98.89 7.85 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.662 ' O ' ' CE ' ' A' ' 27' ' ' LYS . 5.1 tp60 -121.64 129.38 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -131.21 142.52 50.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.022 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.04 146.5 48.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 44' ' ' ILE . 7.5 pt -135.92 142.56 38.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.47 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -124.67 115.84 21.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 111.51 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.74 42.5 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.427 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -21.2 32.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -80.78 115.22 20.16 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -79.36 122.34 26.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.477 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.637 ' HB3' HD13 ' A' ' 23' ' ' ILE . 42.1 mt -79.55 130.61 35.55 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.872 ' O ' HD12 ' A' ' 23' ' ' ILE . 17.2 mt-10 -95.35 -169.47 1.98 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -47.42 7.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 111.926 -2.397 . . . . 0.0 114.432 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.98 44.46 0.49 Allowed Glycine 0 N--CA 1.461 0.325 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.134 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -81.52 153.76 26.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 58' ' ' ASP . 1.9 m -78.45 141.16 38.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 116.402 -2.119 . . . . 0.0 110.336 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.955 HD13 ' O ' ' A' ' 21' ' ' ASP . 6.7 mp -76.7 -31.58 57.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.22 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.733 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.3 t -55.59 -33.28 63.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 55' ' ' THR . 15.6 t70 -71.35 -25.6 62.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.437 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 56' ' ' LEU . 4.0 m-85 -79.93 1.11 28.58 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.591 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.22 44.18 22.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.87 HG13 HD23 ' A' ' 56' ' ' LEU . 16.5 mm -65.57 138.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.98 0.895 . . . . 0.0 110.254 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.743 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 30.6 tt0 -96.24 -178.35 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.732 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.743 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 19.0 ttpt -43.27 29.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.544 -2.116 . . . . 0.0 114.889 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.717 ' N ' ' O ' ' A' ' 62' ' ' GLN . 19.5 tt0 92.37 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.958 0.885 . . . . 0.0 112.59 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.15 154.93 25.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.774 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.557 ' O ' HG23 ' A' ' 66' ' ' THR . 9.3 t -86.62 125.08 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.874 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.1 mp -98.86 138.82 35.45 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -83.56 138.87 33.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 111.529 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -118.73 124.05 46.35 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.075 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' N ' HD13 ' A' ' 69' ' ' LEU . 30.9 t -120.52 162.14 19.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.612 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.523 ' N ' HG12 ' A' ' 70' ' ' VAL . 9.7 mt -38.32 -56.71 1.2 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.723 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.336 179.845 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.27 166.45 11.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.86 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.768 HD11 HD23 ' A' ' 56' ' ' LEU . 1.2 mt -118.52 158.78 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.822 0.82 . . . . 0.0 111.003 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -139.33 135.02 33.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.641 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.588 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 12.1 t -130.67 143.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.052 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -102.3 133.49 47.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.246 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -85.61 163.83 18.09 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.619 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 8' ' ' LEU . 3.8 pp -70.0 -10.82 59.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -96.39 -15.12 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -6.51 50.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -70.29 124.75 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 p -80.19 115.55 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.383 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' ILE . 11.9 tt -110.72 112.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.911 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.709 ' C ' HD23 ' A' ' 15' ' ' LEU . 24.0 p -104.05 139.62 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.07 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.16 143.68 44.41 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.59 109.43 21.67 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.771 HG22 ' N ' ' A' ' 18' ' ' GLU . 8.9 p -151.02 171.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.04 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.771 ' N ' HG22 ' A' ' 17' ' ' VAL . 3.3 pm0 -92.13 174.68 3.96 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.3 Cg_exo -73.59 -6.49 18.8 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 C-N-CA 121.237 1.291 . . . . 0.0 112.35 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.721 ' HA ' ' H ' ' A' ' 57' ' ' SER . 89.8 p -78.03 -27.64 48.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 116.296 -2.162 . . . . 0.0 107.173 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.881 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 32.92 69.76 0.12 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.557 168.784 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.56 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -80.55 135.93 36.18 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 115.07 -2.652 . . . . 0.0 106.15 -175.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.818 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -54.71 -46.75 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 113.318 -1.765 . . . . 0.0 111.077 -173.296 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -57.71 -29.21 64.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -77.88 -39.46 43.15 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.181 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 22' ' ' THR . 36.2 t -72.47 -48.53 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.818 ' HD3' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.39 -41.69 76.7 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.522 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -38.09 68.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -67.59 -37.78 83.07 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 26' ' ' VAL . 27.5 mm -67.7 -32.23 55.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.634 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 27' ' ' LYS . 7.4 tt0 -68.95 -33.37 73.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.669 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -58.91 -45.22 90.84 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' CB ' HD11 ' A' ' 13' ' ' ILE . 19.3 mmtp -70.03 -53.91 15.48 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.2 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -130.82 155.02 47.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 114.4 3.85 Favored Glycine 0 C--O 1.23 -0.102 0 C-N-CA 119.003 -1.57 . . . . 0.0 111.733 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.0 tp -151.84 117.47 3.12 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -71.54 137.36 30.29 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 121.362 1.374 . . . . 0.0 111.945 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.4 -36.01 29.5 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.605 2.203 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -61.88 -25.93 67.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -109.32 9.34 25.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.42 -179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 6.4 tp-100 -113.54 124.5 52.52 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 6.2 ptp85 -131.81 134.5 45.86 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mt -122.88 159.32 28.44 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.8 143.8 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.252 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -144.54 128.92 17.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.7 45.38 18.08 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.33 -20.45 1.24 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.41 124.21 27.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -81.79 122.45 27.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.943 0.402 . . . . 0.0 111.337 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.089 HD22 HD11 ' A' ' 56' ' ' LEU . 73.1 mt -77.18 117.46 18.74 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.66 ' O ' HG21 ' A' ' 23' ' ' ILE . 15.7 mt-10 -92.83 -168.02 1.86 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -174.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.69 7.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 111.325 -2.671 . . . . 0.0 115.481 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.52 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . 118.82 43.14 0.54 Allowed Glycine 0 C--N 1.318 -0.456 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.193 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.451 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 36.6 mtt85 -82.59 152.46 25.93 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -78.31 141.69 38.29 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.989 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.089 HD11 HD22 ' A' ' 50' ' ' LEU . 3.3 mp -76.42 -30.71 57.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.022 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.721 ' H ' ' HA ' ' A' ' 20' ' ' SER . 10.9 t -53.27 -30.69 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 55' ' ' THR . 3.1 t70 -73.4 -28.67 62.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.184 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 56' ' ' LEU . 9.4 m-85 -79.33 6.17 10.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.694 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m120 51.65 44.75 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.539 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.694 HG13 HD23 ' A' ' 56' ' ' LEU . 34.7 mm -64.18 138.84 22.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 122.178 0.99 . . . . 0.0 111.09 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . 0.739 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 47.3 tt0 -96.57 -179.76 4.72 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.195 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.739 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.5 ttpt -43.36 30.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.623 -2.08 . . . . 0.0 115.225 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.688 ' N ' ' O ' ' A' ' 62' ' ' GLN . 10.0 mt-10 91.73 54.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.181 0.991 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -61.7 156.9 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 m -82.53 126.52 32.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.0 110.189 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.57 137.65 36.91 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -91.64 137.45 32.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.994 0.426 . . . . 0.0 111.295 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD11 ' CG1' ' A' ' 5' ' ' VAL . 5.9 mp -121.45 167.36 12.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.409 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.501 ' C ' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -130.52 157.14 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.939 0.399 . . . . 0.0 110.273 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -162.88 149.43 12.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.675 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.776 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 10.6 mm-40 . . . . . 0 CA--C 1.516 -0.36 0 CA-C-O 120.986 0.422 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.429 ' CD1' ' CG ' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -142.1 136.75 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 6.3 m-30 -108.2 136.13 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.939 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.99 133.59 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -106.29 134.02 50.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.939 0.399 . . . . 0.0 110.976 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 p -117.14 150.85 38.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.156 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.66 -3.87 3.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 9' ' ' THR . 29.9 m -91.12 -8.97 47.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.594 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.39 78.16 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -77.42 124.57 28.06 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.675 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -82.31 121.21 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.228 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 13' ' ' ILE . 19.4 tt -120.1 129.46 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.712 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 p -117.21 137.76 52.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.755 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -115.48 147.17 40.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.9 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.91 109.85 22.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.789 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.0 p -149.88 175.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.836 -177.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.789 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -102.0 173.95 3.22 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.1 Cg_exo -74.51 -6.49 18.36 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 CA-C-N 120.751 1.304 . . . . 0.0 110.92 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.796 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -77.22 -27.34 53.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 116.833 -1.947 . . . . 0.0 105.745 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.787 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 31.57 64.01 0.22 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.551 168.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -83.73 135.89 34.39 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 114.903 -2.719 . . . . 0.0 106.469 -175.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.676 HG13 ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -52.78 -41.07 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.203 -1.817 . . . . 0.0 110.843 -173.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 0.0 OUTLIER -61.6 -30.0 70.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 22' ' ' THR . 11.1 t30 -79.28 -46.02 18.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.995 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.654 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.3 t -72.47 -45.64 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.08 0.467 . . . . 0.0 110.172 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.705 ' NZ ' HD12 ' A' ' 30' ' ' ILE . 2.7 mmtm -54.83 -51.86 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.367 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.22 -35.99 70.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.512 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -64.23 -36.68 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.705 HD12 ' NZ ' ' A' ' 27' ' ' LYS . 73.3 mt -75.88 -28.93 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.547 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.588 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -56.72 -35.29 68.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -44.75 73.09 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -60.92 -52.28 65.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 56.1 mt-10 -146.65 154.24 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.94 116.64 4.65 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 119.042 -1.551 . . . . 0.0 111.241 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.975 HD13 ' OE1' ' A' ' 41' ' ' GLN . 2.7 pp -149.47 117.25 3.72 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 2.9 Cg_endo -73.13 131.06 16.13 Favored 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.911 1.741 . . . . 0.0 111.833 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 -45.29 22.59 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.908 1.739 . . . . 0.0 111.926 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.55 -16.71 40.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.621 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -111.09 -15.72 13.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.165 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.975 ' OE1' HD13 ' A' ' 36' ' ' ILE . 52.4 tt0 -111.4 138.32 48.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.405 HH11 ' HB3' ' A' ' 42' ' ' ARG . 29.0 mtp-105 -128.48 144.85 51.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.745 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' HZ1' ' A' ' 27' ' ' LYS . 18.0 mt -116.27 174.47 6.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -134.75 138.27 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.507 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.36 117.31 21.96 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.721 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 44.66 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.31 -20.38 17.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -78.55 135.41 37.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -84.65 118.75 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.39 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 56' ' ' LEU . 13.2 mt -81.05 146.31 30.69 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.676 ' O ' HG13 ' A' ' 23' ' ' ILE . 2.6 mt-10 -96.62 -173.33 2.71 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -54.97 8.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 111.343 -2.662 . . . . 0.0 114.306 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.52 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . 121.58 43.05 0.43 Allowed Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.708 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mmt-85 -83.12 165.62 19.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 172.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 57' ' ' SER . 67.8 m -87.27 142.32 27.99 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 116.96 -1.896 . . . . 0.0 111.124 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' ' 21' ' ' ASP . 3.2 mp -76.97 -33.53 57.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.409 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.796 ' H ' ' HA ' ' A' ' 20' ' ' SER . 15.8 m -57.53 -36.11 71.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -24.14 64.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 2.8 m-85 -83.49 6.53 19.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.51 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.6 43.2 28.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.182 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.661 HG13 HD23 ' A' ' 56' ' ' LEU . 20.7 mm -65.73 140.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 122.181 0.991 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.819 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 23.3 tt0 -94.47 -176.49 3.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.35 -1.75 . . . . 0.0 113.254 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.819 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.2 tmtm? -41.15 25.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.546 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.771 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.3 pt-20 91.01 53.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.265 1.031 . . . . 0.0 113.429 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.61 152.62 18.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.43 177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.507 ' C ' HD12 ' A' ' 67' ' ' LEU . 30.8 m -86.71 119.36 26.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.167 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.783 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.8 mp -98.8 131.13 45.16 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -120.32 138.56 53.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.933 0.397 . . . . 0.0 111.227 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.569 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.192 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 . . . . . 0 C--O 1.23 0.07 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.512 HG12 HG21 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -117.13 151.35 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.316 0.579 . . . . 0.0 110.261 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -139.95 132.47 28.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.646 -179.005 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.543 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 87.8 t -119.79 132.3 69.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -101.87 121.86 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.926 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p -89.32 161.34 16.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.34 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.35 -4.81 28.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -95.72 1.76 53.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.97 -4.01 63.16 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -72.61 123.08 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.834 0.35 . . . . 0.0 110.281 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -91.95 125.01 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.973 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 13' ' ' ILE . 1.2 tp -119.03 121.62 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.788 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 p -110.79 133.08 53.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.8 145.9 42.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.635 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 8.4 mp0 -96.25 110.68 22.95 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 18' ' ' GLU . 7.1 p -150.52 149.61 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.764 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.938 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.4 pm0 -70.55 177.04 1.55 Allowed Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.0 Cg_exo -74.49 -6.56 18.46 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 121.584 1.522 . . . . 0.0 111.868 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 56' ' ' LEU . 83.2 p -78.82 -27.32 44.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 116.365 -2.134 . . . . 0.0 107.647 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 1.128 ' O ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 31.54 67.86 0.13 Allowed 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.885 169.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.65 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.14 133.4 36.06 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 114.331 -2.947 . . . . 0.0 106.097 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -54.41 -35.1 29.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 112.872 -1.967 . . . . 0.0 110.744 -173.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.4 ' H ' ' HA2' ' A' ' 53' ' ' GLY . 15.8 tt0 -62.88 -33.29 74.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 22' ' ' THR . 3.4 t30 -78.86 -45.68 20.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.345 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' THR . 16.9 t -72.6 -37.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.403 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.608 ' NZ ' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.7 -51.34 65.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.457 . . . . 0.0 110.418 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.06 -35.38 69.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.382 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -63.48 -37.77 88.57 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.16 -42.6 79.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.639 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -69.14 -32.27 71.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.716 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -58.93 -37.73 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.816 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -61.83 -54.12 46.51 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 110.736 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.639 ' O ' ' O ' ' A' ' 31' ' ' GLN . 36.9 mt-10 -140.94 176.63 8.65 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.68 113.8 3.83 Favored Glycine 0 CA--C 1.51 -0.252 0 C-N-CA 118.532 -1.794 . . . . 0.0 110.637 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.476 HD13 ' HD2' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -151.83 118.86 3.21 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' HD13 ' A' ' 36' ' ' ILE . 3.4 Cg_exo -71.67 130.14 16.6 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 120.564 0.843 . . . . 0.0 111.722 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 3.3 Cg_exo -57.82 -34.46 98.29 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.047 1.831 . . . . 0.0 111.597 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -66.57 -26.75 67.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.044 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -104.42 0.67 29.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.814 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.501 ' NE2' ' N ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -104.71 126.74 52.09 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.597 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.501 ' N ' ' NE2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.08 142.43 50.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.608 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 7.2 mt -118.44 162.42 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.7 mt -136.03 139.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.27 119.44 17.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.287 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 35.41 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.336 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.98 -19.7 24.46 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -82.18 116.84 21.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.397 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.37 127.77 33.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' A' ' 23' ' ' ILE . 43.5 mt -76.73 127.76 33.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.889 ' O ' HD12 ' A' ' 23' ' ' ILE . 1.2 mp0 -81.65 -169.81 2.51 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -48.8 6.09 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 111.646 -2.524 . . . . 0.0 115.09 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 23' ' ' ILE . . . 117.85 44.1 0.55 Allowed Glycine 0 C--N 1.316 -0.534 0 C-N-CA 119.93 -1.129 . . . . 0.0 111.964 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -81.67 159.14 24.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 173.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -79.08 141.17 37.58 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 116.916 -1.914 . . . . 0.0 110.039 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.128 HD23 ' O ' ' A' ' 21' ' ' ASP . 2.2 mm? -74.52 -32.5 62.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.985 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.69 ' H ' ' HA ' ' A' ' 20' ' ' SER . 7.2 t -54.77 -30.71 57.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.542 ' H ' HG22 ' A' ' 55' ' ' THR . 8.6 t70 -71.98 -29.29 64.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 19.0 m-85 -79.4 -6.39 56.73 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.66 44.64 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.843 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.909 ' CG1' HD12 ' A' ' 56' ' ' LEU . 31.7 mm -64.43 137.66 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.947 0.879 . . . . 0.0 110.152 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.696 ' O ' ' N ' ' A' ' 64' ' ' GLU . 10.8 pt20 -102.55 -174.37 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.714 -1.584 . . . . 0.0 114.057 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.584 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 49.1 mttt -42.05 30.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.365 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 62' ' ' GLN . 9.1 mt-10 91.38 53.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.919 0.866 . . . . 0.0 113.282 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 153.57 35.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.745 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 66' ' ' THR . 5.8 t -86.24 126.68 34.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.06 139.19 35.07 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -88.49 138.04 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 111.23 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.199 179.928 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 . . . . . 0 CA--C 1.521 -0.155 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -120.61 155.65 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 2.5 t80 -137.21 132.72 34.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.857 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.6 t -128.8 146.74 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.725 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -98.34 120.63 39.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 p -87.19 161.77 17.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.187 0.518 . . . . 0.0 111.382 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 8' ' ' LEU . 4.6 mp -71.77 -11.8 60.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.662 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -94.01 -10.89 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.34 2.15 77.33 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -81.07 131.51 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 110.564 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.79 121.84 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 13' ' ' ILE . 11.6 tt -115.04 122.09 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.117 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -112.74 137.64 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.057 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.75 147.83 39.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.128 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.26 109.77 21.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.779 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.6 p -150.51 173.6 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.496 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.779 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.0 mp0 -99.4 175.98 2.18 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -73.54 -7.54 20.42 Favored 'Trans proline' 0 C--N 1.288 -2.633 0 C-N-CA 121.245 1.297 . . . . 0.0 111.066 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.721 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.11 -28.21 48.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 116.542 -2.063 . . . . 0.0 106.807 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.726 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 32.88 67.19 0.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.994 169.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -80.62 133.44 35.74 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 114.645 -2.822 . . . . 0.0 105.826 -175.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.809 HD12 ' O ' ' A' ' 51' ' ' GLU . 1.1 mt -55.13 -43.58 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.015 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -59.73 -29.58 68.24 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 175.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -77.66 -44.68 27.3 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.821 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 22' ' ' THR . 10.7 t -72.25 -39.73 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.347 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.706 ' HZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.53 -41.99 70.34 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.596 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.68 78.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -36.4 81.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 26' ' ' VAL . 21.1 mm -62.04 -40.35 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' O ' ' A' ' 34' ' ' GLU . 4.9 tt0 -69.1 -31.99 71.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.2 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.37 -44.64 88.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.504 ' H ' ' HD2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.93 -53.59 55.38 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.935 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.7 mt-10 -135.92 155.56 50.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.94 112.37 3.47 Favored Glycine 0 CA--C 1.505 -0.54 0 C-N-CA 118.529 -1.796 . . . . 0.0 110.72 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pt -152.85 119.03 2.98 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.49 128.91 32.03 Favored 'Trans proline' 0 C--N 1.287 -2.695 0 CA-C-N 118.839 0.621 . . . . 0.0 110.706 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.21 -34.91 93.67 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.934 1.756 . . . . 0.0 112.288 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.5 -8.18 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.175 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.99 -12.96 14.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.403 ' NE2' HG21 ' A' ' 30' ' ' ILE . 26.1 mm100 -83.82 126.0 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.814 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.4 mtt180 -129.38 128.28 42.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -131.61 149.75 52.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.444 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.25 143.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.604 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 41.0 t80 -120.59 115.54 23.6 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.916 0.389 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 39.22 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 -20.9 34.0 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 20.2 mttm -79.19 117.5 20.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 12.4 pt20 -76.79 121.3 23.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.298 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.117 HD22 HD11 ' A' ' 56' ' ' LEU . 67.6 mt -76.99 127.03 31.96 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.809 ' O ' HD12 ' A' ' 23' ' ' ILE . 22.3 mt-10 -90.63 -169.32 2.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -174.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -47.59 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 111.798 -2.456 . . . . 0.0 114.504 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.81 44.6 0.58 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.383 -176.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -81.17 160.55 24.33 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 57' ' ' SER . 21.7 m -79.37 140.44 37.46 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 116.257 -2.177 . . . . 0.0 110.34 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.117 HD11 HD22 ' A' ' 50' ' ' LEU . 3.2 mp -77.54 -30.46 52.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.009 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.721 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.9 t -54.96 -30.51 59.13 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.27 -27.72 62.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.242 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 56' ' ' LEU . 10.5 m-85 -79.25 -5.4 54.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.968 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.47 45.13 11.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.729 HG13 HD23 ' A' ' 56' ' ' LEU . 37.9 mm -64.42 136.89 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.141 0.972 . . . . 0.0 109.978 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.74 ' O ' ' N ' ' A' ' 64' ' ' GLU . 9.0 pt20 -97.53 -173.76 2.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.291 -1.777 . . . . 0.0 114.284 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.703 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 1.6 pttm -41.62 26.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 112.123 -2.308 . . . . 0.0 115.259 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER 90.64 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.875 1.321 . . . . 0.0 113.111 -178.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.4 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.5 OUTLIER -62.4 157.02 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.74 177.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.561 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.8 p -84.16 131.55 34.76 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.751 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.09 142.84 28.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.794 0.33 . . . . 0.0 110.504 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 134.99 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.463 0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 179.096 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.767 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.8 mp0 . . . . . 0 CA--C 1.518 -0.28 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.02 135.78 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 121.489 0.661 . . . . 0.0 110.262 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.448 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 4.3 m-30 -110.29 142.62 41.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.543 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.54 59.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -101.19 122.83 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -98.06 151.79 19.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -71.25 -10.74 60.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.13 2.41 56.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.577 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.98 15.11 78.47 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -93.49 127.57 39.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -86.55 115.92 24.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 33' ' ' LYS . 19.1 tt -112.6 118.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.915 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.599 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -107.21 138.56 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.623 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.86 145.27 43.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 109.98 22.33 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.782 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.6 p -149.64 171.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.937 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.782 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -95.8 172.48 5.22 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.649 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -75.18 -7.88 19.39 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 121.392 1.394 . . . . 0.0 111.074 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.698 ' HA ' ' H ' ' A' ' 57' ' ' SER . 1.1 m -78.0 -27.08 48.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 116.712 -1.995 . . . . 0.0 105.805 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.724 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 33.43 68.27 0.16 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.795 169.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -79.46 132.74 36.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 114.25 -2.98 . . . . 0.0 105.481 -175.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -55.69 -40.37 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.878 -1.965 . . . . 0.0 110.859 -173.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -60.38 -29.9 69.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -78.01 -44.58 26.18 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.956 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 30' ' ' ILE . 6.8 t -72.2 -35.73 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.302 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.638 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.5 -51.85 63.8 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.808 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.71 76.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.65 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' NZ ' ' ND2' ' A' ' 25' ' ' ASN . 19.8 mttp -64.57 -36.76 85.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.2 mm -63.5 -45.7 97.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.631 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -69.94 -33.16 71.77 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.45 -44.77 92.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.743 ' HB2' HD11 ' A' ' 13' ' ' ILE . 2.6 mtpt -68.58 -54.5 16.18 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.766 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLN . 13.9 mm-40 -123.91 151.4 43.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.44 111.06 3.17 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 118.317 -1.897 . . . . 0.0 111.104 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.513 HD13 ' OE1' ' A' ' 41' ' ' GLN . 1.8 tt -154.19 117.0 2.58 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.4 129.68 32.38 Favored 'Trans proline' 0 C--N 1.288 -2.621 0 CA-C-N 119.093 0.712 . . . . 0.0 111.156 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.56 -27.48 76.96 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.095 1.863 . . . . 0.0 112.086 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.84 -27.46 68.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.017 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -107.35 7.74 29.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.566 HE21 ' N ' ' A' ' 42' ' ' ARG . 36.9 tp60 -89.19 127.01 35.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.988 0.423 . . . . 0.0 110.918 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.566 ' N ' HE21 ' A' ' 41' ' ' GLN . 55.7 mtp180 -128.23 132.84 48.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.104 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -124.06 151.44 43.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 110.762 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.5 mt -135.44 139.99 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.6 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' LYS . 70.7 t80 -121.75 116.4 24.44 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.584 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.09 33.54 3.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.03 -20.32 48.19 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' PHE . 55.2 mttm -78.15 120.38 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.901 0.381 . . . . 0.0 110.357 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -75.17 123.48 25.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 56' ' ' LEU . 83.8 mt -76.77 132.86 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.849 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.9 mt-10 -86.94 -170.6 3.14 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -49.0 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 111.595 -2.548 . . . . 0.0 114.781 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.62 44.18 0.6 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.856 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 159.32 23.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 102.874 -3.009 . . . . 0.0 102.874 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -78.29 140.36 38.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 116.179 -2.208 . . . . 0.0 109.254 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HD22 ' A' ' 50' ' ' LEU . 3.0 mp -77.37 -31.14 54.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.368 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.698 ' H ' ' HA ' ' A' ' 20' ' ' SER . 35.6 p -55.12 -30.33 59.55 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 55' ' ' THR . 33.0 t0 -71.73 -26.32 62.42 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.846 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' LEU . 5.8 m-85 -79.22 3.86 16.62 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.522 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.69 40.45 19.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.423 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.629 HG13 HD23 ' A' ' 56' ' ' LEU . 21.9 mm -64.97 132.17 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.031 0.92 . . . . 0.0 109.018 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.763 ' O ' ' N ' ' A' ' 64' ' ' GLU . 7.8 pt20 -96.82 -172.39 2.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.68 -1.6 . . . . 0.0 114.223 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.749 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 5.8 mmtt -41.03 26.3 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.482 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.767 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 1.8 pt-20 90.94 52.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.441 1.115 . . . . 0.0 113.246 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.6 OUTLIER -61.74 152.75 30.32 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.894 176.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -86.1 128.97 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -98.65 132.61 43.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -88.3 141.83 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.604 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.696 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 7.3 mt-30 . . . . . 0 N--CA 1.463 0.192 0 CA-C-O 120.469 0.176 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -120.74 159.96 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' A' ' 3' ' ' ILE . 5.1 t80 -140.92 134.74 30.44 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.012 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.528 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 71.4 t -130.72 141.51 46.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.84 140.4 36.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.095 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -106.15 149.44 26.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.926 0.393 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mt -72.85 -11.97 60.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 p -91.82 -10.61 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.02 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.66 -4.86 73.06 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -78.87 128.29 33.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.203 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 m -76.49 116.14 16.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.5 tt -115.51 113.5 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.256 0.551 . . . . 0.0 110.182 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 p -117.6 139.61 50.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.13 144.13 43.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -95.81 111.08 23.14 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.808 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.2 p -149.86 174.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.338 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.808 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.9 mp0 -100.04 177.32 1.58 Allowed Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.08 -7.62 20.08 Favored 'Trans proline' 0 C--N 1.29 -2.539 0 C-N-CA 121.459 1.439 . . . . 0.0 112.155 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.731 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -78.17 -28.47 48.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 116.238 -2.185 . . . . 0.0 106.525 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.821 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 32.24 66.86 0.17 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.234 168.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -81.5 135.41 35.61 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 115.118 -2.633 . . . . 0.0 105.83 -176.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.727 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -54.27 -43.95 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.152 -173.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.18 -29.95 67.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 22' ' ' THR . 2.8 t-20 -78.26 -44.87 24.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.676 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.2 t -72.73 -39.42 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.638 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.66 ' NZ ' HD11 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -54.33 -52.05 62.76 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.153 0.501 . . . . 0.0 110.392 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.48 68.27 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.326 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -38.06 89.69 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.627 HG22 HD11 ' A' ' 36' ' ' ILE . 19.4 mm -67.46 -39.79 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.516 ' O ' ' O ' ' A' ' 34' ' ' GLU . 14.9 tt0 -61.95 -34.06 75.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -59.24 -34.31 72.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.204 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HG3' HD11 ' A' ' 13' ' ' ILE . 29.1 mmtt -60.17 -31.23 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.208 0.528 . . . . 0.0 109.928 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 31' ' ' GLN . 2.8 pt-20 -160.46 -116.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.54 111.4 0.52 Allowed Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.692 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -153.6 119.27 2.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 2.9 Cg_endo -71.76 140.45 35.57 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 121.313 1.342 . . . . 0.0 112.18 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.34 -27.7 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.131 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.11 -31.54 69.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.768 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.37 8.79 23.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.409 ' OE1' ' O ' ' A' ' 37' ' ' PRO . 3.0 mp0 -112.03 126.11 54.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.469 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 42' ' ' ARG . 54.5 mtt85 -130.34 141.66 50.57 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.546 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.66 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 16.2 mt -120.41 163.06 18.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.778 0.323 . . . . 0.0 110.69 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -135.58 143.33 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LYS . 8.2 t80 -141.47 125.08 16.79 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.774 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.44 45.74 17.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 -19.11 1.87 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -81.68 115.72 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 0.0 110.087 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.625 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -72.76 125.0 26.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.666 HD13 HD11 ' A' ' 56' ' ' LEU . 45.5 mt -77.3 137.38 38.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.569 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 16.4 mp0 -95.05 -171.54 2.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 5.6 t0 -47.92 7.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 111.907 -2.406 . . . . 0.0 114.599 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.71 43.46 0.53 Allowed Glycine 0 C--N 1.32 -0.361 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.884 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -82.63 161.94 22.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 57' ' ' SER . 51.9 m -85.34 143.15 28.83 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 117.188 -1.805 . . . . 0.0 111.763 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.863 HD23 HG13 ' A' ' 61' ' ' ILE . 3.5 mp -77.21 -32.88 56.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.999 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.731 ' H ' ' HA ' ' A' ' 20' ' ' SER . 5.4 t -55.85 -33.57 64.64 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.58 -26.91 61.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.571 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 9.7 m-85 -79.26 1.84 23.39 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 57.8 45.1 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.639 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 56' ' ' LEU . 34.8 mm -64.93 139.66 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 122.111 0.957 . . . . 0.0 110.588 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.762 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 5.5 tt0 -95.25 -179.28 4.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.693 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.777 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 39.0 mttp -43.05 28.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.265 -2.243 . . . . 0.0 115.197 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.777 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.52 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.837 1.303 . . . . 0.0 112.756 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 p -61.96 154.29 26.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.055 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 66' ' ' THR . 0.0 OUTLIER -86.88 115.9 24.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.198 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.8 mp -98.16 137.97 36.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.01 142.73 31.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.401 HD13 ' C ' ' A' ' 69' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 2.8 mp0 . . . . . 0 N--CA 1.461 0.095 0 N-CA-C 110.072 -0.344 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.796 HD11 HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -118.3 152.62 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.336 0.589 . . . . 0.0 109.505 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 63.3 t80 -138.89 132.51 30.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.702 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 69' ' ' LEU . 85.1 t -130.16 140.34 49.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -128.66 144.13 51.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 110.548 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 p -115.91 173.09 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.2 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.83 -7.85 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -92.73 -11.48 33.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.592 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.44 6.49 84.12 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -61.49 132.17 52.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 12' ' ' THR . 7.9 t -89.51 115.36 26.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 13' ' ' ILE . 8.1 tt -121.47 120.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.295 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.677 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.8 p -117.28 135.65 53.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.181 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -116.15 146.42 42.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.772 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -95.8 111.0 23.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.769 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.1 p -148.68 171.79 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.162 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.769 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.3 pm0 -105.55 153.55 39.75 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.824 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.3 Cg_endo -52.02 -8.86 0.37 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 121.881 1.721 . . . . 0.0 112.641 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 21' ' ' ASP . 5.9 t -77.61 -28.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 115.224 -2.59 . . . . 0.0 105.988 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.728 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 31.32 65.64 0.17 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.339 168.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.61 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -81.48 132.67 35.33 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 114.374 -2.931 . . . . 0.0 105.893 -175.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 51' ' ' GLU . 1.2 mt -54.9 -39.52 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 CA-C-N 112.686 -2.052 . . . . 0.0 110.819 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.68 -29.87 70.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' THR . 4.6 t-20 -78.55 -44.62 23.81 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.187 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 22' ' ' THR . 3.4 t -72.34 -32.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.223 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' CD ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.86 -47.92 60.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -178.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.2 76.17 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.513 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -65.93 -35.98 82.09 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.3 mm -61.7 -45.56 98.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.68 -33.1 70.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.977 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -58.35 -44.85 88.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -62.76 -54.26 41.81 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.479 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 31' ' ' GLN . 75.8 mt-10 -132.59 157.21 45.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.58 111.87 3.34 Favored Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 118.445 -1.836 . . . . 0.0 110.597 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 30' ' ' ILE . 1.4 pt -153.86 119.55 2.8 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.78 127.52 21.77 Favored 'Trans proline' 0 C--N 1.288 -2.607 0 CA-C-N 119.401 0.822 . . . . 0.0 110.977 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.57 -42.9 24.1 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.282 1.988 . . . . 0.0 112.269 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.26 -17.67 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.693 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -109.97 7.41 23.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -116.58 128.64 55.6 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.151 0.501 . . . . 0.0 111.217 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mtp-105 -126.42 140.77 52.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.857 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.72 148.65 47.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.874 0.369 . . . . 0.0 111.28 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.94 141.33 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.97 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 48' ' ' LYS . 39.6 t80 -123.64 131.7 53.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.135 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.17 44.25 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.902 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.1 -20.64 6.54 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 45' ' ' PHE . 20.6 mtpt -79.58 138.46 37.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -92.06 121.49 33.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.726 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.873 HD22 HD11 ' A' ' 56' ' ' LEU . 67.3 mt -76.29 106.04 7.69 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.816 ' O ' HD12 ' A' ' 23' ' ' ILE . 4.1 mt-10 -69.13 -168.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 31.7 t0 -46.79 5.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 111.644 -2.526 . . . . 0.0 115.159 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.88 45.47 0.55 Allowed Glycine 0 C--N 1.318 -0.461 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.69 -176.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.75 26.92 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 172.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 20' ' ' SER . 1.2 m -77.87 140.91 39.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 116.382 -2.127 . . . . 0.0 110.52 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.873 HD11 HD22 ' A' ' 50' ' ' LEU . 2.9 mp -76.35 -30.06 57.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.726 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.824 ' N ' ' O ' ' A' ' 19' ' ' PRO . 6.2 t -54.77 -32.8 60.53 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 55' ' ' THR . 30.9 t70 -72.66 -26.0 61.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.176 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' LEU . 7.9 m-85 -79.29 4.85 13.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.233 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.73 44.64 29.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.65 HG13 HD23 ' A' ' 56' ' ' LEU . 35.3 mm -64.6 137.56 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.719 0.771 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.733 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.9 pt20 -101.78 -173.97 2.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.304 -1.316 . . . . 0.0 113.975 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.672 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 3.4 ttpm? -41.74 28.66 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 111.867 -2.424 . . . . 0.0 115.07 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.733 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.2 pt-20 91.35 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 122.846 1.308 . . . . 0.0 112.874 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -61.63 153.77 26.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.384 177.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.434 ' C ' HD12 ' A' ' 67' ' ' LEU . 10.3 m -85.51 123.86 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.85 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.9 mp -98.41 136.79 38.04 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 0.5 OUTLIER -83.25 135.48 34.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.875 -179.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.641 HD11 ' CG1' ' A' ' 5' ' ' VAL . 42.3 mt . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.108 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 59.9 mt-30 . . . . . 0 CA--C 1.527 0.067 0 CA-C-O 120.767 0.318 . . . . 0.0 110.701 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.636 HD11 HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -120.41 156.42 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 2.7 t80 -140.89 132.72 27.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.242 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 79.6 t -129.84 142.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.243 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -122.44 121.33 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -84.17 175.1 9.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.9 mp -69.95 -10.04 57.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.443 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.9 p -91.8 -4.19 55.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.317 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.24 82.25 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -65.0 131.52 46.82 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.45 116.23 28.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.42 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 33' ' ' LYS . 13.6 tt -120.07 122.53 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.364 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.488 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 10.1 p -116.0 139.95 49.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.738 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.99 148.1 37.5 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -94.25 109.78 21.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.82 HG21 ' OD1' ' A' ' 21' ' ' ASP . 9.6 p -150.36 171.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.864 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.772 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.6 pm0 -93.99 174.29 3.91 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.16 -5.91 17.67 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 121.293 1.329 . . . . 0.0 111.768 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.32 -28.73 57.02 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 116.226 -2.19 . . . . 0.0 105.764 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.82 ' OD1' HG21 ' A' ' 17' ' ' VAL . 3.4 m-20 32.71 64.96 0.25 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.026 168.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.664 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -84.68 137.7 33.09 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 115.849 -2.34 . . . . 0.0 107.375 -175.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.613 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.1 mm -53.07 -40.98 40.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.311 -174.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.86 -33.12 71.39 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.634 ' HB3' ' O ' ' A' ' 22' ' ' THR . 13.6 t-20 -78.79 -46.55 18.54 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.78 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.4 t -73.51 -35.3 44.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.146 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.562 ' NZ ' HD21 ' A' ' 43' ' ' LEU . 1.6 mmtm -54.3 -51.88 63.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.95 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.6 76.14 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.004 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -61.31 -36.01 78.94 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.7 mm -63.46 -45.87 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.696 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' GLU . 24.6 tt0 -69.23 -31.96 70.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.022 0.439 . . . . 0.0 111.062 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -41.67 82.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.347 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.558 ' CB ' HD11 ' A' ' 13' ' ' ILE . 14.6 mmtp -64.45 -54.42 32.89 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.244 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.9 mt-10 -141.22 171.69 13.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.39 112.14 3.41 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 118.647 -1.739 . . . . 0.0 110.551 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 tt -153.85 122.0 3.03 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.84 126.23 14.97 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 CA-C-N 119.392 0.819 . . . . 0.0 111.404 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 -45.56 9.5 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.649 2.233 . . . . 0.0 112.62 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.96 -27.01 66.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.448 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -97.68 9.2 43.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.307 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.608 HE22 ' CD2' ' A' ' 69' ' ' LEU . 2.1 tm0? -112.12 126.76 55.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.741 ' C ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -129.48 138.1 51.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.107 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -131.55 159.5 38.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.709 0.29 . . . . 0.0 110.265 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 68' ' ' HIS . 7.6 tt -136.4 140.34 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.352 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 48' ' ' LYS . 6.5 t80 -128.57 134.68 48.69 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.11 33.9 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.925 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.6 -21.0 11.78 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 45' ' ' PHE . 5.8 mtmm -80.52 115.33 19.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -71.05 121.51 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.64 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.959 HD22 HD11 ' A' ' 56' ' ' LEU . 64.4 mt -77.4 114.07 15.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.601 ' O ' HG13 ' A' ' 23' ' ' ILE . 16.9 mt-10 -87.95 -167.69 1.97 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -45.65 8.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 111.902 -2.408 . . . . 0.0 114.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 119.68 44.62 0.46 Allowed Glycine 0 C--N 1.318 -0.451 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.161 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 150.22 28.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -79.41 141.18 37.08 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 116.912 -1.915 . . . . 0.0 111.364 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.959 HD11 HD22 ' A' ' 50' ' ' LEU . 3.9 mp -78.06 -31.7 50.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.802 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.615 ' N ' ' O ' ' A' ' 19' ' ' PRO . 5.8 t -54.38 -31.59 55.15 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -72.36 -30.26 64.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.649 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 56' ' ' LEU . 6.7 m-85 -79.06 5.36 12.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 52.18 45.02 29.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.306 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.696 HG13 HD23 ' A' ' 56' ' ' LEU . 24.8 mm -64.8 138.1 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.173 0.987 . . . . 0.0 110.636 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.68 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.0 pt20 -100.72 -173.31 2.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.899 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.786 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 56.8 mttm -41.24 28.66 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 111.681 -2.509 . . . . 0.0 115.749 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.786 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.94 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.859 1.314 . . . . 0.0 113.271 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -60.55 154.74 20.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.766 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.438 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -85.63 126.75 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 6.5 mp -98.93 134.37 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.312 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.559 ' O ' HG22 ' A' ' 44' ' ' ILE . 6.3 t-80 -85.84 132.48 34.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.923 0.392 . . . . 0.0 110.218 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.608 ' CD2' HE22 ' A' ' 41' ' ' GLN . 12.6 mt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.528 0.204 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.593 HD12 ' CG ' ' A' ' 21' ' ' ASP . 1.6 mt -121.11 152.44 24.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.397 0.617 . . . . 0.0 110.817 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.17 133.64 31.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.903 -179.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 89.5 t -123.82 144.24 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 111.133 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.701 ' O ' HD11 ' A' ' 69' ' ' LEU . 19.7 tttm -100.58 139.57 36.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 p -115.95 161.21 19.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.835 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.99 -4.01 15.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.262 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -92.07 -14.01 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 15.16 80.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -94.0 130.94 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 12' ' ' THR . 1.7 t -76.82 120.21 21.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 13' ' ' ILE . 10.0 tt -116.37 117.95 57.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.888 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.787 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.4 p -115.73 135.56 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.275 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -115.21 147.55 40.2 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -95.63 109.4 21.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.778 HG22 ' N ' ' A' ' 18' ' ' GLU . 10.6 p -149.95 174.19 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.953 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.778 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -109.27 155.06 41.74 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.826 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.2 Cg_endo -49.77 -7.96 0.1 Allowed 'Trans proline' 0 C--N 1.29 -2.512 0 C-N-CA 121.725 1.617 . . . . 0.0 113.348 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 56' ' ' LEU . 66.1 m -75.81 -28.81 58.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 114.992 -2.683 . . . . 0.0 105.553 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.745 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER 30.53 64.65 0.16 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 117.892 -1.052 . . . . 0.0 111.682 168.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -82.56 135.35 35.11 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 114.683 -2.807 . . . . 0.0 106.586 -175.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.88 -31.1 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.831 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.709 -173.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -29.83 67.57 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.635 ' N ' ' O ' ' A' ' 22' ' ' THR . 1.6 t-20 -78.23 -44.47 25.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' THR . 64.1 t -72.23 -34.72 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.27 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.64 -51.94 61.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -178.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -61.02 -35.07 75.89 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -62.17 -36.86 83.14 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.683 HG21 ' HG2' ' A' ' 41' ' ' GLN . 30.4 mm -62.78 -37.05 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -70.54 -35.77 73.31 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 4.9 m-20 -62.78 -44.35 96.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -61.45 -54.28 45.5 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.25 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -138.32 168.34 19.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.03 111.32 3.22 Favored Glycine 0 CA--C 1.507 -0.436 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.187 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 118.25 2.75 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.05 128.3 19.38 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.21 -27.51 85.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.845 1.697 . . . . 0.0 112.195 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -67.58 -27.93 67.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.388 . . . . 0.0 110.374 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -93.98 -13.05 27.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.449 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.683 ' HG2' HG21 ' A' ' 30' ' ' ILE . 6.7 tp-100 -81.09 139.66 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 43' ' ' LEU . 2.3 tpt85 -124.45 136.59 54.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.379 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 42' ' ' ARG . 4.5 mp -125.05 130.95 53.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.842 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.2 mt -135.67 142.15 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.1 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' LYS . 7.2 t80 -144.68 137.69 26.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.915 0.388 . . . . 0.0 111.199 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.04 44.48 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.39 -19.71 1.06 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 46' ' ' ALA . 5.7 mtmt -83.4 124.98 31.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 110.828 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.709 ' NE2' ' H ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -79.55 126.43 30.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.647 ' HB3' HD13 ' A' ' 23' ' ' ILE . 14.0 mt -76.44 129.26 36.29 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.877 ' O ' HD12 ' A' ' 23' ' ' ILE . 17.4 mt-10 -87.26 -169.56 2.67 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.51 5.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 111.806 -2.452 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 117.9 45.35 0.51 Allowed Glycine 0 C--N 1.321 -0.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.241 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.605 ' NH2' ' H ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -80.37 159.3 25.77 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 173.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.605 ' H ' ' NH2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -78.45 139.45 38.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 116.341 -2.144 . . . . 0.0 109.52 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.796 HD23 HG13 ' A' ' 61' ' ' ILE . 5.0 mp -77.41 -28.93 52.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.689 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 19' ' ' PRO . 3.6 t -53.51 -30.14 39.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 55' ' ' THR . 74.4 m-20 -73.36 -28.08 61.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.023 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 56' ' ' LEU . 13.6 m-85 -78.9 2.07 21.41 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.341 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.94 46.09 27.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.644 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.796 HG13 HD23 ' A' ' 56' ' ' LEU . 33.8 mm -63.71 139.1 21.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.87 0.843 . . . . 0.0 110.67 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.739 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 24.1 tt0 -96.92 -179.37 4.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.214 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.739 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 6.1 mtpm? -43.28 30.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.353 -2.203 . . . . 0.0 115.001 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.6 mt-10 91.02 52.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.166 0.984 . . . . 0.0 111.498 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -62.89 152.11 37.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.194 177.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.01 123.45 32.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.414 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.91 144.96 29.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.815 0.34 . . . . 0.0 110.453 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -98.54 147.26 24.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.991 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 -179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.696 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 2.6 mt-30 . . . . . 0 CA--C 1.52 -0.198 0 CA-C-O 120.557 0.218 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 12.7 mt -140.97 142.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.807 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -141.01 133.99 29.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.475 0.655 . . . . 0.0 110.945 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 t -109.54 131.1 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.283 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.53 124.84 50.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.63 0.252 . . . . 0.0 110.449 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.11 158.65 15.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.754 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -3.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.194 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.3 p -90.54 6.99 41.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.475 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.73 16.83 74.54 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -98.24 123.43 42.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.704 0.287 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 t -100.69 120.39 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.696 HG23 ' O ' ' A' ' 13' ' ' ILE . 20.5 tt -117.49 110.12 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.228 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.667 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.3 t -101.07 138.15 38.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.138 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.34 146.49 40.46 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.495 ' OE1' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -95.3 109.49 21.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 18' ' ' GLU . 10.0 p -150.07 162.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.726 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 1.4 mp0 -84.38 177.84 2.74 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 4.0 Cg_exo -73.76 -6.74 19.12 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 121.611 1.541 . . . . 0.0 111.786 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.733 ' HA ' ' H ' ' A' ' 57' ' ' SER . 8.0 t -80.28 -27.21 38.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 116.386 -2.125 . . . . 0.0 107.863 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.955 ' O ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 33.36 68.76 0.15 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 117.698 -1.144 . . . . 0.0 111.955 170.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -79.83 132.71 36.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 114.437 -2.905 . . . . 0.0 105.297 -175.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -55.47 -37.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 112.878 -1.964 . . . . 0.0 111.557 -172.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.35 -31.15 68.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' THR . 5.0 t-20 -78.83 -44.65 22.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.043 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.4 t -72.37 -49.21 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.476 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.679 ' CG ' HG22 ' A' ' 23' ' ' ILE . 10.4 mmmm -55.18 -35.33 64.7 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.586 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.44 -35.84 78.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -65.91 -36.92 84.71 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.419 HG21 HE21 ' A' ' 41' ' ' GLN . 32.6 mm -63.25 -42.01 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 34' ' ' GLU . 51.8 tt0 -69.91 -34.22 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.732 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.83 -45.49 92.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.128 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' CB ' HD11 ' A' ' 13' ' ' ILE . 23.2 mmtp -67.19 -52.9 35.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.094 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 31' ' ' GLN . 77.6 tt0 -129.01 153.81 47.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.95 113.89 3.91 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.276 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.647 HD13 ' HD2' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -151.96 120.23 3.31 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.647 ' HD2' HD13 ' A' ' 36' ' ' ILE . 3.1 Cg_exo -69.83 130.66 19.64 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 CA-C-N 119.458 0.842 . . . . 0.0 110.976 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -49.68 -40.44 46.91 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.364 2.042 . . . . 0.0 112.222 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -59.49 -29.22 67.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -98.89 7.85 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.662 ' O ' ' CE ' ' A' ' 27' ' ' LYS . 3.9 tp-100 -121.64 129.38 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -131.21 142.52 50.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.022 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.04 146.5 48.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 44' ' ' ILE . 7.5 pt -135.92 142.56 38.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.47 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -124.67 115.84 21.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 111.51 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.74 42.5 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.427 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -21.2 32.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -80.78 115.22 20.16 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -79.36 122.34 26.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.477 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.637 ' HB3' HD13 ' A' ' 23' ' ' ILE . 42.1 mt -79.55 130.61 35.55 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.872 ' O ' HD12 ' A' ' 23' ' ' ILE . 17.2 mt-10 -95.35 -169.47 1.98 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -47.42 7.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 111.926 -2.397 . . . . 0.0 114.432 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.98 44.46 0.49 Allowed Glycine 0 N--CA 1.461 0.325 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.134 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -81.52 153.76 26.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 58' ' ' ASP . 1.9 m -78.45 141.16 38.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 116.402 -2.119 . . . . 0.0 110.336 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.955 HD13 ' O ' ' A' ' 21' ' ' ASP . 6.7 mp -76.7 -31.58 57.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.22 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.733 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.3 t -55.59 -33.28 63.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 55' ' ' THR . 15.6 t70 -71.35 -25.6 62.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.437 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 56' ' ' LEU . 4.0 m-85 -79.93 1.11 28.58 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.591 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.22 44.18 22.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.87 HG13 HD23 ' A' ' 56' ' ' LEU . 16.5 mm -65.57 138.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.98 0.895 . . . . 0.0 110.254 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.743 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 30.6 tt0 -96.24 -178.35 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.732 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.743 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 19.0 ttpt -43.27 29.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.544 -2.116 . . . . 0.0 114.889 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.717 ' N ' ' O ' ' A' ' 62' ' ' GLN . 19.5 tt0 92.37 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.958 0.885 . . . . 0.0 112.59 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.15 154.93 25.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.774 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.557 ' O ' HG23 ' A' ' 66' ' ' THR . 9.3 t -86.62 125.08 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.874 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.1 mp -98.86 138.82 35.45 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -83.56 138.87 33.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 111.529 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.463 0.176 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.075 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 . . . . . 0 CA--C 1.519 -0.245 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.768 HD11 HD23 ' A' ' 56' ' ' LEU . 1.2 mt -118.52 158.78 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.822 0.82 . . . . 0.0 111.003 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -139.33 135.02 33.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.641 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.588 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 12.1 t -130.67 143.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.052 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -102.3 133.49 47.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.246 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -85.61 163.83 18.09 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.619 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 8' ' ' LEU . 3.8 pp -70.0 -10.82 59.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -96.39 -15.12 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -6.51 50.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -70.29 124.75 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 p -80.19 115.55 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.383 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' ILE . 11.9 tt -110.72 112.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.911 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.709 ' C ' HD23 ' A' ' 15' ' ' LEU . 24.0 p -104.05 139.62 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.07 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.16 143.68 44.41 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.59 109.43 21.67 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.771 HG22 ' N ' ' A' ' 18' ' ' GLU . 8.9 p -151.02 171.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.04 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.771 ' N ' HG22 ' A' ' 17' ' ' VAL . 3.3 pm0 -92.13 174.68 3.96 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.3 Cg_exo -73.59 -6.49 18.8 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 C-N-CA 121.237 1.291 . . . . 0.0 112.35 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.721 ' HA ' ' H ' ' A' ' 57' ' ' SER . 89.8 p -78.03 -27.64 48.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 116.296 -2.162 . . . . 0.0 107.173 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.881 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 32.92 69.76 0.12 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.557 168.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.56 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -80.55 135.93 36.18 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 115.07 -2.652 . . . . 0.0 106.15 -175.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.818 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -54.71 -46.75 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 113.318 -1.765 . . . . 0.0 111.077 -173.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -57.71 -29.21 64.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -77.88 -39.46 43.15 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.181 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 22' ' ' THR . 36.2 t -72.47 -48.53 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.818 ' HD3' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.39 -41.69 76.7 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.522 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -38.09 68.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -67.59 -37.78 83.07 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 26' ' ' VAL . 27.5 mm -67.7 -32.23 55.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.634 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 27' ' ' LYS . 7.4 tt0 -68.95 -33.37 73.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.669 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -58.91 -45.22 90.84 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.539 ' CB ' HD11 ' A' ' 13' ' ' ILE . 19.3 mmtp -70.03 -53.91 15.48 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.2 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -130.82 155.02 47.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 114.4 3.85 Favored Glycine 0 C--O 1.23 -0.102 0 C-N-CA 119.003 -1.57 . . . . 0.0 111.733 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.0 tp -151.84 117.47 3.12 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HG2' HE21 ' A' ' 40' ' ' GLN . 3.2 Cg_exo -71.54 137.36 30.29 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 121.362 1.374 . . . . 0.0 111.945 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.4 -36.01 29.5 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.605 2.203 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -61.88 -25.93 67.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.419 HE21 ' HG2' ' A' ' 37' ' ' PRO . 26.4 mt-30 -109.32 9.34 25.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.42 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 25.4 tp60 -113.54 124.5 52.52 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.472 ' H ' HE21 ' A' ' 41' ' ' GLN . 6.2 ptp85 -131.81 134.5 45.86 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mt -122.88 159.32 28.44 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.8 143.8 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.252 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -144.54 128.92 17.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.7 45.38 18.08 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.33 -20.45 1.24 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.41 124.21 27.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -81.79 122.45 27.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.943 0.402 . . . . 0.0 111.337 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.089 HD22 HD11 ' A' ' 56' ' ' LEU . 73.1 mt -77.18 117.46 18.74 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.66 ' O ' HG21 ' A' ' 23' ' ' ILE . 15.7 mt-10 -92.83 -168.02 1.86 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -174.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.69 7.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 111.325 -2.671 . . . . 0.0 115.481 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.52 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . 118.82 43.14 0.54 Allowed Glycine 0 C--N 1.318 -0.456 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.193 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.451 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 36.6 mtt85 -82.59 152.46 25.93 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -78.31 141.69 38.29 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.989 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.089 HD11 HD22 ' A' ' 50' ' ' LEU . 3.3 mp -76.42 -30.71 57.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.022 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.721 ' H ' ' HA ' ' A' ' 20' ' ' SER . 10.9 t -53.27 -30.69 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 55' ' ' THR . 3.1 t70 -73.4 -28.67 62.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.184 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 56' ' ' LEU . 9.4 m-85 -79.33 6.17 10.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.694 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m120 51.65 44.75 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.539 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.694 HG13 HD23 ' A' ' 56' ' ' LEU . 34.7 mm -64.18 138.84 22.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 122.178 0.99 . . . . 0.0 111.09 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . 0.739 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 47.3 tt0 -96.57 -179.76 4.72 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.195 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.739 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.5 ttpt -43.36 30.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.623 -2.08 . . . . 0.0 115.225 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.688 ' N ' ' O ' ' A' ' 62' ' ' GLN . 10.0 mt-10 91.73 54.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.181 0.991 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -61.7 156.9 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 m -82.53 126.52 32.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.0 110.189 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.57 137.65 36.91 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -91.64 137.45 32.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.994 0.426 . . . . 0.0 111.295 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.431 HD11 ' CG1' ' A' ' 5' ' ' VAL . 5.9 mp . . . . . 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.409 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.637 ' O ' ' O ' ' A' ' 17' ' ' VAL . 3.7 mmt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 10.6 mm-40 -74.78 164.3 26.72 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.986 0.422 . . . . 0.0 110.701 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.429 ' CD1' ' CG ' ' A' ' 21' ' ' ASP . 0.7 OUTLIER -142.1 136.75 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.074 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.431 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 6.3 m-30 -108.2 136.13 48.38 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.939 -177.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.99 133.59 62.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.101 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -106.29 134.02 50.07 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.939 0.399 . . . . 0.0 110.976 -179.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 31.4 p -117.14 150.85 38.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.156 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 57.3 mt -64.66 -3.87 3.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.843 -179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.413 ' O ' HG22 ' A' ' 9' ' ' THR . 29.9 m -91.12 -8.97 47.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.594 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.85 -0.39 78.16 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.577 -0.609 . . . . 0.0 111.577 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -77.42 124.57 28.06 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.675 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.5 m -82.31 121.21 26.39 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.228 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.469 HG23 ' O ' ' A' ' 13' ' ' ILE . 19.4 tt -120.1 129.46 75.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.712 -179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 3.9 p -117.21 137.76 52.15 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.755 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.498 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 0.1 OUTLIER -115.48 147.17 40.95 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.9 179.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -95.91 109.85 22.14 Favored 'General case' 0 CA--C 1.511 -0.52 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.789 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.0 p -149.88 175.01 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.836 -177.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.789 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -102.0 173.95 3.22 Favored Pre-proline 0 N--CA 1.452 -0.357 0 N-CA-C 106.137 -1.801 . . . . 0.0 106.137 176.635 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.548 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.1 Cg_exo -74.51 -6.49 18.36 Favored 'Trans proline' 0 C--N 1.298 -2.103 0 CA-C-N 120.751 1.304 . . . . 0.0 110.92 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.796 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -77.22 -27.34 53.37 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 116.833 -1.947 . . . . 0.0 105.745 179.207 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.787 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 31.57 64.01 0.22 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 117.902 -1.047 . . . . 0.0 111.551 168.674 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.654 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -83.73 135.89 34.39 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 114.903 -2.719 . . . . 0.0 106.469 -175.616 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.676 HG13 ' O ' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -52.78 -41.07 37.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 113.203 -1.817 . . . . 0.0 110.843 -173.111 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.532 ' HG3' ' OG1' ' A' ' 22' ' ' THR . 0.0 OUTLIER -61.6 -30.0 70.4 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.768 -1.938 . . . . 0.0 105.768 175.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.618 ' N ' ' O ' ' A' ' 22' ' ' THR . 11.1 t30 -79.28 -46.02 18.57 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 114.528 -1.215 . . . . 0.0 111.995 178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.654 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.3 t -72.47 -45.64 58.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-O 121.08 0.467 . . . . 0.0 110.172 -179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.705 ' NZ ' HD12 ' A' ' 30' ' ' ILE . 2.7 mmtm -54.83 -51.86 64.53 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.367 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.22 -35.99 70.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.512 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.8 mttm -64.23 -36.68 84.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.705 HD12 ' NZ ' ' A' ' 27' ' ' LYS . 73.3 mt -75.88 -28.93 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.547 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.588 ' NE2' ' O ' ' A' ' 36' ' ' ILE . 0.4 OUTLIER -56.72 -35.29 68.38 Favored 'General case' 0 N--CA 1.462 0.165 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.75 -44.75 73.09 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.477 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 29.5 mmtm -60.92 -52.28 65.7 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 56.1 mt-10 -146.65 154.24 41.23 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.94 116.64 4.65 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 119.042 -1.551 . . . . 0.0 111.241 -178.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.975 HD13 ' OE1' ' A' ' 41' ' ' GLN . 2.7 pp -149.47 117.25 3.72 Favored Pre-proline 0 N--CA 1.444 -0.773 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 177.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 36' ' ' ILE . 2.9 Cg_endo -73.13 131.06 16.13 Favored 'Trans proline' 0 C--N 1.293 -2.371 0 C-N-CA 121.911 1.741 . . . . 0.0 111.833 179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -60.49 -45.29 22.59 Favored 'Trans proline' 0 N--CA 1.49 1.303 0 C-N-CA 121.908 1.739 . . . . 0.0 111.926 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.55 -16.71 40.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.621 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -111.09 -15.72 13.64 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.214 -0.448 . . . . 0.0 112.165 -179.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.975 ' OE1' HD13 ' A' ' 36' ' ' ILE . 52.4 tt0 -111.4 138.32 48.05 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 113.067 0.766 . . . . 0.0 113.067 -178.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.405 HH11 ' HB3' ' A' ' 42' ' ' ARG . 29.0 mtp-105 -128.48 144.85 51.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.745 179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.629 HD21 ' HZ1' ' A' ' 27' ' ' LYS . 18.0 mt -116.27 174.47 6.03 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 121.036 0.446 . . . . 0.0 110.875 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 17.8 tt -134.75 138.27 49.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.507 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -127.36 117.31 21.96 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.721 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.56 44.66 17.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.771 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.31 -20.38 17.66 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 110.771 -0.932 . . . . 0.0 110.771 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.5 ttmm -78.55 135.41 37.3 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 mt-30 -84.65 118.75 24.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.39 -179.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.692 HD22 HD11 ' A' ' 56' ' ' LEU . 13.2 mt -81.05 146.31 30.69 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 178.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.676 ' O ' HG13 ' A' ' 23' ' ' ILE . 2.6 mt-10 -96.62 -173.33 2.71 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 116.954 2.205 . . . . 0.0 116.954 -174.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -54.97 8.31 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 111.343 -2.662 . . . . 0.0 114.306 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.52 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . 121.58 43.05 0.43 Allowed Glycine 0 C--N 1.319 -0.392 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.708 -174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 44.2 mmt-85 -83.12 165.62 19.37 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 102.624 -3.102 . . . . 0.0 102.624 172.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.491 HG22 ' H ' ' A' ' 57' ' ' SER . 67.8 m -87.27 142.32 27.99 Favored 'General case' 0 C--N 1.317 -0.81 0 C-N-CA 116.96 -1.896 . . . . 0.0 111.124 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.787 HD22 ' HB3' ' A' ' 21' ' ' ASP . 3.2 mp -76.97 -33.53 57.63 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.988 -1.005 . . . . 0.0 112.409 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.796 ' H ' ' HA ' ' A' ' 20' ' ' SER . 15.8 m -57.53 -36.11 71.15 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.5 -24.14 64.63 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.482 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 2.8 m-85 -83.49 6.53 19.99 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.51 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 55.6 43.2 28.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.182 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.661 HG13 HD23 ' A' ' 56' ' ' LEU . 20.7 mm -65.73 140.81 19.0 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.159 0 CA-C-O 122.181 0.991 . . . . 0.0 110.835 -179.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.819 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 23.3 tt0 -94.47 -176.49 3.95 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 113.35 -1.75 . . . . 0.0 113.254 -176.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.819 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.2 tmtm? -41.15 25.52 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 112.901 -1.954 . . . . 0.0 114.546 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.771 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.3 pt-20 91.01 53.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.722 0 CA-C-O 122.265 1.031 . . . . 0.0 113.429 -178.339 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.61 152.62 18.06 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.43 177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.507 ' C ' HD12 ' A' ' 67' ' ' LEU . 30.8 m -86.71 119.36 26.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.167 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.783 ' N ' HD12 ' A' ' 67' ' ' LEU . 4.8 mp -98.8 131.13 45.16 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -120.32 138.56 53.64 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.933 0.397 . . . . 0.0 111.227 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.569 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.1 OUTLIER -121.76 131.47 54.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.192 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.492 HG22 ' H ' ' A' ' 72' ' ' ARG . 4.7 p -137.21 151.83 27.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.123 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 4.7 mp -138.68 19.33 2.69 Favored 'General case' 0 N--CA 1.462 0.175 0 C-N-CA 121.019 -0.273 . . . . 0.0 111.127 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.492 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 118.046 -0.978 . . . . 0.0 110.309 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 17' ' ' VAL . 1.8 mpp? . . . . . 0 N--CA 1.489 1.475 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -127.12 168.26 14.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.134 -178.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.512 HG12 HG21 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -117.13 151.35 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.175 0 CA-C-O 121.316 0.579 . . . . 0.0 110.261 -179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.543 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -139.95 132.47 28.66 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.646 -179.005 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.543 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 87.8 t -119.79 132.3 69.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.153 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.2 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -101.87 121.86 42.91 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.926 -179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.4 p -89.32 161.34 16.41 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.34 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -71.35 -4.81 28.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.625 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 2.0 m -95.72 1.76 53.58 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.294 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 78.97 -4.01 63.16 Favored Glycine 0 CA--C 1.525 0.683 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -72.61 123.08 22.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.834 0.35 . . . . 0.0 110.281 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.6 p -91.95 125.01 36.48 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.973 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 13' ' ' ILE . 1.2 tp -119.03 121.62 67.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.788 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.3 p -110.79 133.08 53.66 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.972 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.421 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.8 145.9 42.42 Favored 'General case' 0 CA--C 1.517 -0.323 0 CA-C-N 116.02 -0.536 . . . . 0.0 109.635 179.55 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.464 ' N ' ' CD ' ' A' ' 16' ' ' GLU . 8.4 mp0 -96.25 110.68 22.95 Favored 'General case' 0 CA--C 1.508 -0.662 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.744 HG22 ' O ' ' A' ' 18' ' ' GLU . 7.1 p -150.52 149.61 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.806 0 CA-C-N 114.999 -1.001 . . . . 0.0 111.764 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.938 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 2.4 pm0 -70.55 177.04 1.55 Allowed Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 105.288 -2.115 . . . . 0.0 105.288 175.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.673 ' O ' ' N ' ' A' ' 57' ' ' SER . 4.0 Cg_exo -74.49 -6.56 18.46 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 C-N-CA 121.584 1.522 . . . . 0.0 111.868 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.71 ' O ' ' N ' ' A' ' 56' ' ' LEU . 83.2 p -78.82 -27.32 44.33 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 116.365 -2.134 . . . . 0.0 107.647 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 1.128 ' O ' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 31.54 67.86 0.13 Allowed 'General case' 0 CA--C 1.504 -0.803 0 CA-C-O 117.739 -1.124 . . . . 0.0 111.885 169.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.65 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 0.8 OUTLIER -80.14 133.4 36.06 Favored 'General case' 0 C--N 1.308 -1.226 0 C-N-CA 114.331 -2.947 . . . . 0.0 106.097 -175.791 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.889 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -54.41 -35.1 29.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 112.872 -1.967 . . . . 0.0 110.744 -173.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.4 ' H ' ' HA2' ' A' ' 53' ' ' GLY . 15.8 tt0 -62.88 -33.29 74.98 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.65 ' HB3' ' O ' ' A' ' 22' ' ' THR . 3.4 t30 -78.86 -45.68 20.22 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 114.01 -1.45 . . . . 0.0 112.345 178.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.594 ' N ' ' O ' ' A' ' 22' ' ' THR . 16.9 t -72.6 -37.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-O 120.709 0.29 . . . . 0.0 111.403 -178.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.608 ' NZ ' HD11 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -54.7 -51.34 65.86 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.061 0.457 . . . . 0.0 110.418 -179.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.06 -35.38 69.26 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.382 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 30.7 mttm -63.48 -37.77 88.57 Favored 'General case' 0 C--O 1.231 0.083 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 14.2 mm -70.16 -42.6 79.14 Favored 'Isoleucine or valine' 0 C--O 1.231 0.12 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.639 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -69.14 -32.27 71.51 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.716 179.534 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 33.1 t0 -58.93 -37.73 77.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.816 -178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mmtt -61.83 -54.12 46.51 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.004 0.43 . . . . 0.0 110.736 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.639 ' O ' ' O ' ' A' ' 31' ' ' GLN . 36.9 mt-10 -140.94 176.63 8.65 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.68 113.8 3.83 Favored Glycine 0 CA--C 1.51 -0.252 0 C-N-CA 118.532 -1.794 . . . . 0.0 110.637 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.476 HD13 ' HD2' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -151.83 118.86 3.21 Favored Pre-proline 0 C--N 1.314 -0.97 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 177.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.476 ' HD2' HD13 ' A' ' 36' ' ' ILE . 3.4 Cg_exo -71.67 130.14 16.6 Favored 'Trans proline' 0 C--N 1.295 -2.266 0 C-N-CA 120.564 0.843 . . . . 0.0 111.722 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.58 ' HB3' ' HB3' ' A' ' 27' ' ' LYS . 3.3 Cg_exo -57.82 -34.46 98.29 Favored 'Trans proline' 0 N--CA 1.49 1.266 0 C-N-CA 122.047 1.831 . . . . 0.0 111.597 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 39' ' ' ASP . 0.5 OUTLIER -66.57 -26.75 67.27 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.044 -179.532 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 -104.42 0.67 29.24 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.814 -179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.501 ' NE2' ' N ' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -104.71 126.74 52.09 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.597 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.501 ' N ' ' NE2' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -130.08 142.43 50.61 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.682 179.657 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.608 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 7.2 mt -118.44 162.42 18.36 Favored 'General case' 0 N--CA 1.469 0.492 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 91.7 mt -136.03 139.62 45.49 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-O 120.842 0.353 . . . . 0.0 111.187 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -135.27 119.44 17.67 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.287 179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 53.14 35.41 19.73 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.336 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.98 -19.7 24.46 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.095 -0.802 . . . . 0.0 111.095 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 ttmt -82.18 116.84 21.91 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.846 0.355 . . . . 0.0 110.397 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -71.37 127.77 33.66 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.671 ' HB3' HD13 ' A' ' 23' ' ' ILE . 43.5 mt -76.73 127.76 33.38 Favored 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 179.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.889 ' O ' HD12 ' A' ' 23' ' ' ILE . 1.2 mp0 -81.65 -169.81 2.51 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 116.938 2.199 . . . . 0.0 116.938 -174.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -48.8 6.09 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 111.646 -2.524 . . . . 0.0 115.09 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.508 ' HA2' ' CB ' ' A' ' 23' ' ' ILE . . . 117.85 44.1 0.55 Allowed Glycine 0 C--N 1.316 -0.534 0 C-N-CA 119.93 -1.129 . . . . 0.0 111.964 -175.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 50.6 mtp180 -81.67 159.14 24.04 Favored 'General case' 0 CA--C 1.509 -0.632 0 N-CA-C 103.48 -2.785 . . . . 0.0 103.48 173.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 58' ' ' ASP . 0.7 OUTLIER -79.08 141.17 37.58 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 116.916 -1.914 . . . . 0.0 110.039 -178.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.128 HD23 ' O ' ' A' ' 21' ' ' ASP . 2.2 mm? -74.52 -32.5 62.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.932 -1.031 . . . . 0.0 111.985 179.577 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.69 ' H ' ' HA ' ' A' ' 20' ' ' SER . 7.2 t -54.77 -30.71 57.45 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.542 ' H ' HG22 ' A' ' 55' ' ' THR . 8.6 t70 -71.98 -29.29 64.08 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.517 ' N ' ' O ' ' A' ' 56' ' ' LEU . 19.0 m-85 -79.4 -6.39 56.73 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.737 178.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 64.66 44.64 3.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.843 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.909 ' CG1' HD12 ' A' ' 56' ' ' LEU . 31.7 mm -64.43 137.66 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 CA-C-O 121.947 0.879 . . . . 0.0 110.152 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.696 ' O ' ' N ' ' A' ' 64' ' ' GLU . 10.8 pt20 -102.55 -174.37 2.55 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 113.714 -1.584 . . . . 0.0 114.057 -176.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.584 ' O ' ' CB ' ' A' ' 64' ' ' GLU . 49.1 mttt -42.05 30.24 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 111.558 -2.565 . . . . 0.0 115.365 179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.696 ' N ' ' O ' ' A' ' 62' ' ' GLN . 9.1 mt-10 91.38 53.16 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 121.919 0.866 . . . . 0.0 113.282 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.75 153.57 35.98 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.745 176.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.429 ' O ' HG23 ' A' ' 66' ' ' THR . 5.8 t -86.24 126.68 34.46 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.858 0.361 . . . . 0.0 110.96 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.06 139.19 35.07 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 109.84 -0.429 . . . . 0.0 109.84 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 52.0 m-70 -88.49 138.04 31.78 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.929 0.395 . . . . 0.0 111.23 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 4.5 mt -113.28 157.21 22.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.199 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 27.5 m -143.56 149.77 17.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.447 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -146.07 -47.35 0.2 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.395 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.411 HH11 ' HD2' ' A' ' 72' ' ' ARG . 8.7 ttm105 . . . . . 0 C--O 1.22 -0.486 0 CA-C-O 118.029 -0.986 . . . . 0.0 110.324 179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.522 ' O ' ' O ' ' A' ' 17' ' ' VAL . 4.1 mpp? . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 61.4 mt-30 -127.12 163.56 23.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.192 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.573 ' HA ' ' HA ' ' A' ' 64' ' ' GLU . 0.7 OUTLIER -120.61 155.65 23.9 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.641 ' HB3' ' O ' ' A' ' 64' ' ' GLU . 2.5 t80 -137.21 132.72 34.27 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.857 -177.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.6 t -128.8 146.74 33.67 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.725 -179.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -98.34 120.63 39.09 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 67.9 p -87.19 161.77 17.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.187 0.518 . . . . 0.0 111.382 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 8' ' ' LEU . 4.6 mp -71.77 -11.8 60.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.662 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.8 m -94.01 -10.89 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.611 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.34 2.15 77.33 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.977 -0.849 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -81.07 131.51 35.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.721 0.296 . . . . 0.0 110.564 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -76.79 121.84 23.91 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.596 HG23 ' O ' ' A' ' 13' ' ' ILE . 11.6 tt -115.04 122.09 68.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.117 -179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.2 m -112.74 137.64 50.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.057 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -114.75 147.83 39.18 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.128 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -95.26 109.77 21.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.779 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.6 p -150.51 173.6 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 CA-C-N 114.976 -1.011 . . . . 0.0 111.496 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.779 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.0 mp0 -99.4 175.98 2.18 Favored Pre-proline 0 N--CA 1.447 -0.597 0 N-CA-C 106.27 -1.752 . . . . 0.0 106.27 175.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.656 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -73.54 -7.54 20.42 Favored 'Trans proline' 0 C--N 1.288 -2.633 0 C-N-CA 121.245 1.297 . . . . 0.0 111.066 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.721 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.0 OUTLIER -78.11 -28.21 48.51 Favored 'General case' 0 N--CA 1.442 -0.853 0 C-N-CA 116.542 -2.063 . . . . 0.0 106.807 179.629 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.726 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 32.88 67.19 0.18 Allowed 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 117.933 -1.032 . . . . 0.0 111.994 169.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.62 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -80.62 133.44 35.74 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 114.645 -2.822 . . . . 0.0 105.826 -175.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.809 HD12 ' O ' ' A' ' 51' ' ' GLU . 1.1 mt -55.13 -43.58 70.83 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-N 113.012 -1.904 . . . . 0.0 111.015 -173.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.549 ' OE1' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -59.73 -29.58 68.24 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 105.763 -1.939 . . . . 0.0 105.763 175.18 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.552 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -77.66 -44.68 27.3 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 114.456 -1.247 . . . . 0.0 111.821 179.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.62 ' N ' ' O ' ' A' ' 22' ' ' THR . 10.7 t -72.25 -39.73 64.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.347 -178.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.706 ' HZ3' HD21 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -54.53 -41.99 70.34 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.596 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.21 -34.68 78.0 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.25 -36.4 81.55 Favored 'General case' 0 CA--C 1.529 0.148 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 26' ' ' VAL . 21.1 mm -62.04 -40.35 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.038 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.513 ' O ' ' O ' ' A' ' 34' ' ' GLU . 4.9 tt0 -69.1 -31.99 71.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.2 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.37 -44.64 88.96 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.504 ' H ' ' HD2' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -60.93 -53.59 55.38 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.3 -0.56 . . . . 0.0 109.935 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.513 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.7 mt-10 -135.92 155.56 50.11 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -77.94 112.37 3.47 Favored Glycine 0 CA--C 1.505 -0.54 0 C-N-CA 118.529 -1.796 . . . . 0.0 110.72 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.7 pt -152.85 119.03 2.98 Favored Pre-proline 0 C--N 1.308 -1.237 0 N-CA-C 105.238 -2.134 . . . . 0.0 105.238 176.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -56.49 128.91 32.03 Favored 'Trans proline' 0 C--N 1.287 -2.695 0 CA-C-N 118.839 0.621 . . . . 0.0 110.706 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -60.21 -34.91 93.67 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 C-N-CA 121.934 1.756 . . . . 0.0 112.288 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -59.5 -8.18 1.75 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.85 0.357 . . . . 0.0 110.175 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -109.99 -12.96 14.49 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.548 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.403 ' NE2' HG21 ' A' ' 30' ' ' ILE . 26.1 mm100 -83.82 126.0 32.51 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.066 0.46 . . . . 0.0 111.308 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.814 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.4 mtt180 -129.38 128.28 42.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.851 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.814 HD23 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -131.61 149.75 52.39 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.182 0.515 . . . . 0.0 111.444 -179.598 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.0 mt -131.25 143.24 41.27 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.154 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.604 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.402 ' O ' ' HB2' ' A' ' 48' ' ' LYS . 41.0 t80 -120.59 115.54 23.6 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 120.916 0.389 . . . . 0.0 111.388 -179.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.77 39.22 6.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.379 178.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.13 -20.9 34.0 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.35 -0.7 . . . . 0.0 111.35 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.402 ' HB2' ' O ' ' A' ' 45' ' ' PHE . 20.2 mttm -79.19 117.5 20.27 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 179.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.439 ' O ' ' CG ' ' A' ' 49' ' ' GLN . 12.4 pt20 -76.79 121.3 23.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.298 -179.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.117 HD22 HD11 ' A' ' 56' ' ' LEU . 67.6 mt -76.99 127.03 31.96 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.809 ' O ' HD12 ' A' ' 23' ' ' ILE . 22.3 mt-10 -90.63 -169.32 2.34 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -174.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -47.59 5.32 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 111.798 -2.456 . . . . 0.0 114.504 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.81 44.6 0.58 Allowed Glycine 0 C--N 1.319 -0.394 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.383 -176.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -81.17 160.55 24.33 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 102.793 -3.04 . . . . 0.0 102.793 172.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.438 HG22 ' H ' ' A' ' 57' ' ' SER . 21.7 m -79.37 140.44 37.46 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 116.257 -2.177 . . . . 0.0 110.34 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.117 HD11 HD22 ' A' ' 50' ' ' LEU . 3.2 mp -77.54 -30.46 52.77 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.618 -1.174 . . . . 0.0 113.009 179.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.721 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.9 t -54.96 -30.51 59.13 Favored 'General case' 0 CA--C 1.508 -0.67 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 -179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -72.27 -27.72 62.67 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.242 176.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.599 ' N ' ' O ' ' A' ' 56' ' ' LEU . 10.5 m-85 -79.25 -5.4 54.27 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 115.117 -0.947 . . . . 0.0 108.968 178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 60.47 45.13 11.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.629 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.729 HG13 HD23 ' A' ' 56' ' ' LEU . 37.9 mm -64.42 136.89 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-O 122.141 0.972 . . . . 0.0 109.978 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.74 ' O ' ' N ' ' A' ' 64' ' ' GLU . 9.0 pt20 -97.53 -173.76 2.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.291 -1.777 . . . . 0.0 114.284 -176.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.703 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 1.6 pttm -41.62 26.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 112.123 -2.308 . . . . 0.0 115.259 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.74 ' N ' ' O ' ' A' ' 62' ' ' GLN . 0.9 OUTLIER 90.64 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 122.875 1.321 . . . . 0.0 113.111 -178.407 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.4 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.5 OUTLIER -62.4 157.02 21.0 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 112.934 -1.939 . . . . 0.0 111.74 177.318 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.561 ' CG2' ' CE2' ' A' ' 4' ' ' PHE . 1.8 p -84.16 131.55 34.76 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.751 178.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 20.8 mt -97.09 142.84 28.54 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.794 0.33 . . . . 0.0 110.504 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -88.19 134.99 33.65 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.479 -178.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 3.0 mp -122.05 167.99 12.47 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.957 179.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.423 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 0.0 OUTLIER -118.85 166.48 13.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.143 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.423 ' CB ' ' O ' ' A' ' 70' ' ' VAL . 9.9 tp 77.46 121.36 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.29 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.59 -179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.456 ' O ' ' O ' ' A' ' 17' ' ' VAL . 2.8 tpt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.767 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 1.8 mp0 -90.8 165.31 13.71 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -130.02 135.78 60.27 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.467 0 CA-C-O 121.489 0.661 . . . . 0.0 110.262 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.448 ' CD1' ' HG3' ' A' ' 64' ' ' GLU . 4.3 m-30 -110.29 142.62 41.65 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.591 -1.186 . . . . 0.0 110.543 -178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -131.26 135.54 59.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.1 tttm -101.19 122.83 44.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.872 0.368 . . . . 0.0 110.654 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.9 p -98.06 151.79 19.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.627 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.536 HD23 ' H ' ' A' ' 8' ' ' LEU . 0.3 OUTLIER -71.25 -10.74 60.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.448 179.899 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.13 2.41 56.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.577 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 72.98 15.11 78.47 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.879 -0.888 . . . . 0.0 110.879 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -93.49 127.57 39.2 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.72 0.295 . . . . 0.0 110.43 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.3 m -86.55 115.92 24.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 33' ' ' LYS . 19.1 tt -112.6 118.21 57.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.915 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.599 ' C ' HD23 ' A' ' 15' ' ' LEU . 0.6 OUTLIER -107.21 138.56 43.16 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.352 -178.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.623 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -115.86 145.27 43.01 Favored 'General case' 0 CA--C 1.512 -0.503 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 178.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.14 109.98 22.33 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 107.173 -1.417 . . . . 0.0 107.173 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.782 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.6 p -149.64 171.43 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.937 -177.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.782 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -95.8 172.48 5.22 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 176.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.649 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -75.18 -7.88 19.39 Favored 'Trans proline' 0 C--N 1.295 -2.256 0 C-N-CA 121.392 1.394 . . . . 0.0 111.074 -179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.698 ' HA ' ' H ' ' A' ' 57' ' ' SER . 1.1 m -78.0 -27.08 48.9 Favored 'General case' 0 CA--C 1.503 -0.862 0 C-N-CA 116.712 -1.995 . . . . 0.0 105.805 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.724 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 33.43 68.27 0.16 Allowed 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 117.653 -1.165 . . . . 0.0 111.795 169.109 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.569 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.1 OUTLIER -79.46 132.74 36.44 Favored 'General case' 0 C--N 1.31 -1.13 0 C-N-CA 114.25 -2.98 . . . . 0.0 105.481 -175.674 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.849 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.6 OUTLIER -55.69 -40.37 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.005 0 CA-C-N 112.878 -1.965 . . . . 0.0 110.859 -173.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -60.38 -29.9 69.24 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 105.648 -1.982 . . . . 0.0 105.648 174.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.569 ' N ' ' O ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -78.01 -44.58 26.18 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 114.387 -1.279 . . . . 0.0 111.956 179.084 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.583 ' O ' HG12 ' A' ' 30' ' ' ILE . 6.8 t -72.2 -35.73 53.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 C-N-CA 120.824 -0.35 . . . . 0.0 111.302 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.638 ' NZ ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -54.5 -51.85 63.8 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.808 -178.893 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -59.46 -36.71 76.49 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.65 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' NZ ' ' ND2' ' A' ' 25' ' ' ASN . 19.8 mttp -64.57 -36.76 85.27 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.2 mm -63.5 -45.7 97.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.631 -179.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' OE1' ' O ' ' A' ' 31' ' ' GLN . 0.0 OUTLIER -69.94 -33.16 71.77 Favored 'General case' 0 CA--C 1.534 0.341 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -179.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 -59.45 -44.77 92.9 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.673 0.62 . . . . 0.0 112.673 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.743 ' HB2' HD11 ' A' ' 13' ' ' ILE . 2.6 mtpt -68.58 -54.5 16.18 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.565 -0.454 . . . . 0.0 110.766 -179.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.439 ' O ' ' O ' ' A' ' 31' ' ' GLN . 13.9 mm-40 -123.91 151.4 43.59 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.44 111.06 3.17 Favored Glycine 0 CA--C 1.507 -0.449 0 C-N-CA 118.317 -1.897 . . . . 0.0 111.104 -178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.513 HD13 ' OE1' ' A' ' 41' ' ' GLN . 1.8 tt -154.19 117.0 2.58 Favored Pre-proline 0 C--N 1.309 -1.167 0 N-CA-C 105.049 -2.204 . . . . 0.0 105.049 175.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.4 129.68 32.38 Favored 'Trans proline' 0 C--N 1.288 -2.621 0 CA-C-N 119.093 0.712 . . . . 0.0 111.156 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -57.56 -27.48 76.96 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.095 1.863 . . . . 0.0 112.086 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -64.84 -27.46 68.89 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.017 -179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.5 mm-40 -107.35 7.74 29.31 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.001 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.566 HE21 ' N ' ' A' ' 42' ' ' ARG . 36.9 tp60 -89.19 127.01 35.72 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.988 0.423 . . . . 0.0 110.918 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.566 ' N ' HE21 ' A' ' 41' ' ' GLN . 55.7 mtp180 -128.23 132.84 48.77 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.104 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.9 mt -124.06 151.44 43.81 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.737 0.303 . . . . 0.0 110.762 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 89.5 mt -135.44 139.99 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.6 179.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.414 ' O ' ' N ' ' A' ' 48' ' ' LYS . 70.7 t80 -121.75 116.4 24.44 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.584 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 48.09 33.54 3.63 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.39 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.03 -20.32 48.19 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 110.689 -0.964 . . . . 0.0 110.689 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 45' ' ' PHE . 55.2 mttm -78.15 120.38 22.88 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.901 0.381 . . . . 0.0 110.357 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 5.1 mt-30 -75.17 123.48 25.33 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.705 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.904 HD22 HD11 ' A' ' 56' ' ' LEU . 83.8 mt -76.77 132.86 39.48 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.849 ' O ' HD12 ' A' ' 23' ' ' ILE . 11.9 mt-10 -86.94 -170.6 3.14 Favored 'General case' 0 N--CA 1.471 0.591 0 N-CA-C 117.217 2.303 . . . . 0.0 117.217 -173.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 49.3 p30 -49.0 5.51 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 111.595 -2.548 . . . . 0.0 114.781 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.62 44.18 0.6 Allowed Glycine 0 C--N 1.318 -0.47 0 C-N-CA 120.142 -1.028 . . . . 0.0 111.856 -176.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.86 159.32 23.74 Favored 'General case' 0 CA--C 1.51 -0.57 0 N-CA-C 102.874 -3.009 . . . . 0.0 102.874 173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 57' ' ' SER . 0.6 OUTLIER -78.29 140.36 38.84 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 116.179 -2.208 . . . . 0.0 109.254 -179.049 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.904 HD11 HD22 ' A' ' 50' ' ' LEU . 3.0 mp -77.37 -31.14 54.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.555 -1.202 . . . . 0.0 113.368 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.698 ' H ' ' HA ' ' A' ' 20' ' ' SER . 35.6 p -55.12 -30.33 59.55 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' H ' HG22 ' A' ' 55' ' ' THR . 33.0 t0 -71.73 -26.32 62.42 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.846 177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 56' ' ' LEU . 5.8 m-85 -79.22 3.86 16.62 Favored 'General case' 0 CA--C 1.521 -0.164 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.522 179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 5.8 m120 59.69 40.45 19.87 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.423 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.629 HG13 HD23 ' A' ' 56' ' ' LEU . 21.9 mm -64.97 132.17 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.155 0 CA-C-O 122.031 0.92 . . . . 0.0 109.018 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.763 ' O ' ' N ' ' A' ' 64' ' ' GLU . 7.8 pt20 -96.82 -172.39 2.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 113.68 -1.6 . . . . 0.0 114.223 -175.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.749 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 5.8 mmtt -41.03 26.3 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 111.885 -2.416 . . . . 0.0 114.482 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.767 ' HA ' ' O ' ' A' ' 2' ' ' GLN . 1.8 pt-20 90.94 52.45 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.701 0 CA-C-O 122.441 1.115 . . . . 0.0 113.246 -178.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' CD ' ' A' ' 62' ' ' GLN . 0.6 OUTLIER -61.74 152.75 30.32 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.894 176.537 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.6 p -86.1 128.97 34.97 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.586 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 18.6 mt -98.65 132.61 43.91 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.235 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.0 t60 -88.3 141.83 28.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.604 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.497 ' N ' HD12 ' A' ' 69' ' ' LEU . 0.4 OUTLIER -121.36 162.03 21.07 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.696 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 19.8 m -146.06 163.8 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.303 179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.0 mp -105.53 -55.38 2.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.322 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.32 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' O ' ' A' ' 17' ' ' VAL . 2.7 mtp . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 7.3 mt-30 -126.8 164.79 20.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.747 -179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 4' ' ' PHE . 0.1 OUTLIER -120.74 159.96 21.94 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.431 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.52 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.546 ' N ' ' CG2' ' A' ' 3' ' ' ILE . 5.1 t80 -140.92 134.74 30.44 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.012 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.528 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 71.4 t -130.72 141.51 46.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.332 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -101.84 140.4 36.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.095 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 m -106.15 149.44 26.79 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.926 0.393 . . . . 0.0 110.831 -179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 8.1 mt -72.85 -11.97 60.8 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.093 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.1 p -91.82 -10.61 39.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.02 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 93.66 -4.86 73.06 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 111.073 -0.811 . . . . 0.0 111.073 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -78.87 128.29 33.14 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.821 0.343 . . . . 0.0 110.203 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.1 m -76.49 116.14 16.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.673 -179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 13' ' ' ILE . 7.5 tt -115.51 113.5 43.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.256 0.551 . . . . 0.0 110.182 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.1 p -117.6 139.61 50.75 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.333 -179.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.13 144.13 43.67 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.189 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -95.81 111.08 23.14 Favored 'General case' 0 CA--C 1.507 -0.676 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.808 HG22 ' N ' ' A' ' 18' ' ' GLU . 11.2 p -149.86 174.82 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 114.71 -1.132 . . . . 0.0 111.338 -177.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.808 ' N ' HG22 ' A' ' 17' ' ' VAL . 2.9 mp0 -100.04 177.32 1.58 Allowed Pre-proline 0 N--CA 1.447 -0.602 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 176.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.638 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.08 -7.62 20.08 Favored 'Trans proline' 0 C--N 1.29 -2.539 0 C-N-CA 121.459 1.439 . . . . 0.0 112.155 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.731 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.1 OUTLIER -78.17 -28.47 48.26 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 116.238 -2.185 . . . . 0.0 106.525 179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.821 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 32.24 66.86 0.17 Allowed 'General case' 0 N--CA 1.443 -0.796 0 CA-C-O 117.763 -1.113 . . . . 0.0 112.234 168.675 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.647 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -81.5 135.41 35.61 Favored 'General case' 0 C--N 1.314 -0.974 0 C-N-CA 115.118 -2.633 . . . . 0.0 105.83 -176.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.727 ' N ' HD13 ' A' ' 23' ' ' ILE . 0.6 OUTLIER -54.27 -43.95 63.48 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.592 0 CA-C-N 114.05 -1.432 . . . . 0.0 111.152 -173.586 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -59.18 -29.95 67.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.554 ' CB ' ' O ' ' A' ' 22' ' ' THR . 2.8 t-20 -78.26 -44.87 24.3 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 114.226 -1.352 . . . . 0.0 111.676 178.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.647 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.2 t -72.73 -39.42 60.06 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.272 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.638 -179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.66 ' NZ ' HD11 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -54.33 -52.05 62.76 Favored 'General case' 0 CA--C 1.514 -0.437 0 CA-C-O 121.153 0.501 . . . . 0.0 110.392 -179.709 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -57.04 -34.48 68.27 Favored 'General case' 0 N--CA 1.443 -0.796 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.326 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.33 -38.06 89.69 Favored 'General case' 0 C--O 1.232 0.145 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.627 HG22 HD11 ' A' ' 36' ' ' ILE . 19.4 mm -67.46 -39.79 83.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.516 ' O ' ' O ' ' A' ' 34' ' ' GLU . 14.9 tt0 -61.95 -34.06 75.43 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -59.24 -34.31 72.06 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.204 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HG3' HD11 ' A' ' 13' ' ' ILE . 29.1 mmtt -60.17 -31.23 69.93 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.208 0.528 . . . . 0.0 109.928 -179.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.516 ' O ' ' O ' ' A' ' 31' ' ' GLN . 2.8 pt-20 -160.46 -116.11 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.54 111.4 0.52 Allowed Glycine 0 CA--C 1.509 -0.339 0 C-N-CA 119.923 -1.132 . . . . 0.0 110.692 177.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.627 HD11 HG22 ' A' ' 30' ' ' ILE . 0.1 OUTLIER -153.6 119.27 2.83 Favored Pre-proline 0 C--N 1.313 -0.979 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 176.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' O ' ' OE1' ' A' ' 41' ' ' GLN . 2.9 Cg_endo -71.76 140.45 35.57 Favored 'Trans proline' 0 C--N 1.293 -2.358 0 C-N-CA 121.313 1.342 . . . . 0.0 112.18 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -51.34 -27.7 24.62 Favored 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.685 2.257 . . . . 0.0 112.131 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.11 -31.54 69.01 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.768 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -110.37 8.79 23.45 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.409 ' OE1' ' O ' ' A' ' 37' ' ' PRO . 3.0 mp0 -112.03 126.11 54.81 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 120.44 -0.504 . . . . 0.0 111.469 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' HG3' HH11 ' A' ' 42' ' ' ARG . 54.5 mtt85 -130.34 141.66 50.57 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.546 179.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.66 HD11 ' NZ ' ' A' ' 27' ' ' LYS . 16.2 mt -120.41 163.06 18.46 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-O 120.778 0.323 . . . . 0.0 110.69 179.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 6.6 mt -135.58 143.33 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.254 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.653 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' O ' ' N ' ' A' ' 48' ' ' LYS . 8.2 t80 -141.47 125.08 16.79 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.774 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.505 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.44 45.74 17.2 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.851 179.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 74.22 -19.11 1.87 Allowed Glycine 0 CA--C 1.521 0.449 0 N-CA-C 110.43 -1.068 . . . . 0.0 110.43 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.505 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.2 OUTLIER -81.68 115.72 21.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.825 0.345 . . . . 0.0 110.087 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.625 ' CD ' ' H ' ' A' ' 49' ' ' GLN . 0.3 OUTLIER -72.76 125.0 26.48 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.113 -179.576 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.666 HD13 HD11 ' A' ' 56' ' ' LEU . 45.5 mt -77.3 137.38 38.75 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 178.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.569 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 16.4 mp0 -95.05 -171.54 2.45 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 116.659 2.096 . . . . 0.0 116.659 -173.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 5.6 t0 -47.92 7.17 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 111.907 -2.406 . . . . 0.0 114.599 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.543 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.71 43.46 0.53 Allowed Glycine 0 C--N 1.32 -0.361 0 C-N-CA 120.245 -0.979 . . . . 0.0 111.884 -175.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -82.63 161.94 22.05 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 102.773 -3.047 . . . . 0.0 102.773 172.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 57' ' ' SER . 51.9 m -85.34 143.15 28.83 Favored 'General case' 0 C--N 1.318 -0.799 0 C-N-CA 117.188 -1.805 . . . . 0.0 111.763 -178.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.863 HD23 HG13 ' A' ' 61' ' ' ILE . 3.5 mp -77.21 -32.88 56.26 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.999 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.731 ' H ' ' HA ' ' A' ' 20' ' ' SER . 5.4 t -55.85 -33.57 64.64 Favored 'General case' 0 CA--C 1.503 -0.832 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -72.58 -26.91 61.88 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.571 176.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.589 ' HB2' ' HA ' ' A' ' 56' ' ' LEU . 9.7 m-85 -79.26 1.84 23.39 Favored 'General case' 0 C--N 1.34 0.165 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.983 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.5 m-80 57.8 45.1 19.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.639 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 56' ' ' LEU . 34.8 mm -64.93 139.66 21.03 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.209 0 CA-C-O 122.111 0.957 . . . . 0.0 110.588 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.762 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 5.5 tt0 -95.25 -179.28 4.74 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 113.46 -1.7 . . . . 0.0 113.693 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.777 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 39.0 mttp -43.05 28.05 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 112.265 -2.243 . . . . 0.0 115.197 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.777 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.52 53.81 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 122.837 1.303 . . . . 0.0 112.756 -177.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.7 p -61.96 154.29 26.85 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 112.937 -1.938 . . . . 0.0 111.055 177.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.415 ' H ' HG22 ' A' ' 66' ' ' THR . 0.0 OUTLIER -86.88 115.9 24.6 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.198 179.439 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.8 mp -98.16 137.97 36.14 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 178.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.3 m-70 -83.01 142.73 31.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.141 0.496 . . . . 0.0 111.396 -178.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.545 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -120.95 115.91 24.09 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.869 179.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.545 ' N ' HD13 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -140.94 151.95 20.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.971 0.415 . . . . 0.0 110.554 -179.705 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 11.1 mt -103.07 -37.46 7.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.341 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 36.5 mtm180 . . . . . 0 C--O 1.219 -0.512 0 CA-C-O 118.06 -0.971 . . . . 0.0 110.504 179.906 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 2.8 mp0 -100.42 167.19 10.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.072 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.796 HD11 HD23 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -118.3 152.62 20.41 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.387 0 CA-C-O 121.336 0.589 . . . . 0.0 109.505 179.367 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CB ' ' O ' ' A' ' 64' ' ' GLU . 63.3 t80 -138.89 132.51 30.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.702 -178.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.641 ' CG1' HD11 ' A' ' 69' ' ' LEU . 85.1 t -130.16 140.34 49.15 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.434 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -128.66 144.13 51.09 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.904 0.383 . . . . 0.0 110.548 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.9 p -115.91 173.09 6.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.2 179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 12.3 mt -61.83 -7.85 4.17 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.473 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.9 p -92.73 -11.48 33.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.592 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.44 6.49 84.12 Favored Glycine 0 CA--C 1.526 0.749 0 N-CA-C 111.122 -0.791 . . . . 0.0 111.122 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 3.6 tptm -61.49 132.17 52.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.822 0.344 . . . . 0.0 110.917 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 12' ' ' THR . 7.9 t -89.51 115.36 26.88 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.599 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 13' ' ' ILE . 8.1 tt -121.47 120.9 63.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.295 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.677 ' C ' HD23 ' A' ' 15' ' ' LEU . 11.8 p -117.28 135.65 53.67 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.181 -179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -116.15 146.42 42.29 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.772 179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -95.8 111.0 23.07 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.769 HG22 ' N ' ' A' ' 18' ' ' GLU . 14.1 p -148.68 171.79 2.11 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 115.308 -0.86 . . . . 0.0 112.162 -177.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.769 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.3 pm0 -105.55 153.55 39.75 Favored Pre-proline 0 N--CA 1.45 -0.43 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 176.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.824 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.3 Cg_endo -52.02 -8.86 0.37 Allowed 'Trans proline' 0 C--N 1.293 -2.363 0 C-N-CA 121.881 1.721 . . . . 0.0 112.641 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.522 ' O ' ' C ' ' A' ' 21' ' ' ASP . 5.9 t -77.61 -28.8 51.58 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 115.224 -2.59 . . . . 0.0 105.988 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.728 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.6 OUTLIER 31.32 65.64 0.17 Allowed 'General case' 0 CA--C 1.505 -0.76 0 CA-C-O 117.671 -1.157 . . . . 0.0 111.339 168.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.61 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.1 OUTLIER -81.48 132.67 35.33 Favored 'General case' 0 C--N 1.309 -1.172 0 C-N-CA 114.374 -2.931 . . . . 0.0 105.893 -175.586 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.816 HD12 ' O ' ' A' ' 51' ' ' GLU . 1.2 mt -54.9 -39.52 49.13 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.851 0 CA-C-N 112.686 -2.052 . . . . 0.0 110.819 -173.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 47.5 tt0 -62.68 -29.87 70.97 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.836 -1.913 . . . . 0.0 105.836 175.271 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.583 ' N ' ' O ' ' A' ' 22' ' ' THR . 4.6 t-20 -78.55 -44.62 23.81 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.187 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.61 ' N ' ' O ' ' A' ' 22' ' ' THR . 3.4 t -72.34 -32.73 43.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.223 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' CD ' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -50.86 -47.92 60.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.839 -178.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.91 -34.2 76.17 Favored 'General case' 0 C--N 1.317 -0.827 0 C-N-CA 120.137 -0.625 . . . . 0.0 109.513 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.0 mttt -65.93 -35.98 82.09 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.52 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.3 mm -61.7 -45.56 98.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.506 ' O ' ' O ' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -70.68 -33.1 70.56 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.977 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -58.35 -44.85 88.95 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 -177.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt -62.76 -54.26 41.81 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.628 -0.429 . . . . 0.0 110.479 -179.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.506 ' O ' ' O ' ' A' ' 31' ' ' GLN . 75.8 mt-10 -132.59 157.21 45.33 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.58 111.87 3.34 Favored Glycine 0 CA--C 1.509 -0.311 0 C-N-CA 118.445 -1.836 . . . . 0.0 110.597 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.419 ' CD1' HG22 ' A' ' 30' ' ' ILE . 1.4 pt -153.86 119.55 2.8 Favored Pre-proline 0 C--N 1.309 -1.183 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 176.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -61.78 127.52 21.77 Favored 'Trans proline' 0 C--N 1.288 -2.607 0 CA-C-N 119.401 0.822 . . . . 0.0 110.977 -178.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -62.57 -42.9 24.1 Favored 'Trans proline' 0 N--CA 1.491 1.378 0 C-N-CA 122.282 1.988 . . . . 0.0 112.269 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -59.26 -17.67 30.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.693 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -109.97 7.41 23.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.417 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 6.0 tp60 -116.58 128.64 55.6 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-O 121.151 0.501 . . . . 0.0 111.217 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 2.3 mtp-105 -126.42 140.77 52.23 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.857 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.72 148.65 47.93 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 120.874 0.369 . . . . 0.0 111.28 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 3.6 pt -135.94 141.33 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.97 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.469 ' N ' ' O ' ' A' ' 48' ' ' LYS . 39.6 t80 -123.64 131.7 53.68 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 120.989 0.423 . . . . 0.0 111.135 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.17 44.25 15.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.902 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 81.1 -20.64 6.54 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.469 ' O ' ' N ' ' A' ' 45' ' ' PHE . 20.6 mtpt -79.58 138.46 37.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.144 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -92.06 121.49 33.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.726 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.873 HD22 HD11 ' A' ' 56' ' ' LEU . 67.3 mt -76.29 106.04 7.69 Favored 'General case' 0 CA--C 1.535 0.365 0 N-CA-C 107.991 -1.114 . . . . 0.0 107.991 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.816 ' O ' HD12 ' A' ' 23' ' ' ILE . 4.1 mt-10 -69.13 -168.94 0.16 Allowed 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 116.961 2.208 . . . . 0.0 116.961 -175.476 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 31.7 t0 -46.79 5.99 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 111.644 -2.526 . . . . 0.0 115.159 -178.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.506 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 116.88 45.47 0.55 Allowed Glycine 0 C--N 1.318 -0.461 0 C-N-CA 119.777 -1.201 . . . . 0.0 112.69 -176.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.08 156.75 26.92 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 102.142 -3.281 . . . . 0.0 102.142 172.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.509 HG23 ' HA ' ' A' ' 20' ' ' SER . 1.2 m -77.87 140.91 39.37 Favored 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 116.382 -2.127 . . . . 0.0 110.52 -177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.873 HD11 HD22 ' A' ' 50' ' ' LEU . 2.9 mp -76.35 -30.06 57.46 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.377 -1.283 . . . . 0.0 112.726 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.824 ' N ' ' O ' ' A' ' 19' ' ' PRO . 6.2 t -54.77 -32.8 60.53 Favored 'General case' 0 CA--C 1.503 -0.837 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' H ' HG22 ' A' ' 55' ' ' THR . 30.9 t70 -72.66 -26.0 61.47 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 114.778 -1.101 . . . . 0.0 109.176 177.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.521 ' N ' ' O ' ' A' ' 56' ' ' LEU . 7.9 m-85 -79.29 4.85 13.91 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.233 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 52.73 44.64 29.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.517 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.65 HG13 HD23 ' A' ' 56' ' ' LEU . 35.3 mm -64.6 137.56 24.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 CA-C-O 121.719 0.771 . . . . 0.0 109.669 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.733 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.9 pt20 -101.78 -173.97 2.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.304 -1.316 . . . . 0.0 113.975 -176.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.672 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 3.4 ttpm? -41.74 28.66 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 111.867 -2.424 . . . . 0.0 115.07 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.733 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.2 pt-20 91.35 54.59 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 CA-C-O 122.846 1.308 . . . . 0.0 112.874 -178.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.427 ' O ' ' HB3' ' A' ' 4' ' ' PHE . 0.3 OUTLIER -61.63 153.77 26.99 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 113.383 -1.735 . . . . 0.0 111.384 177.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.434 ' C ' HD12 ' A' ' 67' ' ' LEU . 10.3 m -85.51 123.86 31.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.85 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.509 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.9 mp -98.41 136.79 38.04 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.492 ' N ' ' CD2' ' A' ' 68' ' ' HIS . 0.5 OUTLIER -83.25 135.48 34.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.991 0.424 . . . . 0.0 110.875 -179.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.641 HD11 ' CG1' ' A' ' 5' ' ' VAL . 42.3 mt -111.88 128.18 56.06 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.108 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.18 154.37 23.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.103 0.478 . . . . 0.0 110.667 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 6.3 tp -149.09 119.65 7.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.046 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 9.8 mmm180 . . . . . 0 C--O 1.219 -0.547 0 CA-C-O 118.03 -0.986 . . . . 0.0 110.418 -179.608 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.0 tpp . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.438 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 59.9 mt-30 -86.21 165.25 16.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.701 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.636 HD11 HD23 ' A' ' 56' ' ' LEU . 0.8 OUTLIER -120.41 156.42 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 178.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.57 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 2.7 t80 -140.89 132.72 27.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.242 -179.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.57 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 79.6 t -129.84 142.39 43.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.243 179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -122.44 121.33 36.35 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.867 0.365 . . . . 0.0 110.304 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.2 p -84.17 175.1 9.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.62 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.556 ' N ' HD12 ' A' ' 8' ' ' LEU . 9.9 mp -69.95 -10.04 57.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.443 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 60.9 p -91.8 -4.19 55.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.317 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.21 0.24 82.25 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 179.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -65.0 131.52 46.82 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.205 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.45 116.23 28.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.42 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.558 HD11 ' CB ' ' A' ' 33' ' ' LYS . 13.6 tt -120.07 122.53 68.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.364 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.488 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 10.1 p -116.0 139.95 49.75 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.738 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.99 148.1 37.5 Favored 'General case' 0 CA--C 1.514 -0.413 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -94.25 109.78 21.57 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.82 HG21 ' OD1' ' A' ' 21' ' ' ASP . 9.6 p -150.36 171.6 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 CA-C-N 114.845 -1.07 . . . . 0.0 111.864 -177.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.772 ' N ' HG22 ' A' ' 17' ' ' VAL . 1.6 pm0 -93.99 174.29 3.91 Favored Pre-proline 0 N--CA 1.449 -0.523 0 N-CA-C 106.492 -1.669 . . . . 0.0 106.492 176.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.615 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.9 Cg_exo -74.16 -5.91 17.67 Favored 'Trans proline' 0 C--N 1.298 -2.124 0 C-N-CA 121.293 1.329 . . . . 0.0 111.768 -179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.566 ' HA ' ' H ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.32 -28.73 57.02 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 116.226 -2.19 . . . . 0.0 105.764 179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.82 ' OD1' HG21 ' A' ' 17' ' ' VAL . 3.4 m-20 32.71 64.96 0.25 Allowed 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 118.225 -0.893 . . . . 0.0 112.026 168.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.664 ' O ' ' N ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -84.68 137.7 33.09 Favored 'General case' 0 C--N 1.31 -1.143 0 C-N-CA 115.849 -2.34 . . . . 0.0 107.375 -175.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.613 ' N ' HD13 ' A' ' 23' ' ' ILE . 1.1 mm -53.07 -40.98 40.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.823 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.311 -174.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -59.86 -33.12 71.39 Favored 'General case' 0 N--CA 1.44 -0.954 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 175.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.634 ' HB3' ' O ' ' A' ' 22' ' ' THR . 13.6 t-20 -78.79 -46.55 18.54 Favored 'General case' 0 C--N 1.342 0.277 0 CA-C-N 114.398 -1.274 . . . . 0.0 112.78 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.664 ' N ' ' O ' ' A' ' 22' ' ' THR . 12.4 t -73.51 -35.3 44.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.146 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' NZ ' HD21 ' A' ' 43' ' ' LEU . 1.6 mmtm -54.3 -51.88 63.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.95 -178.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -60.39 -35.6 76.14 Favored 'General case' 0 C--N 1.319 -0.73 0 C-N-CA 120.171 -0.612 . . . . 0.0 110.004 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -61.31 -36.01 78.94 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.53 HG12 ' O ' ' A' ' 26' ' ' VAL . 13.7 mm -63.46 -45.87 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 120.684 -0.407 . . . . 0.0 110.696 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.434 ' O ' ' O ' ' A' ' 34' ' ' GLU . 24.6 tt0 -69.23 -31.96 70.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.022 0.439 . . . . 0.0 111.062 179.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -57.67 -41.67 82.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.347 -177.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.558 ' CB ' HD11 ' A' ' 13' ' ' ILE . 14.6 mmtp -64.45 -54.42 32.89 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.244 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.434 ' O ' ' O ' ' A' ' 31' ' ' GLN . 6.9 mt-10 -141.22 171.69 13.71 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -78.39 112.14 3.41 Favored Glycine 0 CA--C 1.508 -0.4 0 C-N-CA 118.647 -1.739 . . . . 0.0 110.551 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.0 tt -153.85 122.0 3.03 Favored Pre-proline 0 C--N 1.307 -1.258 0 N-CA-C 104.849 -2.278 . . . . 0.0 104.849 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -66.84 126.23 14.97 Favored 'Trans proline' 0 C--N 1.292 -2.404 0 CA-C-N 119.392 0.819 . . . . 0.0 111.404 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -64.25 -45.56 9.5 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.649 2.233 . . . . 0.0 112.62 -179.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -59.96 -27.01 66.46 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.448 -179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 40' ' ' GLN . 0.0 OUTLIER -97.68 9.2 43.16 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.307 -179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.608 HE22 ' CD2' ' A' ' 69' ' ' LEU . 2.1 tm0? -112.12 126.76 55.53 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.226 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.741 ' C ' HD23 ' A' ' 43' ' ' LEU . 0.9 OUTLIER -129.48 138.1 51.2 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.107 179.085 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.741 HD23 ' C ' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -131.55 159.5 38.02 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.709 0.29 . . . . 0.0 110.265 179.376 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.559 HG22 ' O ' ' A' ' 68' ' ' HIS . 7.6 tt -136.4 140.34 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.352 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.458 ' O ' ' N ' ' A' ' 48' ' ' LYS . 6.5 t80 -128.57 134.68 48.69 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.822 0.344 . . . . 0.0 111.111 -179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.11 33.9 2.63 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.925 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.6 -21.0 11.78 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 45' ' ' PHE . 5.8 mtmm -80.52 115.33 19.99 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -71.05 121.51 18.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.64 -178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.959 HD22 HD11 ' A' ' 56' ' ' LEU . 64.4 mt -77.4 114.07 15.85 Favored 'General case' 0 CA--C 1.536 0.435 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.601 ' O ' HG13 ' A' ' 23' ' ' ILE . 16.9 mt-10 -87.95 -167.69 1.97 Allowed 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -174.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -45.65 8.51 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 111.902 -2.408 . . . . 0.0 114.706 -179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.576 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 119.68 44.62 0.46 Allowed Glycine 0 C--N 1.318 -0.451 0 C-N-CA 120.266 -0.969 . . . . 0.0 112.161 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.46 150.22 28.41 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 102.733 -3.062 . . . . 0.0 102.733 172.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.2 m -79.41 141.18 37.08 Favored 'General case' 0 C--N 1.316 -0.86 0 C-N-CA 116.912 -1.915 . . . . 0.0 111.364 -177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.959 HD11 HD22 ' A' ' 50' ' ' LEU . 3.9 mp -78.06 -31.7 50.39 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.802 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.615 ' N ' ' O ' ' A' ' 19' ' ' PRO . 5.8 t -54.38 -31.59 55.15 Favored 'General case' 0 CA--C 1.506 -0.725 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 -179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.8 m-20 -72.36 -30.26 64.54 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 114.645 -1.161 . . . . 0.0 108.649 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.567 ' N ' ' O ' ' A' ' 56' ' ' LEU . 6.7 m-85 -79.06 5.36 12.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 179.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.2 t30 52.18 45.02 29.12 Favored 'General case' 0 N--CA 1.453 -0.279 0 CA-C-N 115.177 -0.919 . . . . 0.0 110.306 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.696 HG13 HD23 ' A' ' 56' ' ' LEU . 24.8 mm -64.8 138.1 23.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 122.173 0.987 . . . . 0.0 110.636 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.68 ' O ' ' N ' ' A' ' 64' ' ' GLU . 4.0 pt20 -100.72 -173.31 2.36 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 113.366 -1.743 . . . . 0.0 113.899 -176.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.786 ' O ' ' CG ' ' A' ' 64' ' ' GLU . 56.8 mttm -41.24 28.66 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 111.681 -2.509 . . . . 0.0 115.749 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.786 ' CG ' ' O ' ' A' ' 63' ' ' LYS . 0.0 OUTLIER 92.94 55.04 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.129 0 CA-C-O 122.859 1.314 . . . . 0.0 113.271 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 1.7 p -60.55 154.74 20.23 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 112.87 -1.968 . . . . 0.0 111.766 177.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.438 ' C ' HD12 ' A' ' 67' ' ' LEU . 0.0 OUTLIER -85.63 126.75 34.16 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.665 179.367 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.488 ' N ' ' CD1' ' A' ' 67' ' ' LEU . 6.5 mp -98.93 134.37 41.88 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.312 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.559 ' O ' HG22 ' A' ' 44' ' ' ILE . 6.3 t-80 -85.84 132.48 34.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.923 0.392 . . . . 0.0 110.218 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.608 ' CD2' HE22 ' A' ' 41' ' ' GLN . 12.6 mt -87.0 164.54 16.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.591 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 15.8 m -121.18 161.17 21.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.901 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.418 ' O ' ' O ' ' A' ' 72' ' ' ARG . 9.3 mt -47.07 -71.93 0.06 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.464 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.497 ' HE ' HH12 ' A' ' 42' ' ' ARG . 87.5 mtm-85 . . . . . 0 C--O 1.221 -0.443 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.578 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpp? . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -85.24 164.42 18.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.512 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.593 HD12 ' CG ' ' A' ' 21' ' ' ASP . 1.6 mt -121.11 152.44 24.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-O 121.397 0.617 . . . . 0.0 110.817 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.17 133.64 31.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.975 -1.011 . . . . 0.0 109.903 -179.07 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.526 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 89.5 t -123.82 144.24 34.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 111.133 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.701 ' O ' HD11 ' A' ' 69' ' ' LEU . 19.7 tttm -100.58 139.57 36.07 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 16.2 p -115.95 161.21 19.17 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.577 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.835 HD22 ' H ' ' A' ' 8' ' ' LEU . 0.7 OUTLIER -68.99 -4.01 15.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.262 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -92.07 -14.01 29.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.492 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 79.55 15.16 80.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 9.0 tttp -94.0 130.94 39.94 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.854 0.359 . . . . 0.0 110.263 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.421 HG22 ' H ' ' A' ' 12' ' ' THR . 1.7 t -76.82 120.21 21.66 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.539 HG23 ' O ' ' A' ' 13' ' ' ILE . 10.0 tt -116.37 117.95 57.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.888 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.787 ' C ' HD23 ' A' ' 15' ' ' LEU . 1.4 p -115.73 135.56 53.92 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.275 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.787 HD23 ' C ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -115.21 147.55 40.2 Favored 'General case' 0 CA--C 1.515 -0.4 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.251 -179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -95.63 109.4 21.67 Favored 'General case' 0 N--CA 1.448 -0.559 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.778 HG22 ' N ' ' A' ' 18' ' ' GLU . 10.6 p -149.95 174.19 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.953 -176.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.778 ' N ' HG22 ' A' ' 17' ' ' VAL . 0.6 OUTLIER -109.27 155.06 41.74 Favored Pre-proline 0 N--CA 1.451 -0.395 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.355 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.826 ' O ' ' N ' ' A' ' 57' ' ' SER . 2.2 Cg_endo -49.77 -7.96 0.1 Allowed 'Trans proline' 0 C--N 1.29 -2.512 0 C-N-CA 121.725 1.617 . . . . 0.0 113.348 -178.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.576 ' O ' ' N ' ' A' ' 56' ' ' LEU . 66.1 m -75.81 -28.81 58.46 Favored 'General case' 0 CA--C 1.501 -0.941 0 C-N-CA 114.992 -2.683 . . . . 0.0 105.553 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.745 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.7 OUTLIER 30.53 64.65 0.16 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 117.892 -1.052 . . . . 0.0 111.682 168.356 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.635 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -82.56 135.35 35.11 Favored 'General case' 0 C--N 1.309 -1.162 0 C-N-CA 114.683 -2.807 . . . . 0.0 106.586 -175.567 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.877 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.3 OUTLIER -54.88 -31.1 24.06 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.831 0 CA-C-N 112.624 -2.08 . . . . 0.0 110.709 -173.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.49 -29.83 67.57 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.129 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.635 ' N ' ' O ' ' A' ' 22' ' ' THR . 1.6 t-20 -78.23 -44.47 25.52 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 113.792 -1.549 . . . . 0.0 111.951 178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' THR . 64.1 t -72.23 -34.72 50.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.27 -178.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -53.64 -51.94 61.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.143 -178.651 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.413 ' O ' ' OD1' ' A' ' 32' ' ' ASP . . . -61.02 -35.07 75.89 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.139 -0.624 . . . . 0.0 109.7 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -62.17 -36.86 83.14 Favored 'General case' 0 C--N 1.333 -0.113 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.683 HG21 ' HG2' ' A' ' 41' ' ' GLN . 30.4 mm -62.78 -37.05 78.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -70.54 -35.77 73.31 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' OD1' ' O ' ' A' ' 28' ' ' ALA . 4.9 m-20 -62.78 -44.35 96.42 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -177.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 39.0 mmtm -61.45 -54.28 45.5 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 120.374 -0.531 . . . . 0.0 111.25 -178.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -138.32 168.34 19.95 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -79.03 111.32 3.22 Favored Glycine 0 CA--C 1.507 -0.436 0 C-N-CA 118.382 -1.866 . . . . 0.0 110.187 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -153.69 118.25 2.75 Favored Pre-proline 0 C--N 1.308 -1.225 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 177.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -66.05 128.3 19.38 Favored 'Trans proline' 0 C--N 1.291 -2.478 0 N-CA-C 109.802 -0.884 . . . . 0.0 109.802 -179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -60.21 -27.51 85.03 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 121.845 1.697 . . . . 0.0 112.195 -178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . 0.43 ' OD1' ' N ' ' A' ' 39' ' ' ASP . 0.4 OUTLIER -67.58 -27.93 67.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.916 0.388 . . . . 0.0 110.374 179.792 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -93.98 -13.05 27.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.449 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.683 ' HG2' HG21 ' A' ' 30' ' ' ILE . 6.7 tp-100 -81.09 139.66 35.53 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.133 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' O ' HD12 ' A' ' 43' ' ' LEU . 2.3 tpt85 -124.45 136.59 54.16 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.379 179.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 HD12 ' O ' ' A' ' 42' ' ' ARG . 4.5 mp -125.05 130.95 53.34 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.842 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 19.2 mt -135.67 142.15 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.1 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.405 ' O ' ' N ' ' A' ' 48' ' ' LYS . 7.2 t80 -144.68 137.69 26.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.915 0.388 . . . . 0.0 111.199 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.51 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.04 44.48 15.05 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.739 179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 72.39 -19.71 1.06 Allowed Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.826 -0.909 . . . . 0.0 110.826 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.51 ' H ' ' C ' ' A' ' 46' ' ' ALA . 5.7 mtmt -83.4 124.98 31.2 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.07 0.462 . . . . 0.0 110.828 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.709 ' NE2' ' H ' ' A' ' 49' ' ' GLN . 0.9 OUTLIER -79.55 126.43 30.87 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.379 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.647 ' HB3' HD13 ' A' ' 23' ' ' ILE . 14.0 mt -76.44 129.26 36.29 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.877 ' O ' HD12 ' A' ' 23' ' ' ILE . 17.4 mt-10 -87.26 -169.56 2.67 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 116.745 2.128 . . . . 0.0 116.745 -174.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -48.51 5.76 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 111.806 -2.452 . . . . 0.0 114.837 -179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.51 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 117.9 45.35 0.51 Allowed Glycine 0 C--N 1.321 -0.287 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.241 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.605 ' NH2' ' H ' ' A' ' 55' ' ' THR . 0.1 OUTLIER -80.37 159.3 25.77 Favored 'General case' 0 CA--C 1.506 -0.729 0 N-CA-C 102.943 -2.984 . . . . 0.0 102.943 173.432 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.605 ' H ' ' NH2' ' A' ' 54' ' ' ARG . 1.0 OUTLIER -78.45 139.45 38.71 Favored 'General case' 0 C--N 1.32 -0.685 0 C-N-CA 116.341 -2.144 . . . . 0.0 109.52 -178.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.796 HD23 HG13 ' A' ' 61' ' ' ILE . 5.0 mp -77.41 -28.93 52.85 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.683 -1.144 . . . . 0.0 112.689 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.826 ' N ' ' O ' ' A' ' 19' ' ' PRO . 3.6 t -53.51 -30.14 39.96 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 -179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 55' ' ' THR . 74.4 m-20 -73.36 -28.08 61.84 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.023 176.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.597 ' N ' ' O ' ' A' ' 56' ' ' LEU . 13.6 m-85 -78.9 2.07 21.41 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.341 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 17.3 m120 52.94 46.09 27.49 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.644 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.796 HG13 HD23 ' A' ' 56' ' ' LEU . 33.8 mm -63.71 139.1 21.86 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.149 0 CA-C-O 121.87 0.843 . . . . 0.0 110.67 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.739 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 24.1 tt0 -96.92 -179.37 4.54 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 113.781 -1.554 . . . . 0.0 114.214 -175.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.739 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 6.1 mtpm? -43.28 30.9 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 112.353 -2.203 . . . . 0.0 115.001 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.689 ' N ' ' O ' ' A' ' 62' ' ' GLN . 1.6 mt-10 91.02 52.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.166 0.984 . . . . 0.0 111.498 -176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.45 ' O ' ' O ' ' A' ' 4' ' ' PHE . 0.5 OUTLIER -62.89 152.11 37.3 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 113.725 -1.58 . . . . 0.0 110.194 177.643 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.01 123.45 32.12 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.414 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.3 mp -100.91 144.96 29.22 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 120.815 0.34 . . . . 0.0 110.453 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 71.6 m-70 -98.54 147.26 24.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 109.931 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.991 ' H ' HD12 ' A' ' 69' ' ' LEU . 0.0 OUTLIER -112.69 136.93 51.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.347 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 71' ' ' LEU . 2.2 t -146.13 163.37 10.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.316 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.47 ' CB ' ' O ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER 80.01 111.81 0.07 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.424 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 13.4 ptt180 . . . . . 0 C--O 1.219 -0.518 0 CA-C-O 117.965 -1.017 . . . . 0.0 110.628 -179.839 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' SD ' ' O ' ' A' ' 61' ' ' ILE . 15.0 mtt . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.696 ' O ' ' HA ' ' A' ' 64' ' ' GLU . 2.6 mt-30 -75.55 165.72 24.67 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.551 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.531 ' O ' ' HG ' ' A' ' 15' ' ' LEU . 12.7 mt -140.97 142.51 29.83 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.807 179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 4' ' ' PHE . 0.2 OUTLIER -141.01 133.99 29.18 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.475 0.655 . . . . 0.0 110.945 179.8 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.504 ' O ' HG22 ' A' ' 13' ' ' ILE . 2.7 t -109.54 131.1 61.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.107 -0.951 . . . . 0.0 111.283 -178.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -107.53 124.84 50.51 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.63 0.252 . . . . 0.0 110.449 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.11 158.65 15.33 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.754 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.1 -3.66 1.88 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.194 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.3 p -90.54 6.99 41.31 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.475 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 70.73 16.83 74.54 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.159 -0.777 . . . . 0.0 111.159 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 13.1 tptt -98.24 123.43 42.31 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.704 0.287 . . . . 0.0 110.754 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.8 t -100.69 120.39 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.149 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.696 HG23 ' O ' ' A' ' 13' ' ' ILE . 20.5 tt -117.49 110.12 29.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.228 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.667 ' C ' HD23 ' A' ' 15' ' ' LEU . 9.3 t -101.07 138.15 38.48 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.138 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.682 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.34 146.49 40.46 Favored 'General case' 0 CA--C 1.515 -0.403 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 -179.962 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.495 ' OE1' ' NE2' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -95.3 109.49 21.62 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.642 HG22 ' O ' ' A' ' 18' ' ' GLU . 10.0 p -150.07 162.96 3.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.726 -177.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.688 ' CD ' ' H ' ' A' ' 18' ' ' GLU . 1.4 mp0 -84.38 177.84 2.74 Favored Pre-proline 0 N--CA 1.448 -0.552 0 N-CA-C 105.977 -1.86 . . . . 0.0 105.977 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.616 ' O ' ' OD1' ' A' ' 21' ' ' ASP . 4.0 Cg_exo -73.76 -6.74 19.12 Favored 'Trans proline' 0 C--N 1.293 -2.387 0 C-N-CA 121.611 1.541 . . . . 0.0 111.786 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.733 ' HA ' ' H ' ' A' ' 57' ' ' SER . 8.0 t -80.28 -27.21 38.58 Favored 'General case' 0 N--CA 1.443 -0.823 0 C-N-CA 116.386 -2.125 . . . . 0.0 107.863 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.955 ' O ' HD13 ' A' ' 56' ' ' LEU . 0.0 OUTLIER 33.36 68.76 0.15 Allowed 'General case' 0 CA--C 1.507 -0.701 0 CA-C-O 117.698 -1.144 . . . . 0.0 111.955 170.213 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.556 ' O ' ' N ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -79.83 132.71 36.18 Favored 'General case' 0 C--N 1.311 -1.08 0 C-N-CA 114.437 -2.905 . . . . 0.0 105.297 -175.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.872 HD12 ' O ' ' A' ' 51' ' ' GLU . 0.9 OUTLIER -55.47 -37.99 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 112.878 -1.964 . . . . 0.0 111.557 -172.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -59.35 -31.15 68.93 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.556 ' N ' ' O ' ' A' ' 22' ' ' THR . 5.0 t-20 -78.83 -44.65 22.55 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.043 178.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' THR . 14.4 t -72.37 -49.21 43.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 120.776 -0.369 . . . . 0.0 111.476 -178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.679 ' CG ' HG22 ' A' ' 23' ' ' ILE . 10.4 mmmm -55.18 -35.33 64.7 Favored 'General case' 0 CA--C 1.512 -0.498 0 C-N-CA 120.305 -0.558 . . . . 0.0 109.586 -179.641 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -68.44 -35.84 78.17 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.7 mttm -65.91 -36.92 84.71 Favored 'General case' 0 C--O 1.231 0.11 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.419 HG21 HE21 ' A' ' 41' ' ' GLN . 32.6 mm -63.25 -42.01 94.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.109 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' O ' ' O ' ' A' ' 34' ' ' GLU . 51.8 tt0 -69.91 -34.22 73.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.732 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -59.83 -45.49 92.23 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.128 -178.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' CB ' HD11 ' A' ' 13' ' ' ILE . 23.2 mmtp -67.19 -52.9 35.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.138 0.494 . . . . 0.0 110.094 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.497 ' O ' ' O ' ' A' ' 31' ' ' GLN . 77.6 tt0 -129.01 153.81 47.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -76.95 113.89 3.91 Favored Glycine 0 CA--C 1.506 -0.523 0 C-N-CA 118.863 -1.637 . . . . 0.0 110.276 -179.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.647 HD13 ' HD2' ' A' ' 37' ' ' PRO . 0.4 OUTLIER -151.96 120.23 3.31 Favored Pre-proline 0 C--N 1.311 -1.089 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 178.228 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.647 ' HD2' HD13 ' A' ' 36' ' ' ILE . 3.1 Cg_exo -69.83 130.66 19.64 Favored 'Trans proline' 0 C--N 1.295 -2.268 0 CA-C-N 119.458 0.842 . . . . 0.0 110.976 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -49.68 -40.44 46.91 Favored 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 122.364 2.042 . . . . 0.0 112.222 -178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -59.49 -29.22 67.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.283 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -98.89 7.85 45.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.779 0.323 . . . . 0.0 110.491 -179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.662 ' O ' ' CE ' ' A' ' 27' ' ' LYS . 3.9 tp-100 -121.64 129.38 52.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -131.21 142.52 50.19 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.022 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.6 mt -124.04 146.5 48.51 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.407 HG21 HD13 ' A' ' 44' ' ' ILE . 7.5 pt -135.92 142.56 38.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.177 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.47 179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.415 ' CD1' ' C ' ' A' ' 45' ' ' PHE . 1.0 OUTLIER -124.67 115.84 21.42 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 120.932 0.396 . . . . 0.0 111.51 -179.114 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 46.74 42.5 11.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.427 178.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.2 -21.2 32.59 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 111.503 -0.639 . . . . 0.0 111.503 179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 15.9 mtmt -80.78 115.22 20.16 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -79.36 122.34 26.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.477 -178.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.637 ' HB3' HD13 ' A' ' 23' ' ' ILE . 42.1 mt -79.55 130.61 35.55 Favored 'General case' 0 CA--C 1.537 0.468 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.872 ' O ' HD12 ' A' ' 23' ' ' ILE . 17.2 mt-10 -95.35 -169.47 1.98 Allowed 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 -174.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -47.42 7.61 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 111.926 -2.397 . . . . 0.0 114.432 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 51' ' ' GLU . . . 118.98 44.46 0.49 Allowed Glycine 0 N--CA 1.461 0.325 0 C-N-CA 120.368 -0.92 . . . . 0.0 112.134 -176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.5 mtt180 -81.52 153.76 26.63 Favored 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 102.599 -3.111 . . . . 0.0 102.599 172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.419 HG22 ' H ' ' A' ' 58' ' ' ASP . 1.9 m -78.45 141.16 38.48 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 116.402 -2.119 . . . . 0.0 110.336 -178.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.955 HD13 ' O ' ' A' ' 21' ' ' ASP . 6.7 mp -76.7 -31.58 57.32 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.703 -1.135 . . . . 0.0 112.22 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.733 ' H ' ' HA ' ' A' ' 20' ' ' SER . 4.3 t -55.59 -33.28 63.8 Favored 'General case' 0 CA--C 1.505 -0.756 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.419 ' H ' HG22 ' A' ' 55' ' ' THR . 15.6 t70 -71.35 -25.6 62.46 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.437 176.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 56' ' ' LEU . 4.0 m-85 -79.93 1.11 28.58 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.591 179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.22 44.18 22.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.309 -179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.87 HG13 HD23 ' A' ' 56' ' ' LEU . 16.5 mm -65.57 138.92 22.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 121.98 0.895 . . . . 0.0 110.254 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.743 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 30.6 tt0 -96.24 -178.35 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 113.684 -1.598 . . . . 0.0 113.732 -176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.743 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 19.0 ttpt -43.27 29.98 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 112.544 -2.116 . . . . 0.0 114.889 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.717 ' N ' ' O ' ' A' ' 62' ' ' GLN . 19.5 tt0 92.37 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.958 0.885 . . . . 0.0 112.59 -177.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.15 154.93 25.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 113.677 -1.601 . . . . 0.0 109.774 176.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.557 ' O ' HG23 ' A' ' 66' ' ' THR . 9.3 t -86.62 125.08 33.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.898 0.38 . . . . 0.0 111.874 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.651 ' N ' HD12 ' A' ' 67' ' ' LEU . 6.1 mp -98.86 138.82 35.45 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 2.9 t60 -83.56 138.87 33.2 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.99 0.424 . . . . 0.0 111.529 -178.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.592 HD13 ' N ' ' A' ' 70' ' ' VAL . 0.2 OUTLIER -118.73 124.05 46.35 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.075 179.756 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.592 ' N ' HD13 ' A' ' 69' ' ' LEU . 30.9 t -120.52 162.14 19.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.612 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.523 ' N ' HG12 ' A' ' 70' ' ' VAL . 9.7 mt -38.32 -56.71 1.2 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.723 179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? . . . . . 0 C--O 1.219 -0.506 0 CA-C-O 117.953 -1.023 . . . . 0.0 110.336 179.845 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 tpt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 23.2 mt-30 -98.27 166.45 11.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.86 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.768 HD11 HD23 ' A' ' 56' ' ' LEU . 1.2 mt -118.52 158.78 19.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.373 0 CA-C-O 121.822 0.82 . . . . 0.0 111.003 -179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -139.33 135.02 33.31 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.174 -1.376 . . . . 0.0 109.641 -179.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.588 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 12.1 t -130.67 143.77 39.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.836 0.351 . . . . 0.0 111.052 -179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 13.5 ptmt -102.3 133.49 47.11 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.246 179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.6 p -85.61 163.83 18.09 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.93 -0.308 . . . . 0.0 110.619 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.431 ' C ' HD12 ' A' ' 8' ' ' LEU . 3.8 pp -70.0 -10.82 59.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.499 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.4 m -96.39 -15.12 22.0 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.335 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 103.21 -6.51 50.63 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.678 -0.969 . . . . 0.0 110.678 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -70.29 124.75 24.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.721 0.296 . . . . 0.0 110.304 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 5.8 p -80.19 115.55 19.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.905 0.383 . . . . 0.0 110.891 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.634 HG23 ' O ' ' A' ' 13' ' ' ILE . 11.9 tt -110.72 112.24 39.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.911 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.709 ' C ' HD23 ' A' ' 15' ' ' LEU . 24.0 p -104.05 139.62 38.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.07 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.81 ' N ' HD23 ' A' ' 15' ' ' LEU . 0.0 OUTLIER -114.16 143.68 44.41 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.254 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -95.59 109.43 21.67 Favored 'General case' 0 CA--C 1.51 -0.592 0 N-CA-C 107.489 -1.3 . . . . 0.0 107.489 179.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.771 HG22 ' N ' ' A' ' 18' ' ' GLU . 8.9 p -151.02 171.31 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.66 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.04 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.771 ' N ' HG22 ' A' ' 17' ' ' VAL . 3.3 pm0 -92.13 174.68 3.96 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 106.468 -1.679 . . . . 0.0 106.468 176.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.571 ' O ' ' N ' ' A' ' 57' ' ' SER . 3.3 Cg_exo -73.59 -6.49 18.8 Favored 'Trans proline' 0 C--N 1.298 -2.083 0 C-N-CA 121.237 1.291 . . . . 0.0 112.35 -179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.721 ' HA ' ' H ' ' A' ' 57' ' ' SER . 89.8 p -78.03 -27.64 48.84 Favored 'General case' 0 CA--C 1.502 -0.875 0 C-N-CA 116.296 -2.162 . . . . 0.0 107.173 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.881 ' HB3' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER 32.92 69.76 0.12 Allowed 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 117.99 -1.005 . . . . 0.0 112.557 168.784 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.56 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 0.0 OUTLIER -80.55 135.93 36.18 Favored 'General case' 0 C--N 1.309 -1.18 0 C-N-CA 115.07 -2.652 . . . . 0.0 106.15 -175.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.818 HG22 ' HD3' ' A' ' 27' ' ' LYS . 0.5 OUTLIER -54.71 -46.75 73.94 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.486 0 CA-C-N 113.318 -1.765 . . . . 0.0 111.077 -173.296 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -57.71 -29.21 64.52 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' A' ' 22' ' ' THR . 0.4 OUTLIER -77.88 -39.46 43.15 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 113.972 -1.467 . . . . 0.0 112.181 178.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.559 ' N ' ' O ' ' A' ' 22' ' ' THR . 36.2 t -72.47 -48.53 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 113.577 0.954 . . . . 0.0 113.577 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.818 ' HD3' HG22 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -56.39 -41.69 76.7 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 120.234 -0.586 . . . . 0.0 110.522 -178.328 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -55.4 -38.09 68.44 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 108.695 -0.854 . . . . 0.0 108.695 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mttm -67.59 -37.78 83.07 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 177.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 26' ' ' VAL . 27.5 mm -67.7 -32.23 55.84 Favored 'Isoleucine or valine' 0 C--N 1.339 0.127 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.634 178.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.449 ' N ' ' O ' ' A' ' 27' ' ' LYS . 7.4 tt0 -68.95 -33.37 73.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.669 179.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -58.91 -45.22 90.84 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.539 ' CB ' HD11 ' A' ' 13' ' ' ILE . 19.3 mmtp -70.03 -53.91 15.48 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.509 -0.477 . . . . 0.0 110.2 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -130.82 155.02 47.4 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -80.01 114.4 3.85 Favored Glycine 0 C--O 1.23 -0.102 0 C-N-CA 119.003 -1.57 . . . . 0.0 111.733 -178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.586 HG23 ' O ' ' A' ' 36' ' ' ILE . 6.0 tp -151.84 117.47 3.12 Favored Pre-proline 0 C--N 1.315 -0.894 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HG2' HE21 ' A' ' 40' ' ' GLN . 3.2 Cg_exo -71.54 137.36 30.29 Favored 'Trans proline' 0 C--N 1.294 -2.304 0 C-N-CA 121.362 1.374 . . . . 0.0 111.945 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -48.4 -36.01 29.5 Favored 'Trans proline' 0 N--CA 1.491 1.335 0 C-N-CA 122.605 2.203 . . . . 0.0 111.849 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -61.88 -25.93 67.85 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.527 -178.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.419 HE21 ' HG2' ' A' ' 37' ' ' PRO . 26.4 mt-30 -109.32 9.34 25.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.027 -0.269 . . . . 0.0 111.42 -179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' HB3' ' HZ3' ' A' ' 27' ' ' LYS . 25.4 tp60 -113.54 124.5 52.52 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.146 179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.472 ' H ' HE21 ' A' ' 41' ' ' GLN . 6.2 ptp85 -131.81 134.5 45.86 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.716 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 5.8 mt -122.88 159.32 28.44 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.007 0.432 . . . . 0.0 110.955 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 90.8 mt -135.8 143.8 35.36 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.252 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -144.54 128.92 17.91 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 120.949 0.404 . . . . 0.0 110.98 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.513 ' C ' ' H ' ' A' ' 48' ' ' LYS . . . 47.7 45.38 18.08 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.871 179.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.33 -20.45 1.24 Allowed Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.579 -1.008 . . . . 0.0 110.579 -179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.513 ' H ' ' C ' ' A' ' 46' ' ' ALA . 0.1 OUTLIER -77.41 124.21 27.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 179.572 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -81.79 122.45 27.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.943 0.402 . . . . 0.0 111.337 -179.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.089 HD22 HD11 ' A' ' 56' ' ' LEU . 73.1 mt -77.18 117.46 18.74 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 107.613 -1.255 . . . . 0.0 107.613 178.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.66 ' O ' HG21 ' A' ' 23' ' ' ILE . 15.7 mt-10 -92.83 -168.02 1.86 Allowed 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -174.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -46.69 7.09 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 111.325 -2.671 . . . . 0.0 115.481 -179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.52 ' HA2' HG12 ' A' ' 23' ' ' ILE . . . 118.82 43.14 0.54 Allowed Glycine 0 C--N 1.318 -0.456 0 C-N-CA 119.967 -1.111 . . . . 0.0 112.193 -176.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.451 ' CZ ' ' OE1' ' A' ' 51' ' ' GLU . 36.6 mtt85 -82.59 152.46 25.93 Favored 'General case' 0 CA--C 1.51 -0.579 0 N-CA-C 103.338 -2.838 . . . . 0.0 103.338 173.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . 0.463 HG22 ' H ' ' A' ' 58' ' ' ASP . 0.9 OUTLIER -78.31 141.69 38.29 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 116.878 -1.929 . . . . 0.0 109.989 -178.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.089 HD11 HD22 ' A' ' 50' ' ' LEU . 3.3 mp -76.42 -30.71 57.54 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.703 -1.135 . . . . 0.0 113.022 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.721 ' H ' ' HA ' ' A' ' 20' ' ' SER . 10.9 t -53.27 -30.69 39.85 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -178.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.463 ' H ' HG22 ' A' ' 55' ' ' THR . 3.1 t70 -73.4 -28.67 62.14 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 115.045 -0.98 . . . . 0.0 109.184 176.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 56' ' ' LEU . 9.4 m-85 -79.33 6.17 10.67 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.637 -0.711 . . . . 0.0 109.694 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.3 m120 51.65 44.75 28.97 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.539 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.694 HG13 HD23 ' A' ' 56' ' ' LEU . 34.7 mm -64.18 138.84 22.34 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 122.178 0.99 . . . . 0.0 111.09 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . 0.739 ' CG ' ' H ' ' A' ' 63' ' ' LYS . 47.3 tt0 -96.57 -179.76 4.72 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 113.355 -1.748 . . . . 0.0 113.195 -176.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.739 ' H ' ' CG ' ' A' ' 62' ' ' GLN . 3.5 ttpt -43.36 30.63 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 112.623 -2.08 . . . . 0.0 115.225 179.355 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.688 ' N ' ' O ' ' A' ' 62' ' ' GLN . 10.0 mt-10 91.73 54.17 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 122.181 0.991 . . . . 0.0 112.488 -177.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 36.0 p -61.7 156.9 18.99 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 113.667 -1.606 . . . . 0.0 110.585 177.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.7 m -82.53 126.52 32.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.918 0.39 . . . . 0.0 110.189 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.57 137.65 36.91 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.998 -179.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -91.64 137.45 32.36 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 120.994 0.426 . . . . 0.0 111.295 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.431 HD11 ' CG1' ' A' ' 5' ' ' VAL . 5.9 mp -121.45 167.36 12.9 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.409 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.501 ' C ' HD23 ' A' ' 71' ' ' LEU . 0.0 OUTLIER -130.52 157.14 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-O 120.939 0.399 . . . . 0.0 110.273 179.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.715 HD23 ' N ' ' A' ' 71' ' ' LEU . 1.0 OUTLIER -162.88 149.43 12.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.675 -179.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.4 tpp85 . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 117.957 -1.02 . . . . 0.0 110.776 179.951 . . . . . . . . 0 0 . 1 stop_ save_